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Abstract
Temporal and spatial regulation of nuclear transport of transcription
factors is important for regulating the function of many cellular and
developmental processes. Here the regulation of nuclear transport of a Xenopus
transcription factor, mesoderm induction-ear1y response 1, MI·ER1, was
investigated.
It was shown that MI-ER1 is actively transported to the cell n'uclei of
transfected NIH 3T3 cells as well as in Xenopus embryos. The active import of
MI·ER1 into the cell nuclei is dependent on the presence of an intact nuclear
localization signal (NLS) located in the C·terminus of the protein. The core of this
NLS consists of amino acids ~RPIKRaRM0471 but we show that addition of
amino acids flanking this region results in more efficient import into the cell
nuclei. It was also shown that an additional, albeit weak, NLS is present in the N-
terminus of MI-ER1.
During embryonic development in Xenopus Jaevis MI·ER1 is localized in
the cytoplasm by cytoplasmic retention, but localizes to the nucleus during the
mid-blastula stages. Investigation into the regulation of cytoplasmic retention of
MI-ERl in Xenopus laevis embryos, showed that the NLS (ER457-475) of MI-
ER1 is able to direct jl-GAl to the nucleus prematurely, which suggests that
cytoplasmic retention of MI-ERl is not dependent on NLS recognition and
binding by the import machinery.
Investigation of a phosphorylation site in the vicinity of this NLS shows,
that the regulation of nuclear transport of MI-ER1 in Xenopus 'aevis is not
regulated by phosphorylation of this cdc2 kinase! PKA site. FurthermOf'e, it is
shown that cytoplasmic retention of MI-ERl in embryos appears to be regUlated
by binding of MI-ER1 to an "anchor" molecule in the cytoplasm. It was shown that
the region important for cytoplasmic retention is localized between amino acid
residues 1 and 282.
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Chapter 1 Introduction
Transcription factors are essential for the initiation of RNA synthesis.
Initiation of transcription occurs when transcription factors bind to the promoter
and recruit other proteins of the transcription machinery. including RNA
polymerases. Temporal and spatial regulation of nuclear transport of transcription
factors is important for regulating the function of many cellular and
developmental processes (Nothias at a/., 1995). During Xenopus laevis
embryonic development, the genome ;s transcriptionally silent until a specific
stage in development. the mid-blastula transition. around the 12th cleavage
(Newport and Kirschner, 1982b; Shiokawa et a/., 1994). At this time transcription
factors are imported into the nucleus and transcription starts. Regulating the
timing of nuclear import of transcription factors is crucial for the development of
many organisms (Nothias et al., 1995).
Regulation of import can be modulated by phosphorylation of the
transported protein, masking of the nuclear localization signal(s), cytoplasmic
retention by binding to a cytoplasmic anchoring protein, modulation of the import
machinery, and possibly interplay between these mechanisms (Dingwall and
Laskey, 1986; Dingwall and Laskey, 1998; Gorlich and Kutay, 1999; Jans, 1995;
Jans and Hubner, 1996; Vandromme et al., 1996).
Here, I. investigate the regulation of nuclear transport of a Xenopus
transcription factor, mesoderm induction-early response 1, MI-ER1, an
immediate early gene activated by FGF signaling (Paterno at af., 1997). The
investigation of regulation of nuclear import of MI-ER1 in NIH 3T3 cells as well as
in Xenopus laevis embryos will be described in this thesis.
1.1 Regulation of Transcription in Xenopus laevls
Early stages of Xenopus development rely completely on maternal stores
of RNA and protein, which are produced during oogenesis (Smith at a/., 1991).
Transcription does not start until the so-called mid-blastula transition, about 7
hours after fertilization and when there are approximately 4000 cells (Newport
and Kirschner, 1982a). The early development of vertebrate and many
invertebrate species is characterized by a period during which the embryonic
genome is transcriptionally silent (Almouzni and Wotffe, 1995; Newport and
Kirschner, 1982a; Veenstra et a/., 1999). During this period, many proteins are
expressed in the embryo. This includes proteins that are stored during oogenesis
as well as proteins translated from mRNAs that are stored during oogenesis. The
developmental stage at which the major transcriptional activity starts ranges from
the 2-ce1l stage in the mouse to the 9-14 cycle in Drosophila. In nematodes and
amphibians the major activation of the embryonic genome starts after 7 cycles (in
C. a/agans) and 12 cycles. respectively (Nothias at al., 1995; Veenstra et al.,
1999; Yasuda and Schubiger, 1992).
1.1.1 Xenopus laevis embryonic: development
The Xenopus egg is 1.2-1.4 mm in diameter and consists of a darkly
pigmented animal hemisphere and a lighter yolky 'vegetal hemisphere'. When
laid, the eggs are oriented randomly with respect to gravity and held in position
by a transparent vitelline membrane inside a jelly coat (Jones and Smith, 1999).
After fertilization, granules located just below the surface of the egg fuse with the
plasma membrane and release their contents into the space between the vitelline
membrane and the egg, allowing the egg to rotate so that the less dense animal
hemisphere is on top. This rotation normally occurs within 20 min. after
fertilization (Jones and Smith, 1999). During fertilization, the sperm enters the
egg in the animal hemisphere. The position of sperm entry defines the future
dorsal-ventral axis of the embryo (Jones and Smith, 1999).
The earliest developmental stage of Xenopus embryogenesis consists of a
period of rapid cleavage divisions. These divisions are nearly synchronous for all
cells within the embryo and occur approximately every 35 minutes. This rapid
cleavage program ends abruptly after about 12 cleavages and is followed by the
activation of several new cell activities, called the mid-blastula transition
(Newport and Kirschner, 1982a). These include the desynchronization of the
embryonic cell cycles, elongation of the cell cycle as a result of the inclusion of
G1 and G2 phases and elongation of both Sand M phases; the onset of cell
motility and the activation of RNA transcription in all the cells of the embryo
(Newport and Kirschner, 1982a).
The first Xenopus cell cycle occupies approximately 90 min at 21°C;
subsequent cell cycles last about 30 min. (figure 1.1.1). The first cleavage in
Xenopus initiates at the animal pole and separates the future left and right-hand
sides of the embryo. The second cleavage, 30 min. later. occurs at right angles
to the first and separates the future dorsal and ventral halves. The third cleavage
is orthogonal and separates the animal and vegetal poles. In coritrast to the first
two divisions, which divide the cells into roughly equal pieces, the plane of the
third cleavage is well above the equator of the embryo. After the fourth and fifth
cleavages the embryo comprises 32 cells arranged in four tiers of eight cells,
which corresponds to stage 6 according to Nieuwkoop and Faber (figure 1.1.1;
(Nieuwkoop and Faber. 1967).
During the early cleavages a small space forms between the blastomeres
that becomes larger as cleavages proceed and eventually becomes the
blastocoel. At this time the embryo is referred to as blastula (Jones and Smith,
1999), a hollow ball of cells. At the twelfth cell division. the cleavage rate slows
down and cell division becomes asynchronous. This point, the mid-blastula
transition (MBT) is also marked by the onset of cell motility and zygotic
transcription (Masui and Wang, 1998; Newport and Kirschner, 1982b).
Figure 1.1.1 Xenopus laevis early embryonic development Is characterized by many
events.
A schematic illustrating Xenopus embryos during different stages of development, as
described by Nieuwkoop and Faber (1967). The animal pole is shown for embryos at
stages 1, 2, 6, 7, 8 and 13; the vegetal· pole is shown for stages 9 and 10 since
identification of these stages is easier detennined from the vegetal pole.
Different developmental milestones are indicated. Arrow indicates that MBT is an event
that cannot be detennined by morphology and takes place during stage 8-8.5.

The next important step in Xenopus development after MBT is
gastrulation. During gastrulation, the blastula is converted into a three-layered
structure with a central midline and bilateral symmetry. The first sign of
gastrulation is the appearance of a pigmented depression in the dorsal-vegetal
quadrant of the embryo, the dorsal lip of the blastopore. This is the first sign of a
series of migration of cells resulting in the formation of three germ layers,
ectoderm, mesoderm and endoderm. The ectodermal layer will later form
epidermis, nervous system and sensory organs. The mesodermal layer develops
into muscle, connective tissue, skeletal tissue and the circulatory and excretory
systems. The endodermal layer eventually differentiates into the gut and
associated organs, such as the liver and the pancreas (Jones and Smith, 1999).
The next vital event in development is neurulation at stage 16. Early
during neurulation, the posterior neural plate undergoes convergence and
extension, assistin9 in blastopore closure. The first Si9n of neurulation in
Xenopus is the thickening of the inner layer of dorsal ectoderm. This is followed
by the formation of a dark pigment line along the dorsal midline of the embryo,
the neural groove. As neurulation proceeds the neural groove deepens and the
lateral neural folds converge on the dorsal midline, where they eventually fuse to
form the neural tube (Jones and Smith, t999).
During and after neurulation the mesoderm becomes subdivided into
different tissues along the dorsal-ventral axis. The most dorsal" cell type is the
notochord. Lateral to the notochord are the cells of the somites, which, in
Xenopus, predominantly form muscle. Lateral and ventral to the somites are cells
of the pronephros. The lateral mesoderm goes on to form structures such as the
limbs, and the most ventral mesoderm forms blood (Jones and Smith, 1999).
Organogenesis is the process by which organs are formed. The
development of most organs begins with aggregates of precursor cells, which
then migrate in response to orientation and positional cues. Once in their defined
positions, extensive variations in cell adhesion, proliferation and apoptosis occurs
which helps to shape the organ. Organogenesis in Xenopus has not been
extensively studied, but there are some recent reports that focus on the
molecular aspects of organogenesis (for reviews see (Capdevila and lzpisua
Belmonte, 2000; Ramsdell and Yost, 1998). Organogenesis leads to the
formation of a free·swimming tadpole (stage 45) at four days after fertilization
(Wolpert ot al., 1998). The final event in the development of the adult Xenopus
laevis is metamorphosis. This is a post-embryonic process that involves the
transformation of a free-swimming tadpole into an adult organism. Indeed, during
this transformation many structural changes occur, but the most dramatic and
obvious are the growth and differentiation of limbs and the death and resorption
of the tadpole's tail. Metamorphosis in Xenopus is triggered by environmental
cues such as nutrition, light and temperature and is controlled by Thyroid
hormone (for review see (Tata, 1996; Tata, 1999). Metamorphosis to form an
adult frog occurs around 60 days after fertilization (Wolpert at al., 1998).
1.1.2 Regulation of the Early Cell Cycle in Xenopus Jaevis
Adult cells do not enter mitosis until they have grown to double their
masses, but also do not grow more than double without dividing (Mitchison and
Creanor, 1971). Thus the cell maintains a constant ratio of the nucleus to the
cytoplasm, the nucleocytoplasmic (N/C) ratio characteristic of the cell type. The
exceptions to this rule are animal oocytes and zygotes. The oocyte continuously
grows during oogenesis to increase the cell mass enormously without cell
division. Therefore. the N/C ratio of the zygote at fertilization is very low.
Conversely, the zygote divides without cell growth during the cleavage period to
diminish cell volume and increase the N/C ratio exponentially as cleavage
progresses (Masui and Wang, 1998).
Cell cycle durations of blastomeres remain constant and synchronous up
to the blastula stage, and then rapidly and variably lengthen (Graham and
Morgan, 1966). In the Xenopus embryo as a whole. cleavage synchrony ends at
the 9th cycle. when blastomeres in the vegetal pole begin asynchronous
cleavage, but the blastomeres near the animal pole cleave synchronously up to
the 12th cell cycle and then cleavage becomes asynchronous (Masui and Wang,
1998).
In order to maintain genetic integrity throughout a cell line, it is necessary
for proliferating cells to have mechanisms that ensure accurate DNA replication
and exact delivery of chromosomes to daughter cells. One of these mechanisms
is referred to as 'checkpoint' control (Hartwell and Weinert, 1989). It operates by
arresting- the cell cyde at S phase until DNA replication is complete, or at M
phase until chromosomes are correctly arranged on the equatorial plate of the
spindle. Therefore, most cells are arrestee! in S phase if DNA synthesis is
inhibited or in G2 phase if DNA is damaged, or in M phase if the mitotic apparatus
is disassembled by microtubule inhibitors (Masui and Wang, 1998). In Xenopus
embryos, experiments have shown that the critical N/C ratio is responsible for the
development of the S phase checkpoint mechanism and not the chronological
age (Kimelman et al., 1987). However, the development of the'M phase
checkpoint is dependent on the chronological age of the cell (reviewed by (Masui
and Wang, 1998).
In the early development of Xenopus laevis, fundamental changes in cell
cycle regUlation occur during MBT or from the 12th to 13th cell cycle (Newport and
Kirschner, 1982b). At this stage, unlike at pre·MBT stages, cell cycles become
highly dependent on cell surface activities of blastomeres. The cleavage of
blastomeres also changes from synchronous to asynchronous division, G1 and
G2 phases first appear in the cell cycle and cell cyde durations suddenly
increase. As well, blastomeres develop checkpoints at S. and M phases. MBT is
also the time when zygotic transcription is initiated (Newport and Kirschner,
1982b).
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1.1.3 Transcription of Embryonic Genes Starts at the Mid-Blastula
Transition
MBT is defined by an interval, during which completion of the rapid
cleavage period is followed by the immediate activation of a new developmental
program, which includes start of zygotic transcription (Meehan and Stancheva,
2001; Newport and Kirschner, 1982a; Newport and Kirschner, 1982b; Stancheva
at al., 2002). This indicates that MBT cannot be observed visually, although it is
known to occur around cleavage 12, during stage 8.
1,1.3.1 Signaling Mechanisms ofthe MBT
Once an egg is fertilized, intracellular Ca2• is elevated, cyclin B
degradation is stimulated and cytostatic factor, CSF, activity declines in concert
with loss of MAPK and RSK activity (Maller at al., 2001). The first 12 cleavage
cycles display only M and S phase, except for the first cycle. which is longer and
has a delectable G2 phase (Masui and Wang, 1998). Despite these short cycles,
the enzymes that control cdc2-tyrosine15 phosphorylation, wee1 and cdc25A,
are rapidly synthesized after fertilization and new cyclin B/cdc2 complexes
appear to undergo a rapid' 'cycle of tyrosine15 phosphorylation!
dephosphorylation in every cell cycle. Since no G2 phase is evident in these
cells, the function of tyrosine-15 phosphorylation is not clear at this time (Maller
at a/., 2001). In contrast, Hartley at al. have shown that tyrosine phosphorylation
of cdc2 is absent until loss of Cyclin E at the MBT (Hartley at a/., 1996). The
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events at MBT fall into two classes: those that occur at a fixed time after
fertilization and those that require a threshold N/C ratio (Masui and Wang, 1998).
For example, the degradation of maternal cyclin E happens at a specific time
after fertilization, while the start of zygotic transcription is dependent on the N/C
ratio (Hartley at al., 1997; Newport and Kirschner, 1982b).
The introduction of the DNA replication checkpoint at MBT is dependent
on the N/C ratio. The block to mitotic entry might be a result of failure to
dephosphorylate and activate cyclin Bledc2. It is implied that edc25 activation is
inhibited by phosphorylation on serine287 which results in the creation of a
docking site for 14-3-3 proteins (Kumagai at al., 1998; Peng at al., 1997). The 14-
3·3 binding is believed to block nuclear translocation andl or interaction with
cyclin B/edc2, thus preventing enzyme/substrate interaction. A role for the
Plxledc25C pathway in the DNA replication checkpoint has not yet been
established (Maller at al., 2001).
1.1.3.2 Regulation of Nuclear Import of transcription factors at MBT
At the time of zygotic gene activation, transcription is under control of
maternally inherited factors (Newport and Kiischner, 1982b). In order to prevent
aberrant expression of genes nonnally transcribed at or soon after the start of
transcription, the activity of these maternal fa:ctors must be tightly regulated.
Although a repressive chromatin structure and a repressed basal transcription
machinery have been implicated in repressing transcription before MBT
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(Almouzni and Wolffe, 1993a; A1mouzni and Wolffe, 1993b; Almouzni and Wolffe,
1995), it is not clear how maternally derived transcription factors are prevented
from activating transcription despite the high levels present in the early embryo.
These transcription factors and the RNAs encoding these factors are produced
and stored in the oocyte. During early development, the proteins present in the
nucleus segregate over an increased number of nuclei (Veenstra at a/., 1999).
Therefore, the total amount of maternal proteins present, are divided over many
nuclei, resulting in a low concentration of protein per nucleus. Transcription
factors, which are stored in the oocyte, would reach high local concentrations if
translocated to the small number of nuclei in pre-MBT embryos. These high local
concentrations might counteract transcriptional repression. Therefore,
cytoplasmic sequestration of maternally inherited transcription factors may
provide a mechanism by which the transcriptional machinery is restrained
(Veenstra et al., 1999). Examples of this regUlation are provided by the CCAAT
box transcription factor (CBTF), which is retained in the cytoplasm by binding to
maternal RNA transcripts. At MBT, these maternal RNA transcripts undergo
degradation and this results in the release of CBTF and subsequent nuclear
translocation (Brzostowski et al.·, 2000). Another example of a protein
translocated at MBT is Xnf7, which is hyperphosphorylated before MBT, which
results in cytoplasmic retention. Dephosphorylation at MBT causes release from
a cytoplasmic anchoring protein and subsequent import into the nucleus (Li at af.,
1994a; Shou at al., 1996).
1.1.4 Regulation of nuclear import and activation of transcription factors is
dependent upon phosphorylation
Nudear transport of transcription factors as well as the activation of
transcription factors can be regulated by phosphorylation. Proteins responsible
for activating other proteins by phosphorylation and dephosphorylation are called
kinases and phosphatases, respectively. Changes in phosphorylation state of a
protein reflect changes in the relative balance between the protein kinase(s) and
protein phosphatase(s) acting on the protein (Maller et al., 2001). The balance
between the action of kinases and phosphatases can be regulated by signal
transduction.
Signal transduction is the path that a signal can travel from the surface of
the cell to the cell nucleus where the message gets translated into action. A
receptor on the cell surface can bind a ligand and can subsequently activate
intracellular proteins. This results in a cascade of proteins being activated until
the signal reaches the cell nucleus, where SUbsequent activation or inhibition of
transcription can occur. Activation of proteins occurs by phosphorylation and/or
dephosphorylation of specific sites in the protein. The cascade of events
triggered after binding'of a ligand to a cell surface receptor is called a signaling
pathway. There are many signaling pathways in a cell (reviewed in (Fiorini at af••
2001; Powers et al., 2000).
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The transcription factor MI~ER1 was isolated as an immediate early gene
following activation of a fibroblast growth factor (FGF) signal transduction
pathway (Patemo at al., 1997). The FGF signaling pathways are well-
investigated pathways, found to be very diverse. FGFs and the FGF signaling
pathways appear to, play significant roles in cell survival, apoptosis, proliferation,
differentiation, matrix composition, chemotaxis, cell adhesion, migration and
growth of cell processes. Different cell types may display altemate, sometimes
even opposite responses to FGFs, depending on the state of differentiation,
biochemical status and the cellular, Rhysical and chemical environment of the cell
(reviewed in (Powers et al., 2000; Szebenyi and Fallon, 1999). Clearly.
misregulation of FGF pathways can lead to disastrous events like neoplasia.
The following section will describe FGF in more detail as well as some
well-known FGF pathways, the RaslRaflMAPK pathway and the PLC-y pathway.
1,2 FGF Signal Transduction
1.2.1 FGFs
FGFs were first isolated in the 1970s from bovine brain extracts based on
their mitogenic activities. SUbsequent research established that FGFs fonn a
family of structurally related polypeptide growth factors. FGFs appear to play
significant roles not only in normal development and wound healing, but also In
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tumor development and progression (reviewed in (Szebenyi and Fallon, 1999)
and (Powers et al., 2000).
Defining features of the FGF family are a strong affinity for heparin and
heparin-like glycosaminoglycans (HLGAGs) (Burgess and Maciag, 1989) as well
as a central core of 140 amino acid residues that ;s highly homologous between
different family members. Structure and not specificity of growth promoting
activity ;s the defining feature of the FGF family, although the nomenclature of
the first isolated FGFs was based on their biological activity (Baird and
Klagsbrun, 1991).
Twenty-two distinct FGFs have been discovered to date, numbered
consecutively from 1 to 22, which have a molecular weight between 17 and 34
kDa (reviewed in (Omitz and ltoh, 2001). FGF-11 to 22 are more correctly called
FGF homologous factors, because they share less than 30% identity to other
FGFs, whereas they show between 50 and 80% homology to each other. They
may therefore constitute a different but related family (Schoorlemmer and
Goldfarb, 2001; Smallwood et al., 1996). FGFs induce mitogenic, chemotactic
and angiogenic activity in cells of mesodermal and neuroectodermal origin
(Omitz and Itoh, 2001). FGF-1 and -2 were the first FGFs to be isolated and are
the prototypes of the FGF family.
Both FGF-1 and FGF-2 were initially isolated from bovine pituitary extracts
based on their stimulation of (3Hjthymidine incorporation in 3T3 fibroblasts
(Armelin, 1973; Gospodarowicz, 1974). In humans, FGF-1 is a 155 amino acid
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protein and the fgf-1 open reading frame is flanked by stop codons resulting in
only one-protein form (Jaye at a/., 1986). FGF·1 does not have a signal peptide
for channelin9 through the classical secretory pathway (Jaye at al., 1986),
however it does possess a nuclear localization signal (Imamura at al., 1990) and
has been found associated with the nucleus (Sano et al., 1990; Speir ._et al.,
1991). The presence ot'this nuclear localization signal appears to be important
for FGF·1 induced mitogenesis and removal has been shown to abrogate FGF-
1's mitogenic effect (Imamura et al., 1990). FGF-1 has been shown to stimulate
DNA synthesis without signaling through a cell surface receptor (Wiedlocha at
al., 1994), suggesting that the nuclear localization signal allows FGF-1 to act
through an intracrine mechanism.
The 18 kilo-Dalton (kOa) form of FGF-2 has a 55% sequence homology
with FGF·1 (Bohlen at a/., 1985; Gimenez-Gallego at al., 1985). Four different
FGF·2 polypeptides can be translated from the one fgf·2 gene by use of
upstream CUG start codons: in addition to the 18-kOa form, 22.5, 23.1 and 24.2·
kOa forms have been identified (Florkiewicz and Sommer, 1989).
Like FGF·1, FGF·2 does not contain a signal for secretion, but also
contains a nuclear localization signal in the N·terminus of the larger isoforms
(Bugler at a/., 1991). The role of nuclear localization in the activity of FGF-2
remains unclear.
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1.2.2 FGF receptors
FGFs usually produce their mitogenic and angiogenic effects in target
cells by signaling through transmembrane tyrosine kinase receptors. There are
four FGF receptors, designated FGFR1. 2, 3 and 4 which share between 55%
and 72% identity at the protein level (Johnson and Williams, 1993). There are
different isoforms for each of the four FGFRs, generated by alternative splicing of
the mRNA (Johnson and Williams, 1993). FGFs can bind to a distinct subset of
FGFRs, creating the possibility for distinct intracellular signaling. Figure 1.2.1
illustrates the sequence motifs found in FGFRs. Note that the immunoglobin (19)
domain 1is not found in all FGFR isoforms (for review, see (Powers at al., 2000».
The highest sequence similarity between the four FGFRs is found in the Ig
domain Ill, the Kinase I and the Kinase II regions.
1.2.3 FGF receptor dimerization and activation
Following ligand binding and dimerization, the receptors become capable
of phosphorylating specific tyrosine residues on their own and each others
cytoplasmic domains (Lemmon and Schlessinger, 1994). The FGFRs can
transphosphorylate in homo- and helerodimers (Bellot et al.• 1991), allowing for
additional complexity in FGF signaling. Phosphorylated tyrosine residues recruit
other signaling molecules to the activated receptors and propagate a signal
through many possible transduction pathways (Pawson, 1995). The key step
from the extracellular to the intracellular pathways is receptor dimerization.
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Figure 1.2.1 Schematic illustration of a FGFR protein,
(Modified from (Powers et al., 2000)
Signal peptide
Igdomain I
Acidic region
IgdomainII
Igdomain III
Transmembrane
domain
Kinase I
Kinase 2
C-lail
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The activated tyrosine kinase receptor recruits target proteins of the
signaling cascade to its cytoplasmic tail and modifies them by phosphorylation.
One way these recruited target proteins may be localized to the activated
receptor is through interaction between their Src-homology 2 (SH2) domains and
specific phosphotyrosine residues on the activated receptor (Pawson, 1995).
These SH2 containing proteins may be substrates for receptor mediated
phosphorylation or they may function as adaptor proteins to recruit other target
proteins (Powers et al., 2000). FGFRs share signaling pathways with other
tyrosine kinases. The biological outcome of FGF stimulation depends on the
exact concentration and combinations of ligand, receptors and signaling
intermediates present in a particular cell. There is accumulating evidence that
effects on different cellular functions are mediated by distinct combinations of
signaling pathways, some of which may involve nuclear forms of FGFs and
FGFRs (Szebenyl and Fallon, 1999). Two extensively studied pathways are the
RaslRaf/MAPK pathway and the PLCy pathway, which are widely used in a
variety of cells.
1.2.3.1 The SHCfFRS2-RAF/MAPklnase pathway
This pathway was shown to be important for growth factor induced cell
cycle progression (Szebenyi and Fallon, 1999). Independent of activation of the
receptors, an SH2 (Src homology 2) protein, SNT-1 (Wang et" al., 1996), better
2\
known under the name FRS2 (FGFR substrate 2) (Kouhara et al., 1997), is
recruited to the receptor (Ong et al., 2000). Following ligand binding and
dimerization of the receptor, FRS2 will be activated. Activation of SNT-lIFRS2
recruits the adaptor protein Grb-2JSos. This recruits Ras to the FGFR complex,
where Ras gets activated (Kouhara et al., 1997). Then membrane associated
Ras activates Raf-1, a serine-threonine MAP kinase kinase kinase (MAPKKK),
an activator of MAPKK (MEK). In tum, MAPKK activates MAPK (also known as
ERK1 (=p44) and ERK2 (=p42». MAPK can signal directly to the nucleus by
phosphorylating transcription factors such as JUN, FOS and the ribosomal 56
kinase, which results in activation of different responses, like proliferation,
differentiation, migration, survival, etc.
In addition, each of the kinases in the MAPK pathway can be regulated by
multiple signals; for example, PKC and PKA are both regulators of Raf-1 kinase.
This results in regulation at different levels of the pathway to prevent
misregulation of cellular events (Szebenyi and Fallon, 1999). MAPKs act in
concert with other cell signaling systems. Therefore, cross-talk between
pathways is crucial to the coordinated responses of cells. MAPKs may act
antagonistically in cells undergoing apoptosis or in supporting cell proliferation
(Robinson and Cobb, 1997); (Powers at a/., 2000; $zebenyi and Fallon, 1999).
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Flgun~ 1.2.2 Schematic illustration of some of the FGF signaling pathways
(modified from (Szebenyi and Fallon, 1999).
The diagram illustrates the cytoplasm and the nucleus. Some of the well-known FGF
signaling pathways are indicated: the RasJ Raf! MAPK pathway and the PLCy pathway.
Molecules indicated are described in the tex.t. After FGF binding to the FGF receptors,
the receptors dimerize and are activated by phosphorylation. Solid arrows indicate direct
activation of proteins. Dashed arrows indicate activation of which is not known whether
it is direct or indirect via activation of other proteins.
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1.2.3.2 The PLCV signaling pathway
This pathway is implicated in responses like neurite extension, and
modulating the cytoskeletal dynamics of neurons (reviewed in (Szebenyi and
Fallon. 1999). Activated PLCy hydrolyses phosphatidyl·inositol-4,5--biphosphate
(PIP2) to inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). In tum, IP3
facilitates the release of calcium stores from the endoplasmic reticulum while
OAG and calcium activate PKC, a serinefthreonine specific kinase (Merle at al.,
1995; Shitaka at al., 1996). PLCy was identified as a 150·kOa phosphoprotein
associated with FGFR following ligand dependent receptor activation (Burgess
and Maciag, 1989) and this association is due to the binding between the SH2
domain of PLCy and tyrosine166 of FGFR·1 (Mohammadi et al., 1991). Mutation
of tyrosine766 did not affect FGFR·mediated mitogenesis, neuronal differentiation,
or mesoderm induction in Xenopus animal cap assays. indicating that this
pathway is not required for these regulatory mechanisms (reviewed in (Johnson
and Williams, 1993; Powers at al., 2000).
FGF is involved in many more signal transduction pathways, some of
which Involve cross-talking of signals between pathways activated by different
receptors (Fambrough et al., 1999; Fanger, 1999; Ferrell, 1998; Karin, 1994; Klint
and Claesson-Welsh, 1999; Pawson and Saxton, 1999; Powers et af., 2000;
Szebenyi and Fallon, 1999). However, in all signal transduction pathways, the
first genes to be activated are called immediate earty genes. Therefore, these
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genes are considered to be master regulators. To date, very few FGF immediate
early genes have been isolated and described.
1.2.4 Immediate Early Genes
Immediate earty genes (or early response genes) are the first genes to be
transcribed differentially hi response to a stimulus, for example in response to
growth factor treatment of a cellular population. Transcription of immediate early
genes is not dependent on de novo protein synthesis and is normally rapid,
within thirty minutes of binding of the ligand to the receptor. The majority of early
response genes are transcription factors; other immediate early genes include
receptor molecules, transmembrane proteins or secretory molecules. The
transcription factors induced as immediate early genes in tum initiate. or
terminate. transcription or activation of new genes and proteins, which carry out
the desired cellular response. For example. the Xenopus homeobox transcription
factor. XVent1 and XVent2 are BMP-4 (Booe morphogenetic protein) induced
immediate early genes important for ventralization of Xenopus laevis embryos
(Henningfeld et al., 2002). The XVent transcription factors have been identified
as pivotal mediators of BMP function in Xenopus. Consistent with the XVents as
downstream effectors of BMP. these genes are expressed in the ventral and
lateral marginal zones and are excluded from the dorsal most region of early
Xenopus embryos (Henningfeld at al., 2002). Ectopic expression of the XVents in
the dorsal blastomeres mimics the BMP induced ventralization of Xenopus
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embryos and results in activation of BMP induced genes (Henningfeld et al.,
2002).
Understanding gene regulation via the signal transduction cascades is
important for elucidating the mechanisms whereby FGF elicits different cellular
actions in different cells and how misregulation can lead to cancer.
C-jun is an immediate early gene involved in mesoderm induction in
Xenopus laevis by FGF activation. C-jun is an oncogene and transcription factor,
which forms homodimers and can heterodimerize with c·fos. The dimer
arrangement composes activator protein-1 (AP1) (Dong et af., 1996).
The Xenopus homologue of the Brachyury (Xbra) gene is a DNA binding
protein upregulated by FGF. Xbra is able to induce mesoderm formation; ventral
mesoderm at low concentrations and intermediate mesoderm at higher
concentrations (Cunliffe and Smith, 1994). Xbra and embryonic FGF (eFGF) are
able to activate transcription of each other and are thought to act in an
autocatalytic manner during mesoderm induction (Isaacs at al., 1994).
FGF inducible kinase, fnk, is another early response gene upregulated by
FGF, More specifically it was shown that induction of fnk in NIH 3T3 cells
occurred after activation by FGF·1 and FGF·2 (Donohue at al., 1995).
Another immediate early gene, cloned in Gillespie'sf Paterno's laboratory,
that is upregulated in response to FGF treatment of Xenopus is mi-er1, for
mesoderm induction early response 1, previously called ar1 (Paterno at al.,
1997). Ml·ER1 is a transcription factor, whose nuclear translocation is
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developmentally regulated in Xenopus laevis development. Its human homologue
is shown to be present in many cancer cells but not in nonnal celts of the same
tissue. It is likely that regulation of nuclear localization of MI·ER1 is important for
development of Xenopus embryos.
1.2.5 Transcription factors
Transcription factors are proteins that allow the cell to respond to
environmental cues (reviewed in (Mar1<s, 1996). There are many parameters that
can influence transcription factor activity. like developmental stage. tissue type,
health and nutritional state, stress and many more. Misregulation of transcription
factors is most profound in cell transformation and oncogenesis.
Almost all eukaryotic transcription factors are regulated by
phosphorylation (Karin, 1994). There are several features that make protein
phosphorylation an attractive device for mediating signal dependent regulation: I)
It is rapid, mediating responses within minutes. II) The phosphorylation-mediated
activation of transcription factors is reversible. III) Molecular information that is
transduced by protein phosphorylation can be amplified; many proteins can be
phosphorylated in a very short period. IV) Because a phosphorylation site on a
protein is usually defined by a short peptide sequence, the identity of a protein as
a substrate for a certain kinase or phosphatase ~n be rapid (Marks. 1996).
Transcription in eukaryotic nuclei is catalyzed by three enzymes called
RNA polymerase I, II and Ill. These RNA pplymerases differ in their target
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specificity; RNA polymerase 1has 1 target gene: the precursor for 28S, 165, and
5.8S ribosomal RNA. RNA polymerase III transcribes tRNAs. 55 rRNA. and a
number of small RNAs including U6 snRNA. RNA polymerase II has the largest
number of target genes and transcribes all protein-encoding genes (Marks,
1996). None of the eukaryotic RNA polymerases can recognize promoters or
transcription initiation sites, nor initiate transcription on their own, they need
transcription factors (Marks, t 996).
There are two classes of transcription factors: general transcription
factors. which are required for all gene transcription with a specific RNA
polymerase. and promoter-selective transcription factors, which are required for
the transcription of a subset of genes transcribed by RNA polymerases II or III.
These transcription factors are sequence specific DNA binding proteins (Marks,
1996). The majority of promoter-selective transcription factors function by
recognition and binding to cis-acting transcription control elements on the DNA.
These cis-acting elements are often part of larger regUlatory entities called
promoters or enhancers. The process of transcriptional activation by promoter-
selective transcription factors involves a series of biochemically discemable
steps:
a) The transcription factor has to move to the site of transcription, the nucleus.
b) In many cases, the transcription factor must homo- or heterodimerize in order
to specifically recognize and bind to their cognate promoter element.
c) The factors must stimulate or repress the transcription of their target gene.
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Transcriptional activation of immediate-earty genes represents the primary
nuclear response to signal reception. This process is independent of de novo
protein synthesis. It is mediated by pre-existing transcription factors, which
become activated in response to the incoming signal (reviewed in (Marks, 1996).
Regulation of transcription factors is important for ensuring correct cellular
responses to signal transduction pathways. The transcription factor MI-ER1 is an
early response gene to FGF activated signaling in Xenopus. The nuclear import
of MI-ER1 into the nuclei of Xenopus laevis embryos is developmentally
regUlated. In the next section the principles of nuclear transport as well as the
different mechanisms of regulation of nuclear import are discussed.
1.3 Nuclear transport of macromolecules
Eukaryotic cells are characterized by distinct nuclear and cytoplasmic
compartments separated by the nuclear envelope (NE), a double membrane that
is continuous with the endoplasmic reticulum. The nuclear envelope is
penetrated by nuclear pore complexes (NPCs), which allow transport of
molecules between the 2 compartments. During mitosis the nuclear envelope
breaks down and the nuclear and cytoplasmic compartments can mix. However,
during interphase all nucleocytoplasmic transport occurs through the NPC
(Gorlich and Kutay, 1999). Amongst the molecules transported are nuclear
proteins such as histones and transcription factors, which are transported from
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the cytoplasm to the nucleus, but also RNAs like transfer RNA (tRNA),
messenger RNA (mRNA) and ribosomal RNA (rRNA), which are synthesized by
transcription in the nucleus and need to be transported to the cytoplasm where
they function in translation (Gorlich and Kutay, 1999).
There are a few reasons for the complexity of the nuclear compartment
found in eukaryotic cells compared to prokaryotes. First, the existence of a cell
nucleus enables the eukaryotic cell to handle large amounts of genetic
infonnation. Second, the compartmentation allows regulation of key cellular
events, for example by controlling the access of transcriptional regUlators to
chromatin, thereby controlling transcription. A third reason is the fact thai
eUkaryotic genes are comprised of introns and exons, which requires splicing of
primary transcripts before translation may occur. Translation of unspliced
transcripts would result in proteins that are not only non-functional, but may act
as dominant-negative inhibitors.
1.3.1 The Nuclear Pore Complex
The Nuclear Pore Complex (NPC) consists of a membrane embedded
basic framework made up of 8 multidomain spokes with two rings on each face.
The ring facing the cytoplasm has eight 50nm fibrils extending into the cytosol,
and the nuclear ring is capped with a basket·like assembly of eight thin, S().-100
nm filaments joint distally with a 3040 nm diameter tenninal ring (see figure
1.3.1, (Izaurralde et al., 1999). The center of the basic framework harbors the
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gated transport central plug, which is involved in the bi-directional transport of
macromolecules bearing a transport signal.
The number of NPCs per cell appears to depend on the demand for nuclear
transport and varies with cell size and synthetic and proliferative activity (Gorlich
and Kutay, 1999). There are 189 NPCs in a yeast cell (Rout and Blobel, 1993),
about 3000-5000 in a proliferating human cell, and about 5xl07 in a mature
Xenopus oocyte (Cordes et al., 1995).
NPCs are aqueous channels through which all nuclear transport occurs
(Richardson at a/., 1988), for review, see (Bagley at al.• 2000; Rout and
Aitchison, 2001; Stewart et al., 2001). Passive diffusion through the pore is
believed to be possible for molecules smaller than 9 nm in diameter, which
corresponds to a protein with a molecular weight of about 45 kOa. However, it is
shown that diffusion is a slow and obviously passive process and that even small
proteins or RNAs smaller than 20·30 kOa, like histones (Jakel et a/., 1999) and
tRNAs (Kutay at al.• 1998) normally cross the membrane by active transport, thus
prOViding a mechanism for regulated transport:
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Figure 1.3.1 Model of the NPC spanning the nuclear envelope, modified from
(Izaurralde et al.• 1999).

1.3.2 Import machinery
Passive diffusion does not require any specific interactions between the
diffusing species and components of the NPC; it is fast for small molecules, but
becomes restricted and inefficient as the diffusing objects approach a size limit of
40-60 kDa (Paine at a/., 1975); (Ribbeck and Gorlich, 2001). Facilitated transport
requires specific interactions between the translocating molecule and the NPC
and is therefore a highly selective process. Only some proteins, called importins
and exportins (both also referred to as karyopherins) have the ability to directly
interact with proteins on the surtace of the NPC. Importins are the proteins that
have the ability to direct cargo to the nucleus. whereas exportins export
molecules from the nucleus to the cytoplasm. The proteins in the NPC are
collectively called nucleoporins (Nig9. 1997). Many nucleoporins contain highly
repetitive motifs conforming to either the consensus FXFG andlor GlFG (single
letter amino acid code is used with X indicating any amino acid). These FG
repeats are shown to interact with the transport receptors in vitro (Rexach and
Blobel, 1995); reviewed in (Nigg, 1997).
The first transport receptor identified was importin-13 that functions
together with an adaptor, importin-a. (Gorlich at al., 1994; Gorlich at al., 1995a;
Gorlich and Kutay, 1999). Importin-a. binds to the protein to be imported, whereas
importin-13 binds to the NPC (Adam and Adam, 1994; Gorlich at al., 1995b;
Imamoto at af., 1995; Moroianu at al., 1995a; Moroianu at al., 1995b; Rexach
and Blobel, 1995; Weis at al., 1995). Both importins contain several hydrophobic
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42 amino acid repeats, known as 'arm' repeats, named after the Drosophila gene
armadillo (Nigg, 1997). There are at least four human a·importins, and
homologues have been characterized in other eukaryotes (Morcianu, 1999). The
importin-j} family consists of about 10 homologues isolated from yeast and
human (Moroianu, 1999).
Other important components of the import machinery are a small GTPase
Ran and the RanGDP·interacting protein, p10INTF-2. Ran was found to be an
essential factor for almost all known nuclear import and export pathways. Ran is
an abundant protein that is mainly localized in the nucleus and switches between
GDP- and GTP-bound states. Ran has low intrinsic activity and requires
regulators for efficient GTP hydrolysis or exchange of nucleotides (Gorlich and
Mattaj, 1996; Morcianu, 1998; Morcianu, 1999; Nigg, 1997).
A significant feature of the RanGTPase system is its asymmetric
distribution. The main GTPase-activating protein RanGAP (Bischoff at al.; 1995)
and a Ran binding protein RanBP1 (Coutavas at al., 1993), which together can
achieve maximal GTPase activity, are mainly cytoplasmic (Richards at 81., 1996;
Richards at al., 1997). In contrast, the nucleotide exchange factor of Ran, RCC1,
is mainly nuclear and bound to chromatin. This leads to the asymmetric
distribution of Ran being converted to the GDP form in the cytoplasm, whereas in
the nucleus Ran is mainly in the GTP·bound form thrcugh the action of RCC1.
The result is a gradient of RanGTP across the NPC with low concentration in the
cytoplasm and high concentration in the nucleus. Disruption of this gradient
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results in blockage of nucleocytoplasmic transport (Izaurralde et al., 1997;
Richards at al., 1997).
1.3.3 Signals for transport
Active transport of macromolecules is based on recognition of specific
signals in the molecule that is transported. This was first found through a study of
nucleoplasmin (Dingwall at al., 1982). Nucleoplasmin is a large 165 kDa
pentameric, thermostable protein found in Xenopus laevis oocytes and consists
of subunits thaI each contain a protease resistant ·core- and a protease
sensitive "tail". Intact nucleoplasmin quickly enters the nucleus after injection in
the cytoplasm of Xenopus oocyt.es. However, when all the tails are removed from
the core by protease treatment, the residual core remains a pentamere but fails
to localize 10 the nucleus. However, the tails show rapid entry into the nucleus.
This experiment showed that the tails of nucleoplasmin contain a signal for
nuclear entry (Dingwall et al., 1982).
In 1984, the first nuclear import signa' was identified by Kalderon et al.,
(Kalderon at al., 1984a; Kalderon et al., 1984b) in the simian virus large T-
antigen. A region necessary for the nuclear import of this protein was identified.
The region identified had a stretch of five basic amino acids 127pKKKRKV133 and
it was shown that the substitution of the '~Lys for Thr completely abolished
nuclear translocation of the SV40 T-Ag (Kalderon at al., 1984a). The nuclear
import signal of nucleoplasmin was identifi.ed in 1991 and consists of two
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interdependent regions of basic amino acids that are spaced by a linker of ten
intervening amino acids (Robbins et al., 1991). The import signals from
nucleoplasmin and the SV40 T antigen are the prototypes of the classical nuclear
localization signal (NLS); bipartite NLS and monopartite NLS respectively
(Kalderon at a/.• 1984a; Lanford and Butel, 1984; Robbins at af., 1991).
Since the discovery of the SV40 T antigen and the nucieoplasmin NLS.
many NLS have been described. Boulikas has described the requirements of a
functional NLS, which are based on the comparison of hundreds of NLS that
have been shown to be functional (Boulikas, 1994; Boulikas. 1997). In short, a
core NLS is often a hexapeptide in which four amino acids are arginine or lysine.
It does not contain any bulky. acidic or hydrophobic residues in the core or in the
flanking regions. The core NLS is often flanked by proline or glycine. which
function as helix breakers. for better exposure of the signal to the importins.
There are three classes of classic NLS: The monopartite and bipartite NLS
comprise the first 2 classes. The third class is exemplified by an NLS found in the
human protein c-MYC. In this NLS only 3 out of 6 amino acids are positively
charged and acidic residues in the flanking region are shown to increase the
binding to import receptors (Hodel et al.• 2001; Makkerh at al.. 1996).
Some proteins are actively exported from the nucleus because their
presence in the nucleus can be harmful for the cell survival or can interfere with
cell control. Therefore these proteins carry a Nuclear Export Signal. NES. The
prototypic NES is hydrophobic with high leucine content. NES of this type are
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found in ?KI (rat, (Wen at al., 1995)), viral proteins like Rev (HIV-1, (Fischer at
al., 1995) and TFIIIA (Xenopus) (reviewed by (Nigg, 1997). NES are also found
on regulators of transcription factors, like IKB, which can bind NF-KB in the
nucleus and relocates to the cytoplasm as the complex NF-KB/I-"B, where it is
located until re-activation of the NF-KB pathway. If I-ICB did not possess a NES,
NF-KB function is inhibited in the nucleus by l-teB, resulting in apoptosis
(Henderson and Eleftheriou, 2000; Huang and Miyamoto, 2001). A NES is also
found on MA?KK as localization of MAPKK in the nucleus leads to constitutive
activation of the MAPK pathway. It is therefore important for MA?KK to be
localized in the cytoplasm (Fukuda et al., 1996; Fukuda at al., 1997b; Fukuda et
al., 1997a).
There are also specific signals for nucleocytoplasmic transport found on
shuttling proteins like the mRNA binding protein heterogeneous nuclear
riboprotein, hnRN? A1. Shuttlin9 proteins are proteins that have transport signals
that can function in both import and export and thus Import as well as export are
strictly regulated. The shuttling protein hoRN? A1 contains a sequence that can
function in Import and export, the M9 motif. This approximately 40 amino acid
motif is rich in glycine and aromatic amino acids and was shown to be important
for the transport of mRNAs (Michael at al.• 1997; Siomi and Dreyfuss, 1995;
Weighardl st a/., 1995).
Other signals for transport have been reported, like the hnRN? K bi-
directional signal caned hnRN? K nuclear signal, KNS (Michael et af., 1997), SR-
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proteins (Kataoka et al., 1999)) and more (see (Nigg, 1997) and (Jans at al.,
2000».
1.3.4 Mechanisms of transport
There are several different nuclear trafficking pathways which share a
number of common features (reviewed in (Gorlich and Kutay, 1999; Gorlich and
Mattaj, 1996; Stewart at al., 2001). Generally, substrates do not directly interact
with the NPC, but are transported bound to soluble transport receptors, which are
recycled back to their original compartment after the translocation. The focus of
my research is based on import of macromolecules into the nucleus; therefore
this process will be described here. However, the general principles involving
nuclear translocation are thought to be similar for other nuclear trafficking
pathways (Gorlich and Kutay, 1999).
Translocation through the NPC can be divided into two steps: I) Docking
of the substrate on the cytoplasmic face of the NPC. This requires the presence
of an NLS, but is independent on metabolic energy. II) Translocation of the
complex, which is shown to be dependent on GTP hydrolysis (Bischoff and
Gorlich, 1997; Gorlich et al., 1996; lzaurralde at a/., 1997; Melchior at al., 1995).
It was shown that in the absence of ATP, cargo is located on the cytoplasmic
surtace of the NPC, indicating that either the translocation or the release of the
cargo on the other side of the NPC is energy dependent.
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Figure 1.3.2 Schematic representation of the classical import pathway.
(Modified from (Gorlich and Kutay, 1999). For details see main text. In summary: tbe
protein to be transported (NLS) binds to importin-a (a) and importin-p (Il). The complex
binds to the NPC and translocates to the nucleus. In tbe nucleus RanGTP binds to
importin-Il, releasing it from importin-a and the NLS containing protein. lmportin·a
binds to its export receptor CAS and RanGTP, thereby releasing the NLS bearing protein
in the nucleus. The importin-Il/ RanGTP complex binds to the NPC and translocates to
the cytoplasm directly. Importin-a. is exported by its export receptor CAS. GTP
bydrolysis causes the rclease of the import receptors from RanGTP (in the case of
importin-~) and CASlRanGTP (in the case of importin-a). Importin-o. and Il are now
able to bind other NLS-bearing proteins for subsequent rounds of import.
Abbreviations: a and Il, importin-a and -Il respectively; NLS indicates the import
substrate.

The processes of nudear protein import are schematically shown in figure
1.3.2. In short: importin-a. binds an NLS·bearing protein (1) and is bound by
importin·13 (2). This complex docks at the cytoplasmic side of the NPC and
subsequently is transported through the NPC (3). Exactly how this translocation
occurs is to date unknown (see (Gorlich and Kulay, 1999; Jans et a/., 2000;
Stewart et a/., 2001). Binding of RanGTP to the importin-13 binding site (lBB) on
Importin-a. causes release of Importin-13 (4) from the complex and results in
export of importin-13 to the cytoplasm (5). In the cytoplasm RanBP1 and RanGAP
cause ATP hydrolysis resulting in release of the RanGDP from importin-13 (6). In
tum, binding of RanGTP to importin-a. in the region af the NLS-binding side
causes release of the cargo in the nucleus (7). The RanGTP-lmportin·a. complex
is exported by the transport receptor CAS (8). In the cytoplasm RanBP1 and
RanGAP cause ATP hydrolysis resulting in release of CAS and the RanGOP
from Importin-a., which can be used for subsequent rounds of import (9) (Garlich
and Kulay, 1999).
1.3.5 Regulation of nuclear transport
Nuclear import of proteins is not just dependent on the presence of a
functional NLS. Most proteins containing a functional NLS are not constitutively
translocated to the nucleus, while there are proteins larger than 45 kDa that have
no functional NLS but are actively imported into the nucleus.' This is because
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nuclear translocation is tightly regulated. Cells use regulated nuclear transport in
at least three ways. (Il Cells can use regulated transport as a molecular switch to
control transcription of genes or to regulate transitions in cell cycle. (II) Regulated
transport can also be used as a device to provide a delay between synthesis of a
protein and its ability to act in the nucleus. (III) Regulated nuclear transport is
used to ensure proper maturation of many biological activities as in the case of
mRNA or tRNA or the assembly of ribosomal particles (Izaurralde and Adam,
1998).
Several steps in the movement of proteins across the nuclear envelope
could be targeted for regulation (for review see (Kaffman and O'Shea, 1999;
Vandromme et al., 1996). (a) The cargo itself can be modified in a way that
affects its ability to bind the import or export receptors. (b) The cargo-receptor
complex can be tethered to an insoluble (not freely moving) cellular component
thereby preventing it from binding the NPC. (cl The activity of the soluble
transport machinery can be regulated. (d) The NPC itself might be modified in a
way that affects its transport properties (Kaffnlan and O'Shea, 1999; Vandromme
at al., 1996) and references herein). Examples of each of the mechanisms of
regulation are described below.
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Figure 1.3.3 Model of different mechanisms that directly modulate transcription
factor localization. Phosphorylation of sites adjacent to the NLS can influence the
efficiency of NLS driven import, this can be either (a) positively by casein kinase II, or
(b) negatively by cdc2 kinase. In (c), cytoplasmic retention of the transcription factor is
achieved via a cytoplasmic retention domain in the factor, which binds to a cytoplasmic
anchoring protein. In (d) and (e), the NLS is masked by either intermolecular interaction
with an inhibitor (d), or intra-molecular masking with a subsequently proteolysed
carboxytenninal portion of the molecule (e). In most of these cases phosphorylation or
dephosphorylation (indicated by a circled P) is the event triggering the conformational
changes that will allow nuclear transport of the protein. (Figure is modified from
(Vandromme et al., 1996).
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1.3.5.1 Protein context and competing signals
Possession of an NLS may not be sufficient for the translocation of the
protein into the nucleus: translocation is also dependent on the position of the
NLS within the protein. The NLS has to be exposed on the surface of the proteins
to be accessible by import receptors. An example of regulation of nuclear
transport by controlling aceessability of the NLS is the NF-KB p50/105 protein,
whereby the p50 comprises the N-Ierminal NLS-containing region of the p105
protein. Whereas the p50 protein is mainly nuclear, the p105 precursor is
exclusively cytoplasmic due to intramolecular masking of the NLS (figure 1.3.38)
(Blank at al., 1991; Henkel at al., 1992). This is supported by the observation that
monoclonal antibodies to the NLS recognize native pSO, but fail to recognize
p105, unless it has been denatured (Henkel at al., 1992).
1.3.5.2 Piggy backing into the nucleus
There are examples of proteins larger than 45 kOa, which do not possess
an NLS but are still able to translocale to the nucleus. This is caused by 'co-
transport' with NLS-bearing proteins, so-called 'piggy back'. For example the
non-histone nuclear high-mobility group protein, HMG1, is able to co-transport a
specifically reacting 17o-kDa monoclonal antibody to the nucleus. Also. the
predominant localization of the NLS-deficient cyclin dependent kinase cdc2 in the
nucleus is believed to be through complex formation with Cyclin e, which
possesses three putative NLS. (reviewed in (Jans and Hubner, 1996).
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1.3.5.3 Regulated or conditional nuclear translocation
Advantages for cytoplasmic localization of a transcription factor include
the potential to control its nuclear activity and direct accessibility to cytoplasmic
signal transducing factors. One mechanism regulating nuclear protein import is
cytoplasmic retention, whereby a cytoplasmically localized "anchor" protein or
retention factor specifically binds an NLS containing protein and prevents it from
migrating to the nucleus, as is the case for Xenopus Zinc-finger protein XNF7
and its homologue in the newt, Pwa33 (figure 1.3.3c). The maternally expressed
transcription factor XNF7 is first detected in the oocyte nucleus and then
released into the cytoplasm after maturation. After fertilization the protein is
retained in the cytoplasm until it re-enters the nucleus at MBT (Li et af., 1994a).
The state of XNF7 phosphorylation has been shown to regulate its nuclearl
cytoplasmic distribution. The cytoplasmic fonn of XNF7 is hyperphosphorylated,
whereas the nuclear entry at MBT is coincident with its dephosphorylation, which
results in release from its cytoplasmic anchor and subsequent nuclear import (Li
et 8/., 1994b). Cytoplasmic retention has also been described for c-fos, Xenopus
MyoD. glucocorticoid receptor. an·(j B-type cyclins (reviewed in (Jans and
Hubner, 1996; Vandromme et 8f., 1996). Cytoplasmic retention is dominant over
the function of the NlS. even in the presence of an additional NlS.
Another example of regulated transport is NLS masking (figure 1.3.3d,e). The
definition of Nl$ masking is when the NlS is not exposed on the surface of the
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protein so it cannot be recognized and bound by the import receptors. This can
be a result of different mechanisms:
• Intra- and intermolecular masking
An example of intramolecular masking is the masking of an NlS by the C.
terminus of p105, a precursor of NF-KB p50 (Blank at al., 1991; Henkel at al.,
1992) as described previously.
The active form of NF-KB is composed of the p50 and p6S (Rei A) protein
components. The NF·K.B·binding inhibitor protein h,B functions in retaining the
NlS-carrying NF-KB p6S subunit in an inactive complex in the cytoplasm, by
masking its NLS. Release from retention is effected by proteolytic degradation of
IKB, which is triggered by IKB phosphorylation, and results in unmasking of the
NF-KB p65-NlS (zabel et al., 1993). This is an example of intermolecular
masking.
• NLS masking by phosphorylation
Phosphorylation sites in the vicinity of an NLS can influence the binding of
the NLS to importins by changing the conformation or the charge. An example of
NlS masking by phosphorylation is the cell cycle dependent exclusion of the S.
cerevisiae TF SWIS. Nuclear translocation of SWI5 is affected by
phosphorylation .by cdc28 (Moll at al., 1991), reviewed in (Jans and Hubner,
1996; Kaffman and O'Shea, 1999).
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1.3.5.4 Phosphorylation enhancing NlS dependent transport
A wel1-described example of phosphorylation enhancing nudear import
comes from the casein kinase 2 (CKII) site dose to the NlS (figure 1.3.3a).
Phosphorylation on this site greatly influences the import kinetics; it increases the
rate of import such that there is a maximum accumulation within 20 minutes
compared to an import rate of dose to 10 hours when phosphorylation is
prevented. Aspartic acid can simulate phosphorylation at the CKII site in terms of
accelerating the rate of nudear import, implying that the negative charge
provided by the aspartic acid residue at the CKII site is mechanistically important
in this process (Jans and Jans, 1994).
In c·Rel, phosphorylation on a site 22 amino acids N-terminat of the NlS,
by protein kinase A (PKA) has shown to enhance the import. Substitution for
alanine at this site abolishes nudear localization of the c-Rel protcroncogene,
while substitution with an aspartic acid residue stimulated nuclear transport. The
22 amino acid distance seems to be critical for the function of this PKA site. The
PKA site is conserved between other members of the ReI family (Kidd, 1992).
1.3.5.5 Developmentally regulated NlSs
Altemative NLS. different from the classic NlS have been described. One
example i's developmentally regulated NlS. which are only functional during
specific stages of embryonic development (Standiford and Richter, 1992). A
developmentally regulated NlS (drNlS) has been reported for a 45 amino acid
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region of the adenovillJs E1a protein (Standiford and Richter, 1992), which is
distinct from the constitutive E1a NLS 285KRPRp289. This drNLS is functional in
targeting a cartier protein to the nucleus up to the neurula stage of Xenopus
embryonic development, when it is activated in a hierarchical fashion among the
embryonic germ layers (Standiford and Richter, 1992). Significantly, a sequence
homologous to the drNLS of E1a has been identified in the rat and mouse and
human glucocorticoid receptor (GR) hormone-binding domain (Picard et al.,
1966).
1.3.5.6 CcN motif and phosphorylation regulated NLS
There appears to be a consensus of phosphorylation sites close to the
NLS, which modify the action of these NLSs. The phosphorylation sites. together
with the NLS constitute phosphorylation mediated regUlatory modules for nuclear
localization, referred to as phosphorylation-regulated NLS (prNLS) (Jans, 1995).
Phosphorylation can inhibit or enhance nuclear translocation (Figure 1.3.3a, b).
An example of phosphorylation-regulated NLS is found in the SV40 large
T·antigen. The SV40 large T-antigen contains a specified prNLS. consisting of
both enhancing and inhibitory phosphorylation sites. The CKJI site increases the
rate of NLS-dependent nuclear import, whereas phosphorylation at the cdc2 site
adjacent to the NLS inhibits transport, maf1(edly reducing the level of maximum
nudear accumulation (Figure 1.3.3a, b) (Jans at 81.,1991). The CKII and cdc2
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sites appear to function completely independent of one another. This regulatOf)'
module is called a CcN motif, for .QKII, gjc2 and MLS (Jans et al., 1991).
Phosphorylation of the cdc2 kinase site in the vicinity of the NLS in SV40
large T-Ag inhibited nuclear translocation by about 70% in transfected HTC (Rat
hepatoma) cells (Jans, 1995). Substitution of this phosphorylation site to alanine
mimiced a dephosphorylated amino acid and resulted in increased nuclear
translocation of the SV40 large T-Ag. However, substitution with aspartic acid
mimiCed a phosphorylated amino acid because of the presence of a negative
charge and resulted in cytoplasmic localization of the SV40 large T-Ag.
The casein kinase 2 (CKI1) site in the CcN motif is known to be important
for the rate of nuclear import (Jans and Jans, 1994). Phosphorylation on this site
greatly influences the import kinetics; it increased the rate of import such that
there is a maximum accumulation within 20 minutes compared to an import rate
of close to 10 hours when phosphorylation is prevented. Aspartic acid can
simulate phosphorylation at the CKII site in terms of accelerating the rate of
nuclear import, implying that the negative charge provided by the aspartic acid
residue at the CKII site is mechanistically important in this process (Jans and
Jans, 1994).
A variety of proteins possess putative CcN motifs, including oncogene
prodUcts, viral proteins as well as transcription factors. More specifically, CcN
motifs have been described for mSTl1 (Longshaw et af., 2000), p53 (Bischoff at
al., 1990), lamin (Loewinger and McKeon, 1988), nucleoplasmin (Dingwall at af.•
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1966; Robbins et al., 1991), SWI5 (Jans et al., 1995) and nucleolin (Schwab and
Dreyer, 1997).
Other kinases have been implicated in the regulation of protein import, in
particular the cAMP..cIependent kinase (PKA). Direct phosphorylation by PKA is
shown to regulate nuclear import of the Rei famity of nuclear factors (Mosiatos et
al., 1991). This PKA site is not in the vicinity of the NLS, showing that regulation
of nuclear import by phosphorylation can occur at any site within the protein. An
advantage of using phosphorylation as a mechanism to regulate nuclear import is
that phosphorylation occurs quickly and it is a reversible process, ensuring rapid
regulation of cellular processes, which are dependent on the import of these
molecules (Jans and Hubner, 1996; Kaffman and O'Shea, 1999).
1.3.5.7 Regulation of the soluble transport machinery
The soluble transport machinery includes the importins, exportins and
components of the RanGTPase cycle. These factors could easily be targeted for
regulation, but not a lot of infonnation is available to date. However, evidence
has shown that import· receptors can be tissue specific and have different binding
efficiencies for different NLS (Goriich 'and Kutay. 1999; Kohler et a/., 1999). Also
the change in localization of importin-a in response to cell cycle position is shown
in Drosophila. Pendulin (an importin-o. orthologue in D. melanogaster) enters the
nucleus at the onset of mitosis (Kussel and Frasch, 1995; Torok at al., 1995).
The mechanism for this change in localization is not known. and it might be
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related to the ability of importin-a. to be phosphorylated (Torok at al., 1995).
However, this change in localization suggests that the relative import- or export
rates of Pendulin are subject to cell cyde regulation, possibly providing a
mechanism to block import of a large number of cargoes during mitosis (Kaffman
and O'Shea, 1999).
1.3.5.8 Regulation of the Nuclear Pore Complex
The amount of NPCs in the nuclear membrane is dependent on the
proliferative state of the cell and thus the need for nudear transport. A
transcriptionally quiescent cell has less NPCs than a cell which is
transcriptionally active (Cordes et al., 1995; Gorlich and Kutay, 1999; Rout and
B10be1,1993).
The specific regulation of NPC has been studied using a unique system:
Tetrahema thermophilia, a unicellular organism that has two nuclei. These nuclei,
the macronucleus and the micronucleus share the same cytoplasm (Gorovsky,
1973). The two nuclei serve distinct cellular functions and share some proteins,
but each also contains a unique set of proteins (Gorovsky, 1973). Because these
two nuclei share the same soluble transport system, it was proposed that the
asymmetric distribution of proteins is caused by different transport properties of
the NPC in the nuclei (White eta!., 1989).
Another example of regulation of NPC is given by experiments that show
that quiescent cells show a slower rate of nuclear import of large gold particles
S4
coated with nucleoplasmin, compared to proliferating cells. However. import rates
of smaller gold particles were not different between these cells, indicating that the
difference in import rates was size dependent (Feldherr and Akin, 1990; Feldherr
and Akin. 1991). Quiescent and proliferating cells were fused together to
investigate whether this difference in import rates was caused by differences in
the soluble import machinery or the NPC. Injection of large gold particles into the
cytoplasm of this heterokaryon showed that import into the nucleus of
proliferating cells was more efficient compared with import into the quiescent
nucleus (Feldherr and Akin, 1993). This supports the notion that activity of the
NPC might be regulated (Kaffman and O'Shea, 1999),
It is clear that the regulation of NLS-dependent nuclear import is affected
at different levels, which provides an excellent mechanism of control of diverse
biological processes.
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1.4 Mesoderm induction early response 1, mi-erl
1.4.1 mj--erllsolation
Xenopus laevis
The mi-er1 gene was first discovered by Paterno et al. (1997) using a
technique called differential display (Liang and Pardee, 1992), to identify and
characterize transcripts that were expressed early during cellular response to
FGF-2 (Paterno et al., 1997). The eDNA sequence isolated from the differential
display was used to isolate a full-length 2.3 kilo-base-pair (kb) cDNA from a
Xenopus blastula library. The cDNA contains a predicted 1497 base pair (bp)
open reading frame (ORF), a 214 bp 5' re9ion containin9 several stopcodons in
all three frames and a 626 bp 3' untranslated region (UTR). The start codon is
shown to be within a Kozak consensus sequence containing a purine at position
-3 and a guanine at position +4. The ORF gives rise to a protein of 493 amino
acids, with a predicted size of 55 kOa, which contains 3 regions of similarity to
the metastasis associated protein, mta-1 (Paterno et af., 1997).
Human
There are 6 isofonns of human MI-ER1 isolated to date, which are
generated by alternative splicing of a single gene. The first fonn of human er1
was isolated by peR from a human testis library using Xenopus mi-er1 (Xmi-er1)
specific primer:: and w~s designated hmi-er1o.. A full-length eDNA containing a
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1296 bp ORF surrounded by a 68 bp 5' and a 210 bp 3' UTR was isolated. The
protein of 432 amino acids was shown to be 91 % similar at the amino acid level
to XMI-ER1 (Paterno at al., 1998). The second human isoform, hmi-erl~, was
isolated by peR from MDA-468, a human breast cancer carcinoma cell line. This
isoform is 1536bp,in,length. hmi-er1o. and ~ are identical in the N-terminus, but
differ at the C-terminus due to alternative splicing of the RNA transcript. Also,
both mi-er1o. and ~ transcripts are formed by use of two transcription start sites,
which have corresponding promoter sites. Inclusion of an alternate exon in either
mi-erla or ~ results in two more isoforms, making a total of six isoforms by
alternative splicing of the primary transcript (Gillespie and Paterno, unpublished
data). It was shown that transcription of different hmi-er1a and Jl transcripts is
derived from at least two different specific promoter regions, which results in
alternative isoforms (Ding and Paterno at af., unpublished data).
1.4.2 Expression of mJ-er1 mRNA
Xenopus
Investigation of mi-er1 showed it is an immediate early gene. Its response
is rapid and not dependent on de novo protein synthesis. The FGF induced
increase in mj-e!1 levels was measured in the presence or absence of
cycloheximide, a known inhibitor of protein synthesis. Cycloheximide inhibited
90% of 35S-methionine incorporation into trichloroacetic acid (TeA) precipitated
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material, but did not prevent the FGF-2 induced increase in MI-ER1 levels,
demonstrating mi-er1 is an immediate early gene.
Northern analysis of RNA extracted from Xenopus faevis embryos at
different stages during development showed the presence of mi-er1 during initial
cleavage stages, prior to the start of zygotic transcription, indicating that mi-er1 is
maternally derived. The levels of mRNA expression were constant during early
cleavage (stages 2, 6 and 7). increased slightly at blastula stage and decreased
6-fold during gastrula, neurula and tailbud stages (stages 12, 17 and 22). The
levels then remained below detectable levels during subsequent development
(stages 30 and 41) (Paterno et al., 1997).
FGF expression was shown to be important for mesodenn induction in
embryonic tissue at blastula stages (Slack et al., 1987), therefore the expression
of mi-er1 at blastula and gastrula stages was examined at 1 hour intervals using
quantitative reverse transcription- polymerase chain reaction (RT-peR). It was
shown that expression levels of mi-er1 increased two-fold from early blastula
(stages 7 and 8) to late blastula (stages 8 and 9) followed by a five fold decrease
at gastrulation (stage 10) (Paterno at al., 1997).
Human
The expression of hmi-er1a. in nonnal and neoplastic tissue has been
investigated and described preViously (Paterno at al., 1998). Expression of hmi-
er1 was barely detectable by Northern blotting of total RNA from eight human
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tissues. Dot blot analysis of messenger RNA confirmed that hmi-er1 was
expressed.at very low levels in 50 normal human tissues. RT-PCR analysis of
breast carcinoma cell lines showed mi-er1 expression, while no mi-er1 was
detected in three normal breast cell lines. Varying levels of mi-er1 were detected
in breast cancer tissues examined.
1.4.3 XMI·ER1 protein expression
In vitro translation of Xmi-er1 followed by immunoprecipitation using an
anti-MI-ER1 antibody and separation of the protein by SDS-PAGE. showed that
although the predicted siZe is 55 kDa, the protein runs around 78 kDa, muCh
higher than expected. This is probably due to the presence of acidic domains in
the N-terminus of the protein, which may alter the net charge of the protein even
when separated on denaturing gels (Bell and Bell, 1988). When transfected into
NIH 3T3 cells. translated MI-ER1 is exclusively translocated to the nuclei of these
cells. indicating that in these cells MI-ER1 is constitutively targeted to the nucleus
(Paterno et a/.• 1997).
The subcellular localization of MI-ER1 during Xenopus laevis development
has been well investigated. Ml-ER1 is expressed during earty stages of
development, but only localizes to the nucleus around the mid-blastula transition.
Using an anti-MI-ER1 antibody against the C-terminus of MI-ER1. protein can be
detected during different stages of development by whole mount staining. Whole
mount staining of albino embryos has shown that MI-ER1 is localized in the
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cytoplasm during early stages, is found to be nuclear in marginal zone cells of
stage 8 blastulae and that, over time, more and more nuclei become stained. By
late blastula stage (stage 9) MI-ER1 is found in all nuclei in the animal
hemisphere and by early gastrula (stage 10) Ubiquitous nuclear staining is
observed. Subsequently, during taitbud stages, nuclear staining decreases and
later in development during tadpole stages, the only nuclear staining detected is
in some endodermal tissue (luchman et al., 1999).
1.4.4 Proteln-elomains in XMI-ER1 and their possible function
Putative domains and motifs found in XMI-ER1 were identified by
computer analysis using computer analysis, like MOTiF
(www.motif.genome.ad.jp).PSORT(psort.nibb.ac.jp) and Domain Architecture
Retrieval Tool (DART; www.ncbLnlm.nih.govIStrueture/lexington/lexington.cgi).
The motifs and domains found are indicated in figure 1.4.1. Since XMI-ER1 and
the hMI-ER1 isoforms are about 90% similar at the amino acid level, most motifs
are found on all predicted proteins. In this section some of the motifs found in
XMI-ER1 will be described.
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Figure 1.4.1 Amino acid sequence of Xenopus MI·ERl, indicating the motifs found
by computer analysis of the sequence. The acidic domains, ELM2 domain, SANT
domain. proline rich region and putative NLS are indicated, see boxed legend.
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51 FTSEIEHLER ESEMPIDELL RLYGYGSTVP LPG~NSGCSG
101 EIKDEAIKDS SGQEDETQSS NDDPTPSFTC RDVREV~FDTNHE..
151~YVPSEDWK!S.~J!1YCi~£g~~lfY.~S!t~_I~~v;,y~~l2.~
201 'z1.~e.s..XY!:lS..fJl.nq,F.!~S~.s.Ba!.q..5aCiL_!!,~!,p$.£!~'iI_~Q!i~~!.'!.Ell~
251 ~S.N!~~~~.U~.. ~~~_~9-S~~~ ..~~~~X.~~~.~n~X~~.l?f.~~~9
301 _~_~~~~.:.~~~~n~~~~~.KSERYDFFAQ gTRFGKKKlVN LHPGVTDYMD
351 RLLOESESAT SS~"PP_~ TSNSNTSQSE KEDCTASNNT QNGVSVNGPC
401 ArTAYKDEAK QGVHLNGPTI SSSDPSSNET OTNGYNRENV TOOSRFSHTS
451 GKTDTNPDOT N!fPIKRQRM [J;PGKESTGS SEFSQEVFSH GEV*
-acidicdomains
CJ pulative NLS
---~ ELM2 domain
. SANTdomain
~~~~~; proline rich region
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a. Acidic domains
MI-ER1 has four stretches rich in acidic residues, underlined with a solid line in
figure 1.4.1. Stretches of acidic residues have previously been described to be
characteristic for acidic transcription activation domains. Acidic activator domains
were first described in yeast Gal4 and GCN4 activator proteins (Blair at af., 1994;
Hope and Struhl, 1986; Ma and Ptashne, 1987). In the Gal4 protein,
transcriptional activation is mediated by acidic amino acid residues and activation
closely correlates with net negative charge. This indicated that acidic amino acids
are crucial for transactivation. However, several studies with acidic activation
domains indicated the importance of hydrophobic amino acids for activation (Blair
at al., 1994; Cress and Triezenberg, 1991; Lin et af., 1994). Further studies of
acidic domains will help identify conserved amino acids that are important for the
activation function of these proteins (Kistanova at al., 2001).
The possibility of MI-ER1 functioning as a transcription factor was
investigated by testing the transactivation potential of various regions of the MI-
ER1 protein. Constructs containing different regions of MI·ER1 fused to the Gal4
DNA binding domain were used along with a chloramphenicol acetyltransferase
(CAT) reporter plasmid in transient transfections (Patemo at al., 1997). It was
shown that although full length MI-ER1 did not activate transcription, the N-
terminal region (MI-ER1-175) containing all four acidic stretches stimulated
transcription 10-fold. MI-ER1-98, containing only the first three acidic domains
63
stimulated transcription aD-fold. Fusions with other parts of Ml-ER1 did not show
any transcriptional activation. These results indicate that Ml-ER1 has the
potential to function as a transcriptional activator. However, HMI-ER1a. and HMI·
ER1f3 were recently found to have potent transcriptional repression activity (Ding
et al., unpublished data).
b. SANT domain
The SANT domain is similar to the DNA binding domain (OBO) of the
oncoprotein MYB (Aasland et al., 1996). The SANT domain was first found in
S:W13 (a yeast component of the SWI·SNF complex (Peterson and Tamkun,
1995», 80A2 (a component of a histone acetylase complex; (Horiuchi et al.,
1995)), transcriptional co-repressor !i-CoR (Horlein et al., 1995) and IFIIlB (a
basal polymerase 111 transcription factor in yeast; (Kassavetis at al., 1995), hence
the name SANT domain. SANT-myb 080 alignments show a number of highly
conserved residues, including the three tryptophan aromatic residues, which are
shown to be important for formation of the hydrophobic core of the myb repeats.
The similarity of the SANT domain to myb 080s is further supported by the
SANT secondary structure prediction, resembling the homeodomain helix-loop-
helix motif (Aasland at al., 1996). To date, there are 123 aligned sequences as
found by a conserved domain (cd}-search (RP5-8LAST 2.2.1, NC81;
http://www.ncbi.nlm.nih.gov/StructureJcddtwrpsb.cgi).
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The SANT domain of MI-ER1 does not seem to bind DNA directly, and a function
of this domain has not been found in MI-ER1 (Paterno et al., unpublished
results). In CoRest, a transcriptional regulator containing two SANT domains, the
N-terminus, which contains the SANT domain, is shown to be important for the
co-repression function of the protein, due to interaction of the SANT domain with
the histone deacetylases HDAC112. This interaction of the SANT domain with
HDAC1/2 is also shown in MTA1 and MTA2 (Humphrey at a/., 2001; You at af.,
2001). More recently, Stemer et 8/., have shown that the N·terminal region of the
yeast ADA-2 SANT domain is responsible for binding histone acetylase, HAT
(Sterner et af., 2002). Histone deacetylases and histone acetylases are important
regulators of transcription, because of their ability to influence chromatin
structure. By removing acetyl groups from histones, access of the transcription
machinery is inhibited and transcription cannot occur. However, when acetyl
groups are added to histones by histone acetylase (HAT) transcription can occur.
Therefore binding of a transcription factor like MI-ER1 to regulators of
transcription, like HDAC and HAT implicates tight regulation of transcription.
c. ELM2 domain
The ELM2 domain is a sequence similar to that of a domain found in the EGL-
27 protein" as well as in MTA1 (Solari et al., 1999). The ELM2 domain of human
MI-ER1 is found to be responsible for complexing with HDAC1. This is related to
the repressor function of hMI-ER1 (Ding and Paterno, unpUblished data).
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Interestingly, CoRest contains an ELM2 domain upstream of the N-terminal
SANT domain, which was included in the constructs used in the experiments for
the HDAC1/2 interactions. Therefore, it is possible that in CoRest the ELM2
domain and not the SANT domain is responsible for this interaction.
Most proteins that contain a ELM2 domain also contain one or more putative
SANT domains, as predicted by BLAST search (RP5-BLAST 2.2.1, NCBI;
http://www.ncbLnlm.nih.govIStructure/cddlwrpsb.cgi). Presence of a putative
HDAC binding domain and a HAT binding domain within a protein suggests~
operation between these domains in regulating accessibility of the transcription
machinery to the chromatin.
d. Proline rich region
Proline rich motifs are characterized by the presence of the consensus PXXP
tetrapeptide, in which the P represent prolines and X represents any amino acid
residue. This consensus sequence is found in all proline rich proteins identified
(Alexandropoulos et a/., 1995). It is known that SH3 (Src homology 3) domains
(vide il1ffa) recognize proline rich sequences and that all known SH3 binding
proteins contain proline rich regions with at least one PXXP motif
(Alexandropoulos et al., 1995; Cohen at a/., 1995; Lowenstein at af., 1992;
Scorilas at a/., 2001; Spaf\(s et af., 1996; Wang at a/., 2000). PXXP motifs have
been identified in a number of diverse proteins such as epidermal growth factors
(EGF), phosphatidylinositol-3-kinase (PI3'K), and, more recently the small
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GTPase R-Ras protein and members of the R-Ras superfamily such as the Te21
protein (Lowenstein et al., 1992; Wang at al., 2000).
Proline rich regions display a variety of functions, based on the specific and
unique structure of proline in which the side-chain is cyclized onto the backbone
nitrogen atom. This results in a restriction of the conformation of the proline and
its proceeding residue (MacArthur and Thornton, 1991). Due to the relative
rigidity of the polyproline region, the binding with other proteins is weak, which
has great advantages for fast regulation of binding to these regions. Changes in
the sequence of proline rich region or its binding domain, either by' sequence
changes or by covalent modification such as phosphorylation, can alter the
strength of the interaction (Kay et af., 2000). These changes account for the large
variety of proline motifs in proteins.
Proline rich regions are commonly found in situations requiring the rapid
recruitment or interchange of several proteins, such as during initiation of
transcription, signaling cascades, and cytoskeletal rearrangements (Kay at al.,
2000). For example, the proline rich region on son of sevenless (50s1) binds to
the two SH3 domains of Grb2, thereby bringing Sosl to the cell membrane
following receptor activation, where Sosl in tum then activates the Ras pathway
(Williamson, 1994).
A variety of proteins involved in intracellular signal transduction pathways
contain Src homology 3 (SH3) domains. Originally described in the protein
tyrosine kinase Src, thase domains consist of about 50 amino adds (Koch at al.,
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1991) and bind to proline-rich regions in other intracellular proteins. While SH3
domains from different proteins have poorly conserved sequences, they share a
similar overall structure. 8H3-containing kinases such as Lyn and Hck, both
members of the Src family, may use these domains to bind substrates or interact
with regulatory proteins. Other proteins, termed adaptors, are non-catalytic; yet
contain several SH3 and/or SH2 domains. These domains allow them to interact
with multiple protein partners to form cytoplasmic signalin9 complexes. One such
adaptor protein is Grb2, which links son-of·sevenless (80S) and GOP/GTP
exchanger, and the activated tyrosine kinase receptor during initiation of the Ras
signaling pathway. Additional processes that may be dependent upon SH3
function include vesicle trafficking, cytoskeletal organization, and the targeting of
proteins to subcellular locations. These diverse roles make SH3 domains the
subject of intense effort to further elucidate their complex interactions and
functions (for review see Klint and Claesson·Welsh, 1999 and Kay et a/. 2000).
e. Nuclear Localization Signals
NLS are the signals necessary for import of large proteins into the nucleus.
There are many proteins with different NLS, mostly existing of a region of basic
amino acids, arginines and tysines. Initially two putative NL8 were identified in
MI-ER1 as identified by computer analysis using PSORT (http://psort.nibb.ac.jp)
(Nakai and Horton, 1999). Analysis of the basic amino acids and comparison of
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groups of basic amino acids to NLS described in the literature showed that MI·
ER1 has 2 additional putative NLS (Post et al., 2001).
The analysis of the function of each of these NLS and the regulation of nuclear
transport during Xenopus !aevis development will be described in this thesis.
f. Phosphorylation sites
An important feature of signaling molecules is the ability to be phosphorylated
for activation. Putative phosphorylation sites were identified by computer analysis
of the protein sequence using pbase-predict
(www.cbs.dtu.dkldatabaseslPhospho-Base/predicVpredform.html) and NetPhos
(www.cbs.dtu.dklselVicesiNetPhos) (Blom et al., 1999). MI-ER1 has multiple
putative phosphorylation sites, suggesting MI-ER1 may be phosphorylated
(Table 1.4.1). Whether these phosphorylation sites are functional in MI·ER1 has
yet to be investigated.
MI-ER1 is an immediate early gene in response to FGF. The presence of
different conselVed motifs in MI-ER1 implicates an important role in signal
transduction: It has potent transcriptional regulatory activity and is translocated to
the nucleus. indicating a role as a transcriptional regulator. The presence of a
proline rich region, which might function as an SH3 binding domain. and the earty
response to FGF implies a role in the FGF signaling cascade. The presence of
the ELM2 domain, which functions to bind HDAC1, and a SANT domain, which
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may bind HAT, indicates an important function in modulation of chromatin state
and subsequent trans-activation or repression of transcription.
Table 1.4.1 Example of putative phosphorylation sites predicted by pbase...,predlct
and NetPhos.
Phosphorylation site Kinase NetPhos 2.0 prediction
S-10 LRTASPGGS CaMlI, G3K3, PKA 0.993
T·38 DDEQTLEEE CKll 0.977
S-53 VNFTSEIEH CKII 0.804
S-62 LERESEMPI PKA 0.942
S-l11 IKOSSGQEO CKII 0.991
T-191 KYRETEKW PKC 0.972
Y-247 EQALYEHVK ? 0.709
S-308 VRTRSVGEC CaMII, CKlI, p70s6k, 0.995
S-366 SRAPSPPPT CaMII, CKI, PKA 0.996
5--472 QRMDSPGKE CaMIl, p34cdc2, p70s6k, 0.997
PKA.
5--489 QEVFSHGEV CKII 0.973
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1.5 Objective.
Regulation of transcription factors is important for ensuring correct cellular
responses to signal transduction pathways. One step in the regulation of
transcription factors is regulation of nuclear import. Regulation of import can be
modulated by phosphorylationl dephosphorylation of the transported prolein,
masking of the nuclear localization signal(s), cytoplasmic retention by binding to
a cytoplasmic anchoring protein, modulation of the import machinery, and
possibly interplay between these mechanisms.
In this study, the regulation of nuclear import of an FGF immediate early
gene in Xenopus: the transcription factor mesoderm-induction early response 1,
MI-ER1, was examined. MI-ER1 is localized in the cytoplasm of developing
Xenopus laevis embryos and translocates to the nucleus beginning stage 8.
Investigating the type of regulation of nuclear transport will bring us a step closer
in identifying the role Ml-ER1 plays after FGF activation of the signal transduction
pathway.
Objective 1: To identify and characterize NLS sequences found in XMI-ER1.
Analysis of the XMI-ER1 sequence identified four putative NlS, which
might be responsible for the nuclear translocation of XMI·ER1 in cells and during
embryonic development. My hypothesis is that XMI-ER1 is translocated to the
nucleus by binding of the import receptors to one or more of the putative NlS in
MI·ER1, and thus is translocated by active transport.
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A functional NLS is defined as being able to carry a non-nuclear protein
into the nucleus. As well, deletion of the NLS results in cytoplasmic localization of
the protein. According to this definition, the efficiency of each of the four putative
NLS can be determined by addition of a non-nuclear protein, like enhanced
green fluorescent protein (EGFP) or Il-gala.ct0sidase, to each of the NLS regions
and measurement of the ability to translocate to the nucleus. If a region
containing a functional NLS is localized in the nucleus, the necessity of the NLS
can be determined by deletion of the NLS (or part thereof) region in the context
of the full-length protein.
To identify functional NLS in MI-ER1 the protein will be divided into 6
regions. The regions are chosen based on the position of putative NLS in the
sequence. EGFP or f}-GAl will be fused to these regions and the fusion
constructs will be transfected into NtH 3T3 cells. Subcellular localization of the
fusion proteins can be determined by microscopy. After identification of a region
containing a functional NLS, the NLS will be further analyzed by deletion of the
NLS as well as fusion of the smallest NLS region to EGFP or f}-GAL. This will be
followed by transfeetion into NIH 3T3 cells and determination of the subcellular
localization of the overexpressed protein by microscopy.
Objective2: Elucidation of the regulation of XMI-ER1 nuclear translocation
during embryonic development.
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Maternal transcription factors are present in high concentrations in the
developing embryo. If these factors could ttanslocate to the nucleus before MBT,
the high levels present in the nuclei could result in an early start of transcription.
Therefore, regulation of nuclear import of these transcription factors is an
important means by which the cell can ensure that transcription occurs at a
specific time during development.
There are different levels at which nuclear translocation can be regulated,
and the most direct regulation is modification of the transcription factor itself
whereby nuclear import is blocked for this factor only. An important means of
regulation of transcription factors is phosphorylation. Phosphorylation of proteins
is fast and reversible and can enhance or inhibit nuclear translocation by
interfering with the conformation of the protein. Conformational changes can
influence the NLS directly by masking. MI-ER1 contains numerous
phosphorylation sites, including a putative CcN motif as described for the SV40
large-T antigen. Investigation of the function of this site will be performed by
mutational analysis of a putative cdc2 kinase site in the vicinity of the functional
NLS.
Also, conformational changes can influence protein-protein interaction
sites, influencing th~ binding to cytoplasmic anchoring proteins or proteins that
mask the NLS, as in XNF7 and NF-KB, respectively.
My hypothesis is that XMI-ER1 translocation during embryonic
development is regulated by inhibition of the NLS function.· This could occur
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either by NLS masking (as in the case of heB binding to NF-KB) or by binding to
an anchoring protein in the cytoplasm (as in the case of XNF7). Investigation into
the regulation of cytoplasmic retention can be performed by addition of an NLS to
the N-terminus of MI-ER1 and injection into Xenopus embryos followed by
staining of the protein to observe subcellular localization. If addition of the NLS
causes premature nuclear localization of MI-ER1 (before stage 8.5-9) the import
of MI-ER1 is regulated by NLS-masking. Conversely, if MI-ER1 is retained in the
cytoplasm by cytoplasmic anchoring, addition of the NLS will not interfere with
the normal timing of nuclear localization. Moreover, different regions of MI-ER1
can be fused to the additional NLS to investigate the exact region of regulation:
For my experiments, the NLS of XNF7 will be fused to MI-ER1 to test whether
MI-ER1 is localized in the cytoplasm by binding to a cytoplasmic anchor. The
XNF7 NLS was chosen based on an observation of U et al. (1994), that the
XNF7 NLS can translocate to the nuclei of Xenopus embryos before the mid-
blastula stages (U et al., 1994a). In addition, to test if binding to a cytoplasmic
anchor is responsible for the cytoplasmic localization during ear1y Xenopus
development, I will attempt to identify the smallest region in MI-ER1 responsible
for binding the cytoplasmic anchor. If however, localization of MI-ER1 in the
cytoplasm is due to NLS masking, I will investigate whether masking is intra- or
intermolecular.
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Chapter 2 Materials & Methods
2.1 Generation of constructs
Constructs were generated for use in cell culture as well 85 for use in
Xenopus laevis embryos. Amino acid residues are numbered from the start of
translation (1) to the stop codon (493), as shown in figure 2.1.
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Figure 2.1 Amino acid sequence orXenopus lae.·u MI·ERJ.
The four putative NLS are indicated by solid lines, the dashed line indicales NLS4,
including thc regions flanking the basic core of the NLS.
MAEPSLRTAS PGGSAASDDH EFEPSADMLV HEFDOEQTlE EEEMLEGEVN
51 FTSEIEHlER ESEMPIDEll RlYGYGSlVP lPGEEDEEDM DNDCNSGCSG
1
101 EIKOEAIKOS SGQEO€TQSS NOOPTPSFTC ROVREvIRPifRCi{YFOTNHE
151 IEEESEOOEO YVPSEOWKKE IMVGSMFQAE IPVGICKYRE TEKVYENDOQ
201 llWNPEYVME ERVIDFlNEA SRRTCEERGL OAIPEGSHIK ONEQ4.lYEHV
2
251 KCNFOTEEAl RRlRFNVKAA REElSVWTEE ECRNFEQGlK AYGKDFHlIQ
3
301 ANKVRTRSVG ECVAFYYMWK KSERYOFFAQ QTRFGKKKYN lHPGVTOYMO
351 RlLDESESAT SSRAPSPPPT TSNSNTSQSE KEDCTASNNT QNGVSVNGPC
401 AITAYKOEAK QG~ SSSDPSSNET OTNGYNRENV TDOSRFSHTS
451 GKTDTNPOO-'= -NEC!iPIKRQRM - DS'PGKESTGS SEFSQEVFSH GEv'"
- NlS basic regions
'-"'NLS4 + flanking regions
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Table 2.1 Amino Add sequences of all constructs used.
Construct name Amino acids Sequence
EGFP N/A
EGFP-ER1 1-493 MAEP ..GEV·
EGFP-ER1-143 1-143 MAEP ..RRCK
EGFP-ER1-137 1-137 MAEP.. REVI
EGFP-ER145-250 145-250 FDTN ..YEHV
EGFP-ER251-319 251-319 KCNF ..YVMW
EGFP-ER251-340 251-340 KNCF ..KKYN
EGFP-ER339-493 339-493 YNLH ...GEV·
EGFP-ER1-461 1-461 MAEP ..DDTN
EGFP-ER1-473 1-473 MAEP ..MDSP
EGFP-6NLS4 6464-467 6PIKR
EGFP-NLS1 136-143 VIRPRRCK
EGFP-NLS2 259-273 ALRRLRFNVKAAREE
EGFP-NLS3 317-341 MWKKSERYDFFAQQTRFGKKKYN
EGFP-NLS4a or 461-471 NERPIKRQRMD
EGFP-ER461-471
EGFP-NLS4b or 457-475 PDDTNERPIKRQRMD$PGK
EGFP-ER457-475
EGFP-6NLS1 6138-141 6RPRR
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EGFP-;NLS3 ;320-338 ;KKSERYDFFAQQTRFGKKK
EGFP-aNL$1+ 6138-141 + 6RPRR + JOlUKK + liKKK
6NLS3 320KK=M+6336-
338
EGFP-ER1 SPGK 1-493, "'A .. RMDAPGK...
~APGK
EGFP-ER1 SPGK 1-493, N ...RMDNPGK...
~NPGK
EGFP-ER1 SPGK 1-493, 0 ...RMDDPGK...
~ DPGK
EGFp·ER339-493 339-493, A ...RMDAPGK...
SPGK~ APGK
EGFP-ER339-493 339-493, N ...RMDNPGK...
$PGK -7 NPGK
EGFP-ER339-493 339-493, 0 ...RMDDPGK...
SPGK-70PGK
EGFP-ER457-475 457-475, A ...RMDAPGK...
SPGK~ APGK
EGFP-ER457-475 457-475, 0 ...RMDDPGK...
SPGK~ DPGK
~·GAl or c-f3GAL NIA
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nj}-GAUor SV40 NLS PKKKRKV
jl-GAL-NLS
jl-GAL-XNF7NLS XNF7 NLS KTPQKRKIEEPEPEKKAK
p-GAL-ER1 1-493 MAEP. .GEIr
jl-GAL-ER1-137 1-137 MAEP ..REVI
jl-GAL-ER1-143 1-143 MAEP ..RRCK
jl-GAL-ER145-250 145-250 FDTN ..YEHV
jl-GAL-ER251-340 251-340 KNCF. .KKYN
p-GAL-ER339-493 339-493 YNLH ..GEIr
p-GAL-ER461-471 461-471 NERPIKRQRMD
jl-GAL-ER457-475 457-475 PDDTNERPIKRQRMDSPGK
jl-GAL-"NLS4 .0.464-467 .o.PIKR
jl-GAL-XNF7NLS- 1-282 MAEP ..EEEC
ER1-282
jl-GAL-XNF7NLS- 267-493 VKAA...GEV-
ER267-493
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2.1.1 Generation of EGFP·ER1 fusion constructs
2.1.1.1. peR
For all constructs, full length Xenopus laevis er1 cDNA in PCR2.1 was
used (described in (Patemo et al., 1997). For the generation of EGFP-ER1
fusions, different regions' of er1 were amplified by PCR with er1 specific primers,
see Appendix B: EGFP-ER1 1-493: er14 and er13; EGFP~ER1 1-130: er14 and
er26; EGFP-ER1 1-144: er14 and er28; EGFP~ER1 145-250: er29 and er30;
EGFP-ER1 251-320: er31 and er25; EGFp·ER1 251-340: er31 and er32; EGFP-
ER1 339-493: er27 and er13; EGFP-ER1 1-461: er14 and er34; EGFP-ER1 1-
473: er14 and er35; EGFP-ER1 339-473: er27 and er35; EGFP-NL$-3: er24 and
er25; EGFP-ER1 457-475 (NlS4 b): er38 and er39; EGFP-ER1 457-493: er38
and er13; EGFP-ER1 44&493: er50 and er13. The primers contained Byl If
(agatct) or Sal I (gtcgac) specific regions to facilitate doning (underlined in primer
sequence). The PCR was performed with Pfu Taq (Promega Co.) for accurate
amplification. The 6Nl$1 and 6,Nl$3 were generated by three separate PCRs,
as follows: 2 complementary primers were designed to contain the deletion and
span the flanking regions. The first peR was performed with primer Xen1as
(.1RPRR) or Nl$2as (6bipartite) and primer er14. The second PCR was
performed with primer Xen1s (6RPRR) or NlS2s (6bipartite) and primer er13.
The PCR products for 6RPRR or 6bipartite were then combined and heated to
95°C for 10 minutes and then slowly cooled to RT. A third PCR was then
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performed with primers er13 and er14, creating a full length er1, lacking RPRR or
KKSERYOFFAQQTRFGKKK region, which was then cloned into PCR2.1 (TA
doning, Invitrogen). After plasmid extraction (miniprep Wizard SV, Promega
corporation), the DNA was digested with Bg/II (Invitrogen), and the insert was
ligated into EGFp·C2 (Clontech laboratories Inc.) and sequenced (Sequenase,
version 2, United States Biochemical).
2.1.1.2 Ligation of PCR products Into PCR 2.1
The PCR products were treated with TaQ polymerase to create a TA·
overhang (Invitrogen Laboratories Co.) and ligated into PCR 2.1 according to the
manufacturer's protocol (TA doning or TOPO cloning, Invitrogen Laboratories
Co.). After transformation, a single colony was picked and grown in LB containing
100 ~gl ml ampicillin oIn at 370 C at 225 rpm. The plasmid DNA was then
isolated as described in 2.1.1.6.
2.1.1.3 Digestion and purification of inserts from PCR2.1
PCR2.1 containing the desired insert, were digested with restriction
enzymes (Invitrogen Laboratories Co.) of which the recognition sites were
incorporated in the primers. The digested inserts were gel purified from a 1%
agarose gel in modified TAE (40 mM Tris-acetate pH8.0, 0.1 mM Na2EDTA)
using Ultrafree DA filters (Millipore corporation).
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2.1.1.4 Generation of small fusion constructs.
For the constructs EGFP-NLS1, EGFP-NLS2 and EGFP-NLS4a. two
complementary oligonucleotides (Oligo's Etc.) of the region of the putative NLS
were annealed by heating the complementary oligonucleotides (see below)
together to 95°C and slowly cooling down to RT. EGFP-NLS1: er23K and er33;
EGFP-NLS2: er36s and er36a; EGFp·NLS4: er37s and er37as. After cooling
down, the strands were treated with T4 DNA Kinase (Invitrogen Inc.) according to
the manufacturers protocol. The enzyme was then removed from the reaction
mixture with the enzyme removal filters (Millipore Corporation). The DNA was
ligated into Egfp-C2 (Clontech Laboratories Inc.) and transfonned into XL 1-Bfue
cells.
2.1.1.5. Ligation of purified inserts into EGFP-C2.
After purification, the inserts were directly ligated into the Bgf If site of the
EGFP-C2 expression vector (Clontech Laboratories Inc.), using T4 DNA ligase
according to the manufacturers protocol (Invitrogen Inc.). After transfonnation
into chemically competent XL 1-Bfue cells, and selection on LB plates containing
30 I!g/ml Kanamycin, the colonies were screened by PCR with one mi-er1
specific 3' primer and a 5' vector primer PCZ·S'.
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2.1.1.6. Plasmid isolation and pUrification
For transfection, transformed XL1-Blue cells were grown oIn in 200 ml LB
containing 30 I1g/ml Kanamycin or 50 mglml ampicillin and plasmid DNA was
isolated by large' or midi scale plasmid preparation kits (maxi-prep: Concert,
Invitrogen, midi-prep: high speed plasmid preparation. Qiagen Inc.). Before use,
all constructs were sequenced (Sequenase Version 2.0, United States
Biochemical), according to the manufacturer's protocol.
2.1.2 Deletion or substitution of single or multiple amino acids
For the generation of constructs that only differed from the wild type
sequence by 1-4 amino acids, the Quick·Change mutagenesis™ kit was used
(Stratagene Inc.), according to the manufacturer's protocol, with the following
primers: for the cdc21 PKA phosphorylation site in ER1-493 and ER339-493: S ~
N: er40K and er40R; S~A er41K and er41R; S~ 0: er53K and er53R; in
ER457-475: S~A: er45K and er45R; S ~ 0: er46K and er46R. The ~PIKR
constructs were generated using the primers er51K and er51 R.
2.1.3 Generation of gf~r1 fusions into pT7Ts
Primers were generated against the EGFP-C2 vector, a sense primer
against the start of the egtp gene and an anti-sense primer against the stop-
codon of the egfp-C2 plasmid which is located after the MCS, thus a PCR product
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could be generated spanning the multiple cloning site containing the different
Xer1 inserts. These primers had Xbal restriction recognition sites (tctaga) and
were used to subclone the egfp-fusion constructs into the Xbal site of the pT7Ts
vector (Cleaver et al., 1996). PCR were performed using ?tu Taq (Promega
Corporation) and PCR products were TA or Tapa cloned (Invitrogen) before sub
cloning into pT7Ts, as described before for the egfp-c2 constructs.
2.1.4 Generation of p-galactosidase.r1 fusion constructs
Inserts for the l3-galaetosidase-CS2+ vector (Rupp et al., 1994; Tumer and
Weinlraub, 1994) were subcloned by PCR from the e9fp-c2 constructs using a
sense primer against the MCS (pEGFP-S') 5' of the insert and gfp-as. This was
done to create the right reading frame for fusion with l3-galactosidase. The PCR
products were treated as described above and ligated into the Xbal site of the ~
gal-CS2+ vector.
~-gal-CS2·-Xnf7NLS was generated by annealing of primers Xnf7s and
Xnf7as (Li et al., 1994a), see Appendix B for sequence) after which the dsDNA
strands were treated with T4 DNA Kinase (Invitrogen Inc.) according to the
manufacturers protocol. The enzyme was then removed from the reaction
mixture with the enzyme removal filters (Millipore Corporation). The DNA was
ligated into the Xhol site of the ~al-CS2· vector.
~·gal-xnf7NLS-ER1-282 and ~-gal-xnf7NLS-ER267 -493 were generated
by PCR using primers er54, er55, er56 and er57 and full length Xenopus laevis
8'
er1 eDNA in PCR2.1 as a template. PCR was performed as described before.
After digestion of the peR products with Xbal, the inserts were ligated into the
XbaJ site of 13-gal-CS2· using T4 DNA ligase as described before.
2.1.5 Sequencing
All constructs were sequenced using Sequenase Version 2.0, (United
States Biochemical), according to the manufacturers protocol.
2.2 Cell culture
2.2.1 Materials
Most of the materials used for cell culture were supplied by Invitrogen,
including DMEM, Penicillinl Streptomycin, Trypsin. Galf serum, Fetal Bovine
serum, and cell culture plates. NaCI (BDH), KCI, KH2P04, Na2HPOi7H20,
NaHP04 , EDTA and Paraformaldehyde were supplied by Fisher Scientific.
2.2.2 Methods
NIH 3T3 cells (American type Culture Collection, ATCC, USA) were grown
in DMEM containing 3.7 gIl NaHC03 , 7.5 % Calf serum, 2.5% Fetal Bovine
serum and antibiotics 50 U Penicillin, 50IJgJml Streptomycin; at 37 ·e. 10% e~.
Cells were trypsinized in 0.025% trypsin in PBS (137 mM NaGl, ,2.7 mM KCI, 1.4
mM KH2P04. a 1 mM Na2HP04· 7H20 pH 7.4 with HCIY 1mM EDTAevery 3 days
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and diluted 1:5 into a fresh 100 mm tissue culture dish. Stocks of cells were
frozen at ·70°C in Calf serum containing 10% DMSO. 1x10fl cells were frozen in
a freezing vial (Nalge Nunc International) at a rate of 1°CI minute in a 2·propanol
container. When thawing the cells, the vial was submersed in 3JOC water to
quickly thaw the cells. The cells were washed in 10 ml DMEM and plated into a
100 mm cell culture dish containing DMEM and 10% serum, as described above.
2.3 Transient transfection of NIH 3T3 cells
Cells were plated at a density of 2x105 cellslwell in a 6 well tissue culture
dish and left to grow oln in DMEM containing 10% serum and antibiotics (see
under cell culture). The next day, cells were transfected with 0.5-2 ~g plasmid
DNA. For transfeetion, LipofectAmine plus (Invitrogen Inc.) was used according
to the manufacturer's protocol with the following modifications: 0.5- 2 ~g plasmid,
6 ~l Plus reagent and 6 ~l LipofeetAmine were used. Twenty·four hours after
transfection cells were trypsinized with 0.025% trypsin (Invitrogen) in PBS/EDTA
and plated into a 6 well·plate for analysis of the overexpressed protein and on to
chambe"r slides (Labtek, Nalge Nunc International) for microscopic examination.
Forty-eight hours post transfection the cells were lysed for protein assays (see
section 2.3.2). Cells grown on the chamber slides were fixed with 4%
Paraformaldehyde in PBS (pH7.2) and treated as described below.
All analysis of transiently expressed proteins was performed 48 hrs post·
transfection because the highest level of protein expression was detected at this
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time. using fluorescence microscopy and Western Blot analysis (as described in
section 2.4).
2.3.1 Microscopic examination of transfected cells
2.3.1.1 Detection of fluorescent proteins
Cells transfected with EGFp·C2 vectors. expressing enhanced green
fluorescent protein fused to the protein of interest. were washed twice in PBS
and fixed in 4% Paraformaldehyde for 20 minutes at RT. After fixation. the cells
were washed twice in PBS and were stained by incubation with 10 ng/ml Hoechst
33342 in PBS for 10 min. After washing in PBS, the cells were mounted in 10%
glycerol in PBS, viewed by combined f1uorescenceJ brightfield microscopy on an
Olympus BH2 microscope using DplanApo/UV objectives and the images were
captured with a Coolsnap digital camera. Localization of the nuclei within the
cells was determined by staining of the DNA with Hoechst 33342, which resulted
in a blue stain when viewed by fluorescence microscopy using a DAPI filter (406
nm). Hoechst 33342 binds AT pairs in the DNA and can enter cells that are fixed
as well as live (Holmquist. 1975; Shapiro. 1981).
Cells were scored as either N (exclusive nuclear staining). N>C (nuclear
fluorescence was greater in intensity than cytoplasmic), or we (whole cell
fluorescence. in which nuclear fluorescence was equal in intensity to cytoplasmic
staining). No nuclear exclusion of the overexpressed protein was observed after
transfection of these constructs, since EGFP was able to diffuse' into the nucleus.
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All transfections were pertormed in NIH 3T3 cells. EGFP-fusions generally
displayed transfection efficiencies between 10 and 40 %, meaning that 10-40%
of the total cells expressed EGFP. Cells transfected with 130gal fusions displayed
transfection efficiencies between 50 and 70%. For each construct that was
transfected at least 500 intact cells containing transient protein were counted.
Cells that showed abnormal morphology and cells where the nuclei could not be
distinguished were excluded from the count.
2.3.1.2. Immunocytochemistry
Transfected cells were grown on chamberslides as described above and
MI-ER1 protein was detected by immunocytochemistry using an anti-rabbit
detection system (Santa Cruz Biotechnology ABC staining system) using an anti-
ER1 antibody. The anti-MI-ER1 antibody was generated by injection of the
peptide 4&lPIKRQRMOSPGKESr7B into rabbits. The polyclonal antibody was
used directly from the diluted serum of the rabbits. The staining procedure was
as follows: after fixation in 4% Paraformaldehyde in PBS, the slides were washed
in PBS, then incubated for 10 min in 0.2% Triton X-100 in PBS. The slides were
then incubated for 20 min in 1.5% normal goat serum in PBS (normal blocking
serum) and then directly transferred to a solution containing the primary antibody
(against the C-terminus of XER1, see table in section 2.4; a 1:1000 dilution) in
normal blocking serum and incubated at RT for 2 hrs. The slides were then
washed in 0.2% Triton X-100 in PBS twice for 10 min each. The slides were
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incubated in normal blocking serum containing a secondary antibody
(biotinylated goat-anti rabbit IgG; 1:200) for 30 min at RT followed by washing in
0.1% Triton X-100 in PBS for 3 min and PBS for 3 min. An avidin-biotin-HRP
complex was added to the slides for 30 min followed by washing in PBS for 3
min. Detection was performed by DAB staining (Sigma-Aldrich) for 4-7 min or
until color developed. The gasket was then removed from the slides and the
slides were mounted in a PBS/10% glycerol solution.
2.3.1.3 X-gal staining of transfected NIH 3T3 cells
Cells were grown in chamberslides as described and 24-48 h poSt-
transfection cells were washed in PBS and incubated for 15 min. in fresh 4%
paraformaldehyde in PBS. After fixation the cells were washed for 10 min in
wash buffer (PBS containing 5 mM EGTA, 2 mM MgCI2. 0.01% (wlv)
deoxycholate and 0.02% (vlv) Nonidet P-40) then placed in staining buffer (wash
buffer containing 1 mg/ml X..gal (dissolved in DMSO). 10 mM potassium
ferrocyanide, 10 mM potassium ferricyanide) and incubated at 37 °C for 30-60
min. or until color developed. After staining the cells were washed in PBS for 20
min. and then fixed in 4% Paraformaldehyde for 20 min. The cells were washed
in PBS and then embedded in 10% (vlv) glycerol in PBS and covered with a
large coverslip (24x60 mm) before viewing under the light microscope.
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2.3.2 Cell lysis for direct Western Blot
Transfected NIH 3T3 cells were plated at 3x105 cells! well and left to grow
oIn. After washing in cold PBS on ice, cells were then lysed in protein sample
buffer (0.125 M Tris pH 6.8, 2% 50S. 5% 13-mercaptoethanol, 2% glycerol) and
kept on ice. A determination of the protein concentration was performed with the
Bio-Rad protein assay kit, (Bio-Rad laboratories). 100-l.Ig total protein was
separated on a 10% acrylamide gel (all components of the electrophoresis and
transfer apparatus (systems Protean II and Ill) were pUrchased from Bio-Rad
Laboratories). The separated protein was transferred by electro-blotting on to a
nitrocellulose membrane (Hybond™ ECl'"", Amersham Pharmacia Biotech).
2.3.3 Immunoprecipitation of proteins
Transfected cells were plated at 3x105 cellslwell in a 6-well plate and
allowed to grow oIn at 3rC in a 10% C02 incubator. After washing the cells in
cold PBS the cells were lysed in cold Triton buffer (10 mM Tris pH 7.5,1% Triton
X-100, 10 mM Na2EOTA, 0.002% sodium-azide) and extracts were left on ice for
20 minutes. The soluble proteins were separated from the insoluble proteins by
centrifugation at 12,OOOxg in a mini centrifuge (Eppendorf). The soluble proteins
(supernatant) were transferred to a fresh eppendorf tube and an antibody was
added to precipitate a specific protein. Th,e antibody-protein mixture was
incubated at 4°C for 1hr to OIN (depending on the antibody) with gentle rotation.
After this incubation, 50 J.l1 Protein-A·Sepharose (1 mg/ml, Amersham Pharrnacia
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Biotech) was added to each immunoprecipitation mixture to bind the antibody
and the mixture was incubated at 4°C for 1 hr with gentle rotation. The protein-A-
sepharose-antibody-protein complex was washed 4x with Triton-buffer and 4x
with 150mM NaC!. After washing, the protein was released from the protein-A-
sepharose-antibody complex by adding 30~1 protein sample buffer (0.125 M Tris
pH 6.8, 2% 50S, 5% jl-mercaptoethanol, 2% glycerol) and boiling for 4 minutes.
The protein was separated on a 10% acrylamide gel and transferred to a
nitrocellulose membrane (Hybond ECL, Amersham Phannacia) by electro-
blotting.
2.4 Western Blot Analysis
2.4.1 Materials
The nitrocellulose membranes were purchased from Amersham
Pharmacia Biotech (Nitrocellulose Hybond ECl). Prestained high and low
molecular weight markers, protein-concentration estimation dye and
polyacrylamide (30%) were purchased from Bio-Rad Laboratories. Detection was
performed with chemiluminescence using Femtolucent"Tl.4 (Chemicon
lntemationallnc.). ECll"M.hyperfilm (Amersham Phannacia Biotech) was used for
the detection.
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Table 2.2 Antibodies used for immunocytochemistry, immuDoprecipitation and
Western blot analysis
Name Epitope 50"= Concentration Incubalion
Rabbit-antiMI- C-Ierminus MI-ERl Patemol Gillespie 1:3000 ",
ER' PIKRQRMDSPGKEsT
Anti-GFP GFP Clontech 1:1500 OIN
labofatorieslnc.
Goat anti For use with anti-MI- Amersham 1:3000 ",RabbitlgG- ER1 Ab F't1armacia Biotech
HRP
Sheep anti For use with GFP Ab Amersham 1:1000
'"'Mouse IgG- F't1armacia Biotech
HRP
2.4.2 Methods
After transfer of the proteins to the nitrocellulose membrane, the
membrane was incubated in 5% blocking powder (Chemicon Intemationallnc.) in
TBS-T (20 mM Tris, 137 mM NaCI, 1% (v/v) Tween-20, pH 7.6) for 30 min. and
then washed in large volumes of TBS-T for 30 min. The membrane was then
incubated in TBS.T containing a primary antibody (see table 2.2 for list of
antibodies used, concentration and incubation time for each antibody). After the
first antibody incubation the membrane was washed in large volumes of TBS·T
for 1 hr and then the secondary Ab (see table 2.2) was added in TBS.T and
incubated for 1 ·hr, after which the membrane was washed in TB$-T before
detection of the protein with the FemtolucentTlrol detection system and exposure
on ECl™_HyperfilmTM (Amersham Pharmacia).
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2.5 FertJllzation of Xenopus laevls eggs
2.5.1 Materials
Xenopus laevis were purchased from Nasco International Inc.. Human
Chorionic Gonadotrophin hormone and cysteine were supplied by Sigma-Aldrich.
NaCI (SOH), KCI, Ca(N03n'4H20, MgSO~, Na2HPO~'7H20, EGTA, EDTA,
HEPES were supplied by Fisher Scientific.
NAM (normal amphibian medium; Slack. and Forman, 1980) consisted of
110 mM NaCI, 2 mM KC1, 1 mM Ca(N03n'4H20, 1 mM MgSO~'7H20, 0.1 mM
Na2EDTA, 100 mM HEPES, pH 7.5)
2.5.2 Methods
Mature eggs were isolated and artificially fertilized as per Godsave et at.
(Godsave at al., 1988). Approximately 16 hours before eggs were needed, 500
I.U. of HCG hormone was injected subcutaneously into the upper hind leg of a
female Xenopus laevis, just above the cloaca. Within 12·18 hours, the female
began to lay eggs. which were collected on a plastic petri dish.
Eggs were then fertilized with sperm extracted from a male testis. A male frog
was sacrificed; testes were removed and sto'red at 4 ·C in a 1x NAM solution (11
mM NaCI. 0.2 mM KCI, 0.1 mM Ca(N03n'4H20, 0.1 mM MgSO..·7H20, 0.01 mM
Na2EDTA, '10 mM HEPES, pH 7.5, 1 mM NaHC~, 0.25% gentamycin).
Approximately 100 1-11 of macerated testis were mixed with a large amount of
sterile water and added to the eggs. After a period of 10 minutes to allow for
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fertilization, the eggs were flooded in water. A visible rotation of zygotes to
animal (dark) side up indicated that the eggs had been fertilized.
Approximately 20 minutes after flooding, the eggs were dejellied in a
solution of 2% cysteine, pH 7.8-8.1. The eggs were swirled in the solution until
they visibly touched and then rinsed thoroughly with 1 I of deionized water. Water
was removed and the eggs were submerged in NAM120 (5.5 mM NaGI, 0.1 mM
KC!, 50 J.lM Ca(N03)l'4H20, 50 J.lM MgS04'7H20, 5 J.lM Na2EDTA, 5 mM HEPES,
pH 7.5, 0.25% gentamycin).
2.6 Micro-Injection of RNA into Xenopus/aevls embryos
2.6.1 Preparation of RNA for injection
EGFp·ER1 fusions were subcloned into pT7Ts (see paragraph: 2.1.3) and
were transcribed using the Ribomax RNA transcription kit (Promega corporation)
according to the manufacturers protocol. RNA cap (m7G(5')ppp(5')G; New
England Biolabs) was added to the transcription reaction at a concentration of
100 nM. After transcription the RNA was purified by 2 rounds of precipitation,
once in sodium acetate (CH3C~Na) and ethanol and once in ammonium acetate
(CH3G~NH4) and Ethanol at -70 ·C overnight followed by washing of the
precipitated RNA with 70 % ethanol in DEPC (diettlyl pyrocarbonate) treated
water. The RNA was then resuspended in DEPC- H20 and the RNA
concentration was determined by spectrophotometry at 260/280 nm. The RNA
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was then diluted to 10 ng in 4.6 nl, unless otherwise noted. This could be directly
used for injection of Xenopus embryos.
RNAs were translated in vitro using TN" T7 Coupled Reticulocyte Lysate
according to the manufacturer's protocol, and 35S-methionine (Mandel).
Translation efficiencies and size of proteins were determined by precipitation and
SDS-PAGE respectively.
2.6.2 Injection of RNA into Xenopus embryos
After dejel1ying, the embryos were placed in a solution of NAMI2 (5.5 mM
NaCI, 0.1 mM KCI, 0.05 mM Ca(N03)i4H20, 0.05 mM MgS04"7H20, 5 IJM
Na£DTA. 5 mM HEPES, pH 7.5, 1 mM NaHC03, 0.25% Gentamycin),
containing 4% Ficoll (Amersham Phannacia Biotech) in a petri dish containing a
plastic grid. The grid provides support to the embryos at four sides and separates
individual embryos, so embryos can be injected with RNA. The Ficoll serves to
increase the viscosity and osmotic value of the solution so that the vitelline
membrane will tightly surround the embryo. For injection a micro-injector
apparatus was used with a beveled glass capillary containing the RNA to be
injected. A total volume of 4.6 nl RNA was injected per embryo and the embryos
were left to develop in 4% Ficol1 in NAMI2 to the desired stage. Staging of the
embryos was done according to the table of Nieuwkoop and Faber (1967).
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During development, the translated EGFP-fusions were visualized by
fluorescence microscopy using a 495 nm filter. Embryos injected with I}-
galactosidase fusions were stained with X-gal.
2.6.3 Staging of embryos according to Nleuwkoop and Faber
Identification of the different stages of Xenopus development
performed morphologically according to the table by Nieuwkoop and Faber
(Nieuwkoop and Faber, 1967). Identification of stages by morphology might not
be the best way of determining the exact stage because of the differences in cell
size between embryos of different frogs, and the subUe morphological
differences. Also, there might be slight variations in determining the stages of the
embryos, depending on the researcher. Besides morphological differences we
also use timing after fertilization as a measure of stage, but this is variable
because not all eggs are fertilized at the exact same time. In addition small
differences occur in rate of development between embryos. Fig 1.1.1 shows
morphology of the embryos used in the experiments.
2.6.4 Detection of proteins In microlnjected embryos
2.6.4.1 Detection by fluorescence microscopy
Embryos were fixed in MEMFA (0.1 M MOPS, pH7.4, 2mM EGTA pH8.a.
1 mM MgS04, 3.7 %(wtv) formaldehyde) for at least 1 hr and maximum OIN and
then washed in PBS-A (96 mM NaCI, 1.9 mM KCI, 1 mM KH2P04, 5.7 mM
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Na2HP04'7H20) and stored in PBS·A! 0.02% (w/v) sodium azide. The embryos
were then directly viewed by fluorescence microscopy on an Olympus BH2
microscope using Oplan ApolUV objectives (filter I.B. 495 nm)
2.6.4.2 Detection by whole mount staining
Injected albino embryos were staged by comparison with wiJd·type
embryos that were fertilized in the same dish. Embryos were fixed at the desired
stage by submersion in MEMFA for 1 hr. and then stored in 100% methanol at-
200(;. Before staining embryos, the embryos were incubated in bleaching solution
(1 part 30% hydrogen peroxide and 2 parts Dent's fixative: 20% DMSO, 80%
methanol (Dent et al.• 1989)) for 1-2 hr under white light. The embryos were then
washed in maleic acid buffer (MAS; 100 mM maleic acid. 150 mM NaCI pH 7.5
with 10 N NaOH). Embryos were incubated for 1 hr in blocking solution to
eliminate background staining (MAS, 2% (wlv) Blocking powder for use with
hybridization of nucleic acids (Roche), 5% (vlv) DMSO. 5% (v/v) heat inactivated
goat serum, 1x10·3 % (v/v)! 24.7 }.1M thimerosal (=ethylmercurithiosalicylic acid
sodium salt). The primary antibody (anti-gfp monoclonal antibody. generated in
mouse cells, Clontech laboratories Inc.) was diluted to 1:600 in fresh blocking
buffer and the embryos were incubated oIn at 40 C while shaking. After this
incubation, the embryos were washed in large volumes of MAB over a period of
5-6 hr while shaking at RT. The MAB was replaced every 30-60 min. The
secondary antibody (alkaline phosphatase goat-anti-mouse IgG) was diluted
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1:600 in fresh blocking buffer and the embryos were incubated at 4°C oJn. The
washing was repeated as before over 6 hr. Detection was performed in alkaline
phosphatase (AP) buffer (100 mM Tris pH 9.5, 50 mM MgCI2. 100 mM NaCI, 0.1
% (vlv) Tween-20, 50 mM levamisole) as follows: The embryos were washed in
AP buffer twice for 5-10 min. and then incubated in NBT/BCIP in AP buffer (35 JlI
NBT and 45 Jll BCIP, both from Boehringer Mannheim) until color developed. The
color reaction was stopped by addition of MEMFA. For long time storage
embryos were kept in MAS+ 0.02% (w/v) (3mM) sodium-azide (NaN3).
2.6.4.3 X-gal staining of whole embryos
Embryos were incubated at room temperature until the desired stage was
reached,. collected in ice-cold PBS·A and fixed in 4% Paraformaldehyde in PBS-
A for 1 hr. After fixation the embryos were washed three times for 15 min each in
wash buffer and incubated in staining buffer for 30-60 min. or until color
developed (for recipe see X-gar staining of transtected NIH 3T3 cells, paragraph
2.3.1.3). The embryos were then washed in PBS-A fOf 10 min and incubated 1hr
in 4% Paraformaldehyde in PBS to prevent diffusion of the staining. For long-
term storage, the embryos were kept in PBS-A + 0.02% (wI\!) sodium azide at
4"C.
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Chapter 3
The identification of nuclear localization signals In XMI-ER1"
3.1 Introduction
The subcellular localization of XMI·ER1 during Xenopus Jaevis embryonic
development has been well investigated (Luchman at ai" 1999). XM1·ER1 is
expressed during early stages of development, but only localizes to the nucleus
during the mid-blastula stages (Luchman at a1., 1999). When transfected into NIH
3T3 cells, translated XMI·ER1 is exclusively target~ to the nuclei of these cells
indicating that in these cens XMI·ER1 is constitutively localized to the nucleus
(Paterno at ai" 1997).
XMI-ER1 is a 55kDa protein which is predicted to contain two putative NLS
(Paterno at al., 1997). Nuclear localization of proteins with a molecular weight
greater than 40-60 kOa is dependent on the presence of a functional NLS. The
identification of a functional NLS is based on two criteria:
1) Mutation or deletion of the NLS leads to cytoplasmic localization of the protein.
2) The NLS is active in nuclear targeting of a normally cytoplasmic protein, either
as a peptide covalently coupled to the carrier or when encoded in the same
reading frame as a fusion protein (Jans and Hubner, 1996).
In this chapter, four putative NLS in XMI-ER1 are analyzed for their ability
to direct the nuclear localization of a cytoplasmic protein. A functional NLS was
• Part of the results discussed In this chapter have been "published; (Post at 8/., 2001).
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identified in the C-terminal region of XMI·ER1. It was shown that, in addition to
the basic core NLS, flanking regions were necessary for its efficiency in
translocating a non·nuclear protein to the nucleus. An additional, albeit weak,
NL$ was identified in the N·terminus. The efficiency of these NLS when
expressed in mouse fibroblast cells was similar to their efficiency in Xenopus
cells.
3.2 sequence analysis of basic regions In XMI-ER1.
Previously, two putative NLS were identified in XMI-ER1 (Paterno et al.,
1997) by computer analysis using PSORT (Nakai and Horton, 1999). However,
Schwambom et 8/. (1998) showed that some NLS are not identified by computer
analysis but rather by identification of stretches of basic amino acids
(SChwambom at al., 1998). Therefore, I analyzed XMI·ER1 for existence of
additional putative NLSs. By analyzing the basic amino acids in XM1·ER1 I found
2 additional putative NLSs (see below).
To dete"rmine the regions important for the nuclear translocation of XMI·ER1, a
map of XMI·ER1 was assembled in which the basic amino acids (which can bind
the import receptors) and prolines (which are often found In the regions flanking
the core NLS) were indicated (Figure 3.1). These regions were designated NLS
1, 2, 3 and 4 in the order in which they appeared in the protein (Figure 3.1).
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Figure 3.1 Identification of potential NLS in XMI-ERt. Schematic of the XMI-ERI
protein showing all pralines and basic residues within the sequence, with the remaining
residues as dots. Four clusters of basic amino acids that have the potential to translocatc
M1·ERI to the nucleus were identified (shaded boxes) and called NLSI-4.
NLS1= localized between residues 138 and 143; NLS2-:= 261-271; NLS3= 320·338;
NL$4= 463-472. (Numbers indicate number of amino acid residue as shown in figure
2.1.)
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NLS1 and 2 are similar to NLS of the classic monopartite type (Figure 3.2
A). NLS3 consists of two regions of basic amino acids forming a potential
bipartite NLS. NLS4 is similar to the human c-MYC NLS, in which only 3 basic
amino acids in the core and a proline and acidic residues in the flanking region
are present (see figure 3.2 A).
Analysis of the sequences of the putative NLS found in XM1-ER1 shows
that 'NLS1 C38RPRRCK'~3) is flanked by bulky tyrosine and phenylalanine
residues, predicted to interfere with the recognition of the NLS by importins
(Boulikas, 1997), and contains a proline within the basic cluster, which can
change the conformation of this basic duster and thus interfere with the
interaction with the importins. The NLS2 core cluster consists of five positively
charged residues in a cluster of 11 amino acids (261RRLRFNVKAAR21 '), which
contains bUlky residues, however no helix breakers like glycine or prolines are
present in the flanking regioo making it less likely to be a functional NLS. NLS3 is
similar to the bipartite type of NLS e20KKSERYDFFAOOTRFGKKK338), but the
spacer is longer than the usual 10 amino acid residues (14 amino acid residues)
and contains tyrosine and phenylalanine residues, which are bulky. NLS4
~RPIKRQRMDm) is most similar to the human c--MYC NLS in which the
duster of positively charged residues is flanked by a proline and an acidic
residue (Makkertl et al., 1996), making It the most likely candidate for a functional
NLS. based on theoretical predictions.
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The putative NlS4 in XMI-ER1 is not conserved between Xenopus and human
(Figure 3.2 B). hMI-ER1f3 contains a classic type I NlS: ~68PAKRRR~73 , and hMI-
ER1a does not contain an NlS in its C-terminus. The putative NlS1 however
('3lIRPRRCK1~3), is found in both hMI·ER1a and j3 as well as in XMI·ER1.
Transfection of EGFp·hMI-ER1a. and f3 into NIH 3T3 cells showed that while hMI-
ER1j3 is found exclusively in the nuclei, hMI-ER1o. is predominantly localized in
the cytoplasm (data not shown).
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Figure 3.2 Amino acid sequence comparison of XM1·ERl NLS-4 to the NLS of the
c-MYC protein, and the NLS in the human orthologue of XMI-ERI. hMI·ERI~.
Identical amino acids and conservative changes are indicated by double and single dots,
respectively. A, The SV40 T-Ag NLS, which was the first NLS to be identified, is shown.
B, Amino acid sequence comparison of the XMI-ERI NLS and the IlMI-ERI~ NLS.
While NLS4 of XMI-ERI is similar to the human c-MYC NLS, the NLS ofhMI.ERl~ is
a classic monopartite, similar to the SV40 T-Ag NLS.
PKKKRKV SV40T-Ag
~AA~~VKL!l~ humanc-MYC
A RP- IKRQRMDS XMJ-ERI
~~I~~Q~D~ XMI-ERI
B RPAKRRRVNS human M1-ERIP
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3.3 Identification of a functional NlS was perfonned using different fusion
proteins
To reveal whether these regions of basic dusters represent functional
NLSs, fusion constructs were generated in EGFP·C2, creating fusion proteins in
which EGFP is fused to the N·lerminus of different regions of XMI-ER1. EGFP
was chosen because of the ease of detection of fluorescent EGFP under U.V.
light (495 nm). Fusion of EGFP to full·length XMI·ER1 resulted in exclusive
nuclear localization, showing that EGFP did not interfere with the ability of XMI-
ER1 to translocate the protein to the nucleus of NIH 3T3 cells (see figure 3.3 B).
A disadvantage of usin9 EGFP is that the protein is 29 kDa and that some EGFP
fusions used were below the 4Q..60 kDa range. potentially allowing passive
diffusion through the NPC. Cells transfected with EGFP-XMI-ER1 fusions were
subjected to Western Blot analysis using an anti-GFP antibody to test the lolal
level of transient protein expression (Figure 3.3C). This was done to test whether
high protein levels interfere with the nuclear translocation. Full-length XMI-ER1,
when fused to EGFP, (EGFP-ER1-493, lane 2) is not recognized well by the anti·
GFP antibody, but western blot analysis using an anti-XMI-ER1 antibody shows
expression levels similar to other EGFP·ER1 fusion proteins in the same assay
(data not shown). Exclusive nuclear localization was observed even when the
transient protein was extremely abundant as detected by Western Blot analysis,
indicating that the level of transient protein expression did not interfere with the
nudear translocation. saturating the import machinery.
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Figure 3.3 Fusion of EGFP to XMJ-ERI does not Interfere with the nuclear
translocation of XMJ-ERI.
A, A construct was generated in which enhanced green fluorescent protein, EGFP (gray
box), was fused to XMI-ERI (white box). The colored bars indicate the location of the
four putative NLS (I, 2, 3 and 4) in MI-ERI. B, Subcellular localization of EGFP and
EGFP-ERI was detennined by fluorescence microscopy 48 hours after transfection (left
panel). Nuclci were stained with Hoechst 33342 (right panel). Arrows indicate nuclei
corresponding to EGFP expressing cells. C, cells were harvested 48 hours post-
transfection and subjected to Western Blot analysis using an anti-GFP antibody to show
the level of transiently expressed protein. Molecular weight markers are shown on the
left. Arrows indicate the band corresponding to the protein of interest, EGFP-ERl, which
runs around 120 kDa, and EGFP, which runs around 36 kDa.
Scale bar = 0.0 I rom.
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Different regions of XMI-ER1 were also fused to lklalactosidase, a 120
kDa protein, which is easily detectable by incubation of the cells with X-gal. This
substrate for l3-gal results in blue staining of lklal expressing cells, within 15-30
minutes. An advantage of using 13-gal is that diffusion into the nucleus is not
possible, because of its size (fig 3.4 panel A). As well, when translocated into the
nucleus, lklal fusions are not able to leak out of the nucleus and unless a
nuclear export signal (NES) is present. it will be localized in the nucleus during
interphase.
Fusion of fUll-length XMI-ER1 to the C-tenninus of l3-gal resulted in
nuclear localization of the protein, showing that 13-gal does not interfere with the
ability of XMI-ER1 to transJocate to the nucleus (Figure 3.4 Panel C). When not
fused to an NLS or NLS-containing protein, ~aJ is excluded from the nucleus,
leaVing the nuclei unstained while the cytoplasm is stained blue (Figure 3.4 panel
A). For all lklal transfected cells, photographs were taken with bright field and
phase contrast filters. Under bright field, only the cells expressing l3-gal are
visible. while when viewed under phase contrast all cells in the field are visible.
This gives an indication of the transfection efficiency (number of 13-gal expressing
cells dividec;l by the number of total cells) and the exact subcellular localization of
the 13-gal fusion proteins. Transfection efficiencies for cells transfected with !l-gal-
ER1 fusion constructs ranged from 50-80%.
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Figure 3.4 Addition of j3-galactosidase to the N-terminus of MI-ERJ does not
interfere with the nuclear localization.
NTH 3T3 cells were transfected with different j3-GAL constructs. The subcellular
localization of the p·gal fusion proteins was determined by microscopy 24 hours post-
transfection. Photographs were taken of the same field using brightfield (left) and phase
contrast (right) filters.
A, p-GAL localizes to the cytoplasm of transfected NIH 3T3 cells. B, When p-GAL
fused to the SV40 T-Ag NLS (P-GAL-NLS) is transfected into NIH 3T3 cells, nuclear
staining is observed. C, A p-GAL fusion containing full-length MI·ERI was generated
and transfected into NIH 3T3 cells. Subcellular localization of the p-GAL-ERl fusion
protein was compared to p-GAL and p-GAL-NLS.
Arrows indicate cells that show subcellular localization of the fusion protein that is most
representative or the subcellular localization or the majority of cells expressing the
indicated protein.
Scale bar = 0.01 mm.
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The use of two different fusion proteins is an excellent way for identifying
functional NlS, because the size and structure of the fusion proteins can differ,
which can result in different conformations, which in tum may influence the ability
of the NlS to be recognized by the import machinery. Therefore, by using both
EGFP and f!-gal as fusions, the effects of these variabilities on the outcome of
the experiments were minimized.
The subcellular localization of proteins in the expressing cells was defined
as follows: nuclear localization indicates cells that show expression of fusion-
protein exclusively in the nucleus of the cell, as is the case when XMI-ER1 full
length is fused to EGFP (Figure 3.5 panel B). location of all nuclei within the field
was determined by staining of the DNA with Hoechst 33342, which resulted in a
blue stain when viewed by fluorescence microscopy using a DAPI fitter (406 nm;
Figure 3.5). When staining was observed in the whole cell, with staining in the
nucleus more intense than staining in the cytoplasm, the term -Nuclear greater
than (» Cytoplasm~ was used (Figure 3.5, panel C). When no definite nuclear
staining was observed, but rather staining of the nucleus and the cytoplasm in
equal intensity, the term ·Whole cell- staining, or -Nucleus equal to (=)
Cytoplasm" was used (Figure 3.5, panel A), as is the case for EGFP when not
fused to an NlS. An additional category is added when ~-gal fusions are used,
because the size of the protein restricts diffusion through the NPC. Therefore, f!-
gal, when nol fused to an NLS, is charaeterizecrby an exclusion of the protein
from the nucleus; indicated in figure 3.5, panel D.
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Figure 3.5 Definition of subcellular localization of fusion proteins in NIH 31'3 cells.
The subcellular localization of proteins can be divided into four categories: whole cell
staining (A), Nuclear staining (8), Nuclear greater than cytoplasmic staining (C) and
cytoplasmic staining (D). Arrows indicate cells displaying the indicated subcellular
localization.
Scale bar = 0.01 mm.
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3.4 Identifieatlon of a functional NLS in the C·termlnu5 of XMI-ER1
To,identify whether the putative NLS are functional for translocating XM1-
ER1 to the nucleus. XMI-ER1 was divided into six regions and these regions
were fused to the C-terminus of EGFP. The different regions were chosen based
on the position of the putative NLS in full length XMI-ER1 and were named as
follows: (the numbers indicate the amino aeid numbers of the protein. as shown
in figure 1.4.1 and 2.1) ER1-137; ER1-143 (includes NLS1); ER145-250; ER251-
319 (includes NLS2); ER251-340 (includes NLS2 and NLS3) and ER339493
(includes NLS4) (Figure 3.6). The egfp-~ plasmids including the regions of Xm;-
er1 corresponding to these amino acids were transfected into NIH 3T3 cells.
Forty-eight hours post-transfection the cells were fixed onto chamberslides and
subcellular localization of the fusion proteins was observed by fluorescent
microscopy. The subcellular localization of the fusion proteins was compared to
EGFP and EGFP-ER1-493, as controls (full length, figure 3.3).
Cells transfected with EGFP-ER1-137 showed whole cell staining (55%)
and some nuclear>cytoplasmic (45%) staining (3.6A), while EGFP-ER1-143
showed·nuclear > cytoplasmic staining (88%, 3.68). EGFP-ER145-250, EGFP-
ER251-319 and EGFP-ER251-340 showed whole cell staining (3.6e, D and E).
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Figure 3.6 The nuclear targeting signal of MI-ERl is located In the C-terminus
EGFP·ERI fusions spanning the entire XMI-ERI protein were constructed and
transfected into NIH 313 cells. Subcellular localization was detcnnined by fluorescence
microscopy 48 hours after transfection. A schematic illustration for each of the fusion
constructs is shown on the right. The colored bars are representative for each of the
putative NLS as shown in figure 3.1. Photographs illustrating the subcellular localization
of each EGFP-ERI fusion protein and Hocchst 33342 staining of the same field to
visualize nuclei are shown for each construct. A: EGFP-ERI-137. B: EGFP-ERI-143. C:
EGFP-ERI45·250. D: EGFP-ER251·3l9. E: EGFP-ER251·340. F: EGFP-ER339-493.
Arrows indicate nuclei of cells that express EGFP as shown in the panel on the left.
Scale bar = 0.01 mm.
ECFP HOECIIST CONSTRUCTS
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Only the C-terminus of ER1 (EGFP-ER339-493), containing NLS4, was localized
exclusively to the nucleus, indicating that the NLS4 might function as an NLS
(3.6F). Although none of the other constructs show exclusive nuclear staining, a
high proportion (88%) of the cells transfected with EGFP-ER1-143 showed
nuclear greater than cytoplasmic staining, indicating that NLS1 might function as
a weak NLS (vide infra) (Table 3.1).
Tabl~ 3.1. Subeellular localization of EGFP-XMl-ERl fusion proteins after
transfectlon Into NIH 3T3 cells
Construct %N %N>C %N:C
EGFP 0 6 94
EGFP-ERl-493 98 2 0
EGFP-ERI-137 0 45 55
EGFP-ERI-143 0 88 12
EGFP-ER14S-2S0 0 29 71
EGFP-ER151-319 0 6 94
EGFP-ER151-340 0 3 97
EGFP-ER339-493 96 4 0
To test whether the level of transiently expressed protein in the cells could
saturate the nuclear translocation, cells were lysed in sample buffer 48 h post-
transfection and subjected to Western Blot analysis using a monoclonal anti-GFP
antibody (Figure 3.7). EGFP-ER1-493, EGFP-ER1-137 and EGFP-ER1-143 do
nol run at the expected size (table 3.1.1), but run larger. This is probably due to
the high incidence of acidic residues (Paterno et al., 1997). Presence of many
acidic residues can alter the net charge of the protein, resulting in separation not
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only based on the size of the protein, but also on the net charge of the protein
(Bell and Bell, 1988). This results in slower migration of the proteins. so the
protein appears larger than the expected size (table 3.2).
The six fusion-construets demonstrated similar levels of expression in NIH
3T3 cells (Figure 3.7 lanes 3-8), indicating that cytoplasmic staining is due to the
inability of the NLS to direct the fusion protein to the nucleus and not due to
overloading of the import machinery.
Table 3.2 Predicted molecular weight of the EGFP-fusioD proteIns and tbe
probability of diffusion of the EGFP-ERI fusion proteins through the Duclear pores
as described for other proteins by (Ribbttk and GorJich, 2001).
Construct
EGFP
EGFP-ER I-493
EGFP-ERI-137
EGFP-ERI-143
EGFP-ERI45-250
EGFP·ER251-319
EGFP-ER251-340
EGFP-ER339-493
Predicted size ofEGFP·fusion rotein
29kDa
83kDa
441<0,
45 kDa
41 kDa
37kDa
39kDa
46kDa
Probabiii of diffusion
y"
No
Yes but slow
Yes but slow
y"
y"
y"
Yes. but slow
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Figure 3.7 Western Blot analysis of cells expressing different EGFP-ERI fusion
proteins.
Cells transfected with EGFP, EGFP-ERl, EGFP-ERl-137, EGFP-ERI-143, EGFP-
ERI45-250, EGFP-ER151-319, EGFP-ER151-340 and EGFP-ER339-493 were harvested
and subjected to Westem Blot analysis using an anti·GFP antibody. The positions of the
molecular weight markers are indicated on the left. All constructs demonstrated similar
protein expression levels as EGFP.
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j}-gal fusion constructs (in cll9al-CS2+) were generated by addition of the
regions of XMI-ER1 that showed nuclear or nuclear greater than cytoplasmic
staining: ER1-493, ER1-137, ER1·143, and ER339-493. This was done to
investigate whether the nuclear greater than cytoplasmic staining was a result of
diffusion of the EGFP-ER1 fusion protein or whether there was active nuclear
transport. As a positive control for nuclear translocation j3-galaetosidase was
fused to the NLS of SV40 T·Ag (n~-gal-CS2+), while the l}-galaetosidase without
an NLS was used as a control for cytoplasmic staining (cj3-gal-GS2·) (figure 3.4).
After transfection into NIH 3T3 cells the subcellular localization was detennlned.
The stained cells were viewed by bright field microscopy. For each construct the
percentage of cells displaying nuclear, nuclear greater than cytoplasmic nuclear,
whole cell, and cytoplasmic staining were calculated (Table 3.31 Figure 3.8).
Table 3.3 Subcellular localization of~al fusion constructs in NIH 3T3 cells.
Construct %N %N>C %N=C %C
'·~I 0 5 0 95
l.oal·NLS SV40 92 8 0 0
i:":;'-I.ERl.493 94 6 0 0
~1-ERl-137 6 54 20 20
\.aal·ER1·143 27 66 3 4
\.aal-ER339-493 95 5 0 0
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Transfections into NIH 3T3 cells showed nudear localization of ~-gal-NlS,
ER1-493 and ER339-493 as was shown for EGFP-ER1-493 and EGFp·ER339-
493 cells. jl-Gal·ER1-143 showed nuclear staining in 27% of the cells, indicating
that NlS1 may function as a weak NLS. No nuclear localization was observed for
the negative control [3-gal (see figure 3.4). Cells transfected with jl-gal-ER1-137,
which does not contain the NlS1, displayed little nuclear staining (6%) with 54%
of the cells showing nuclear greater than cytoplasmic (N)C) staining. This
suggests that ER1·137 is translocated by active transport that is not due to
NlS1. As mentioned before, j}-gal is too large to be able to diffuse through the
NPC; therefore these results suggest thai nuclear transport of ER1-137 is due to
active import rather than passive diffusion of this region.
Transfection of regions of XMI-ER1 either fused to EGFP or j}-gal into NIH
3T3 cells have shown that a strong NLS is located in the C-terminus of XMI.ER1,
while a weak NlS is located in the N·terminal region of XMI-ER1. Also an
alternative additional nuclear targeting signal may be located between residues
1-137. This may be a very weak NlS as well as a motif that can bind a molecule
that is targeted to the nucleus, resulting in piggy backing of ER1·137.
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Figure 3.8 NIH 3T3 cells transfected with ~gal-ER339493 display exclusive nuclear
staining, whereas cells transfected with ~glll-ERl-137 or ~gal-ERl-143do not.
NIH 3T3 cells were transfectcd with ll-gal-ERI-137 (A), 13-gal-ERl-143 (B), or Il-gal-
ER339-493 (C). Subcellular localization of the fusion proteins as detennined by
microscopy was compared to p-gal and p-gal-ERI493 (as shown in figure 3.4).
Arrows indicate cells that show subcellular localization oftbe fusion protein that is most
representative of the subcellular localization of the majority of cells expressing the
indicated protein.
Differences in cell size are probably caused by nutritional differences caused by cell
density. Cells thaI lack nutrition spread out and appear to be larger than well-fed cells.
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3.5 NLS4 is necessary and sufficient for the nuclear transport of XMI·ER1
3.5.1 NLS4 is able to direct EGFP and ~-GAL to the nuclei of NIH 3T3 cells.
The signal for nuclear localization is located in the C-terminus of XMI·ER1
between amino acids 339 and 493. To identify whether the putative NLS4, which
is located between residues 463 and 469 is necessary for the nuclear
translocation of XMI-ER1 , two constructs were generated: EGFP-ER1-461, which
is truncated just before the NLS4 and EGFP-ER1-473, which includes the basic
core of NL$4 (see figure 3.9 A and B) Subcellular localiZation of these
constructs, after transfection into NIH 3T3 cells, was compared to the subcellular
localization of EGFP and EGFP-ER1-493.
As is shown in table 3.4 and figure 3.9, the EGFP-ER1-473 was almost
exclusively nuclear (90%, Figure 3.9 B). while EGFP-ER1-461 was not (1%,
Figure 3.9 A). This indicates that the residues between 461 and 473, where the
NLS4 is located, are important for the nuclear import of XMI-ER1. Figure 3.10
shows the level of transient protein expression as analyzed by Westem Blot
using an anti-GFP antibody. EGFP-ER1-461 (panel A, lane 3) and EGFP-ER1-
473 (panel A, lane 4) are expressed at a level similar to EGFP-ER1-493 (panel
A, lane 2).
Table 3.4 Subcellular localization ofEGFP-ERI-461 an EGFP-ERI-473 after
transfectlon Into NIH 3T3 cells.
Construct
EGFp·ER1-473
EGFp·ER1-461
%N
88
%N>C
9
21 79
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Figure 3.9 NLS4 is necessary and sufficient for the nuclear translocation of MI-ERI
in NIH 3T3 cells.
EOFP-ERI fusions used to investigate the function of the putative NLS4 were generated
and transfC1:ted into NIH 3T3 cells. Subcellular localization was detennined by
fluorescence microscopy 48 hours after transfection. EOFP and EOFP·ERI were
transfectcd in the same experiment as controls for whole cell and nuclear staining,
respectively (not shown). A schematic illustrating each of the fusion constructs is shown
on the right. Photographs illustrating the subcellular localization of each of the fusion
proteins and Hoechst 33342 staining of the same field are shown for each construct. A:
EOFP-ERI-461. B: EGFP-ERI-473. C: EGFP·ER461-471. 0: EGFP-ER457-475. E:
EGFP·aNLS4.
Arrows indicate cells that show subcellular localization of the fusion protein that is most
representative of the subcellular localization of the majority of cells expressing the
indicated protein.
Scale bar = O.Olmm.
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To identify the precise region of the NLS necessary for the nuclear
translocation of XMI-ER1, two EGFP fusion constructs were generated: EGFP-
ER457-475, which contains NLS4 including 6 amino acid residues flanking on
both sides, and EGFP-ER461-471, which contains the basic core region (Figure
3.9). EGFP-ER457-475 ('51PDDTNERPIKRQRMDSPGK(75) was almost as
efficient as the full-length sequence at directing exclusive nuclear targeting
(74%N vs. 98% N for the full·length), while EGFP-ER461-471 was less efficient
with 38% nuclear staining (vs. 98% for the full·length), with the remaining cells
showing nuclear greater than cytoplasmic staining (62%) (Figure 3.9 C and DI
Table 3.5). When fused to jl-galactosidase amino acids 457-475 show 93%
nuclear staining in transiently transfected NIH 3T3 cells (Table 3.51 Figure 3.11,
B). The greater number of cells showing nuclear staining after transfection with ~­
Gal-ER457-475 as compared to the EGFp·ER457-475 fusion could be due to a
conformational difference, or due to the ability of the EGFP-ER457-475 to diffuse
through the NPC from the nucleus to the cytoplasm, resulting in some
cytoplasmic staining. A second ~-gal-ER1 fusion containing amino acid residues
461-471 was 37% nuclear, with 61% nuclear greater than cytoplasmic staining
(Figure 3.11 A). This indicates that amino acids flanking the NL$4 basic core are
necessary for the efficient transport of XMI·ER1 to the nucleus. Figure 3.10
shows the level of protein expression of EGFP-ER461-471 (panel A, lane 5) and
EGFP-ER457-475 (panel B, lane 8) as revealed by Western Blot analysis.
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Figure 3.10 Western Blot analysis of EGFP-ERI fusions used to Identify the
minimal NLS4 region.
Cells transfected with the indicated EGFP·ERl fusion constructs were harvested 48 hours
after transfection and subjected to Western Blot analysis using an anti-GFP antibody. The
positions of the molecular weight markers are indicated on the left.
Protein expression levels of different EGFP-ERI fusions were compared to the
expression of EGFP and EGFP·ERI-493. Panels A, 8 and C indicate different Western
blots. A, Expression of EGFP-ERI-461 (lane 3), EGFP-ERI-473 (lane 4) and EGFP-
ER461-471 (lane 5), compared to EGFP (lane 1) and EGFP·ERI-493 (lane 2). B,
Expression of EGFP·ER457-475 (lane 8) compared to EGFP (lane 6) and EGFP-ERl·
493 (lane 7). C, Expression of EGFP-EMNLS4 (lane II) compared to EGFP (lane 9)
and EGFP·ERI-493 (lane 10).
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3.5.2 Deletion of the NLS4 results in cytoplasmic localization of XMI-ER1
Analysis of core NLS has shown that mutation of 1 basic residue can
abolish nuclear transport (Goldfarb at al., 1986; Kalderon et al., 1984a). In the
SV40 large T-Ag NLS substitution of the second lysine of PK'28KKRKV with
threonine abolishes nuclear translocation of the protein (Goldfarb et al., 1986;
Kalderon et af., 1984a); while substitution of either of two basic residues in the
human c-MYC NLS PAA323KRVKLDS for alanine resulted in decreased affinity
for importin-a, and subsequent cytoplasmic localization (Hodel et al.• 2001). Thus
substitution or deletion of the first and I or second basic residue in the core NLS
results in abolished nuclear localization. Therefore, to verify that the NLS4 is a
bona fide NLS necessary for the nuclear import of XMI-ER1, we deleted four
amino acids of NLS4, 464pIKR, from the full length EGFP-ER1-493, desi9nated
6.NLS4. Transfection of EGFP-6.NLS4 into NIH 3T3 cells showed nuclear staining
in only 4% of the cells, while whole cell staining was obselVed in 75% of the
cells, showing that the nuclear import of XMI-ER1 is abolished after partial
deletion of the core NLS (Figure 3.9, E. Table 3.5). The level of protein
expression 8S revealed by Western BioI analysis indicated that the cytoplasmic
staining is not due to the abundance of transient protein expression in these cells
and Ihus saturation of the import machinery (Figure 3.10, panel C, lane 3).
Deletion of 04&4pIKR in the l}-gal-ER1-493 (l}-gal-6NLS4) also resulted in a
decrease in nuclear localization (11% N) with 78% of the cells showing
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cytoplasmic staining (Figure 3.11, C. Table 3.5). This indicated that the NLS4 is
necessary for efficient nuclear translocation of XMI-ER1.
Table 3.5 Subcellular localization of EGFP-ER461-471. EGFP~ER457-47S. EGFP-
ERMlKR, ~al-ER461-471.J}-gal-ER4S7-47S and ~gal~&NLS4 after transfectlon
into NIH 3T3 cells.
Construct %N %N>C %N=C %C
EGFPcER461-471 38 62 0
EGFP·ER457-475 74 22 4
EGFP·ER.6.NLS4 4 21 75
I B-~I·ER461-471 37 61 2 0
I B-2al-ER457-475 93 7 0 0
1-2al·ERANLS4 11 11 0 78
Together these results indicate that an intact NLS4 is necessary for the
efficient nuclear localization of XMI-ER1 and that addition of the complete NLS4
region, the core basic cluster and the flanking region (6 residues N-terminal and
4 residues C-terminal of the basic cluster), to a cytoplasmic protein is sufficient
for nuclear import. Since these are the requirements for a functional NLS, NLS4
(ER457-475) can be called an NLS.
Since deletion of the NLS4 -in XMI-ER1 does not completely abolish
nuclear translocation (4% N for EGFP-b.NLS4 and 11% N for j!.GAL-b.NLS4) and
ER1-143 showed a large amount of nuclear greater than cytoplasmic staining
(80%), we investigated the possibility of the presence of an additional NLS in
XMI-ER1.
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Figure 3.11 The NLS4 basic cluster and nanking regions are necessary for the
nuclear translocation of MI·ERI in NIH 3T3 cells.
NIH 3T3 cells were transfected with ~-gal-ER461-471 (A). ~-gal-ER457-475 (8), or f}.
gal-EMNLS4 (C). Subcellular localization of the fusion proteins as detennined by
microscopy was compared to ~·gal and ~·gal·ERI-493 (as shown in figure 3.4),
Arrows indicate cells that show subcellular localization of the fusion protein that is most
representative of the subcellular localization of the majority of cells expressing the
indicated protein.
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3.6 Additional weak NLSs in XMI·ER1
Several of the ER1 fusion constructs, which did not contain NLS4,
appeared to have a greater level of fusion protein in the nucleus than in the
cytoplasm, nol accountable by simple diffusion (Figures 3.6,3.8,3.9,3.11). This
suggested that there might be additional, albeit weak, NLSs in XMI-ER1. In an
attempt to identify these regions, additional fusion constructs were generated.
These included EGFp·ER136-143 (NLS1), EGFp·ERf)138-141 (6.NLS1), EGFP-
ER259-273 (NLS2), EGFP-ER318-340 (NLS3) and EGFP-ERA320-338 (6NLS3).
After transfection into NIH 3T3 cells, only EGFP-ER136-143 demonstrated
a significant number of cells (76%) in which nuclear fluorescence was greater
than cytoplasmic (Figure 3.12). Also, after transfection of EGFP-ER1-143, which
includes the NLS1, 88% of transfected cells demonstrated nuclear greater than
cytoplasmic staining (Figure 3.6). Moreover, when the NLS4 core region is
partially deleted, nuclear staining (4% for EGFP-6NLS4, 11% for ~-gal-6NLS4)
was observed after transfeetion into NIH 3T3 cells. Thus, in absence of NLS4,
the predicted NLS1 appears to function as a weak nuclear targeting signal for
XMI·ER1. However, deletion of NL$1 (ERf)138-141) does not affect the nuclear
localization of the EGFP-ER1 fusion (Figure 3.14), indicating that NLS1 is not
necessary for import of XMI-ER1 into nuclei of NIH 3T3 cells. The percentages of
nuclear, nuclear greater than cytoplasmic and nuclear equal to cytoplasmic
staining for each EGFp·ER1 fusion protein were calculated, shown in table 3.6.
For each construct at least 500 transfected cells were counted.
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Table 3.6 Percentage nuclear staining in I'm 3D cells transfected with EGFP-
NLSI, 2, 3 and EGFP-dNLSI and 3
Construct %N %N>C %N::C
EGFP-NLSI ERI36-143 0 76 24
EGFP-NLS2 ER259-273 0 29 71
EGFP·NLS3 ER318-340 0 14 86
EGFP-ER..6.NLS I M138-141 100 0 0
EGFp·EUNLS3 RA320-338 100 0 0
NlS2 (ER259·273) and 3 (ER318-340) were not able to efficiently direct
EGFP to the nucleus (Table 3.6). The abundance of transient protein in these
transfected celis was determined by western blotting (Figure 3.13). levels of
protein expression were similar for all EGFP-NLS constructs.
These transfection experiments also showed that the putative NlS2 and 3 are
not inhibited by the context in which they appear in the XMI-ER1 sequence.
Directly adding the NLS region to EGFP does not change the observation that
these putative NLSs are unable to direct the fusion protein to the nucleus.
indicating that they are not functional NLSs.
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Figure 3.12 NLSI functions as a weak NLS when fused to EGFP, while NLS2 and
NLS3 do not.
EGFP-NLS fusions containing the core NLS of putative NLSI, 2 or 3 were transfected
into NIH 3T3 cells. Subcellular localization, compared to EGFP and EGFP-ERI-493,
was determined 48 hours post-transfection. Schematic illustrating each EGFP·NLS
construct is shown on the right Photographs illustrating the subcellular localization of
each of the fusion proteins and Hoechst 33342 staining of the same field arc shown for
each construct. A: EGFP·NLSI (ERJ37·143). B: EGFP-NLS2 (ER259-273). C: EGFP-
NLS3 (ERJ17·341).
Scale bar = 0.0 I mm.
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Figure 3.13 Western Blot analysis showing the level of protein expression of EGFP-
NLSl,:Z and 3
Cells transfected with the indicated EGFP fusion construct were harvested 48 hours after
lransfection and subjected to Western Blot analysis using an anti-GFP antibody. The
positions of the molecular markers are shown on the left. All EGFP-NLS fusions
demonstrated similar levels of expression in NIH 3T3 cells. Arrows indicate EGFP-ERI
(top) and EGFP and EGFP-NLS (bottom).
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3.7 Deletion of NLS1 and/or NLS3 does not interfere with the nuclear
translocation of XMI·ER1
It has been described that nuclear translocation of proteins can be
dependent on multiple NlS. To investigate whether the efficiency of nuclear
transport is dependent solely on NlS4 or on a eo-operation of multiple putative
NlS, the following constructs were generated: EGFP-ERl!.138-141, EGFP-
ERl!.32D-338 and EGFP-ER8138-141 -+320KK = AA -+ to336·338 (referred to as
6NLS1, toNlS3 and 6NlS1-+6NlS3 respectively, Figure 3.14A).
Transfection of these constructs into NIH 3T3 cells showed exclusive
nuclear localization for all these constructs (see figure 3.14B). This indicates that
these NLS are not essential for the nuclear localization of XMI-ER1 and that the
function of NlS4 is not dependent on a co-operation with NLS1 and/or NlS3.
The level of protein expression was tested by immunoprecipitation using an anti-
XMI·ER1 antibody, after which the immunoprecipitated proteins were subjected
to Western Blotting with an anti-GFP antibody (Figure 3.15). Protein expression
was observed for all immunoprecipitated proteins; EGFP expression levels could
not be determined by this because it is not precipitated with anti-XMI-ER1. In all
lanes a very abundant protein is observed around the 47-kDa markers. This
staining is probably due to presence of the IgG heavy chain, which is observed
when polyclonal antibodies are used for immunoprecipitation.
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Figure 3.14 Nuclear translocation of MI·ERl Is not dependent on co·operatlon of
NLS4 with NLSl, NLS3 or NLSI and 3
A, Schematic illustrating EGFP·ERI fusions containing deletions of the putative NLS1,
NLS3 and NLSI+3, compared to full-length MI-ERI (ERI-493). The asterisk indicates
substitution of KK. to AA, rather than deletion of this region. 8, Subcellular localization
of these constructs after transfection into NIH 3T3 cells 48 hours after transfection as
shown by fluorescence microscopy using filters for EGFP (a,c,e) and corresponding
Hoechst staining of the same field (b,d,f). Arrows indicate cells that show subcellular
localization of the fusion protein thaI is most rcpresentati~e of the subcellular localization
of the majority of cells expressing the indicated protein and the corresponding nuclei as
identified by Hoechst staining.
Scale bar = 0.01 mm.
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Figure 3.15 Western Blot analysis of EGFP·ERI fusion proteins after immuno-
precipitation using anti-MJ-ERI show similar levels of expression in NIH 3T3 cells
EGFP is not detected because it is not recognized by the anti-MI-ERI antibody. In all
lanes a very abundant protein is observed around the 47·kDa marker. This staining is
most likely the IgG heavy chain, which can be observed when polyclonal antibodies are
used for immunoprecipitation. Arrows indicate the different EGFP-ER1 proteins.
200-
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~EGFP-ERI
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3.8 Analysis of the putative NLS for XMI.ER1 In Xenopus/aevis embryos
When transfected into NIH 3T3 cells, a mouse fibroblast cell line, XM1·ER1
is constitutively localized to the nucleus. However, nuclear translocation of XMI·
ER1 in developing Xenopus embryos is stage dependent (Luchman at al., 1999).
No nuclear localization is observed until after stage 8 (5 hours after fertilization)
and protein levels and nuclear staining diminishes at the tailbud stages
(Luchman et al., 1999). Regulation of nuclear import of many proteins is
dependent on the developmental stage of the embryos. There are examples of
proteins which possess a developmentally regulated NlS (drNLS) (Jans and
Hubner, 1996). There are also proteins described that translocate during a
specific phase of the cell cycle (Madeo af a/., 1998; Moll et a/., 1991). Also,
different signaling pathways are activated during different stages of development.
Since, XMI·ER1 was first isolated as an FGF inducible early response gene in
stage 8 Xenopus. Activation of the FGF signaling pathway around stage 8 may
be important for nudear translocation of XMI·ER1 at this stage.
Transfection of XMI-ER1 into NIH 3T3 cells does not provide us with
information about the regulation of nudear import during Xenopus development.
The translocation of XM1·ER1 in Xenopus embryos could be dependent on cell
cycle dependent mechanisms that regulate the NLS, on use of an altemative
drNLS, or activation of a signaling pathway like the FGF pathway. Therefore, the
importance of NLS4 for nuclear translocation of XMI-ER1 in Xenopus needed to
be determined. The observation that XMI·ER1 contains a' very strong NLS
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(NLS4) and an additional weak NLS (NLS1) suggests that the regulation and use
of these NLS might be dependent on the context of the cell and! or the stage of
de....elopment. Therefore. it is important to identify whether the NLS4 is capable of
directing the nuclear localization of XMI-ER1 in embryos. or whether alternate
sequences in XMI·ER1 are responsible for nuclear translocation that is
dependent on de....elopmental e....ents.
To in....estigate whether NLS4 is necessary for nuclear translocation of
XMI·ER1 in Xenopus embryos, a number of different egfp-er1 cRNAs were
injected into the marginal zone of 1-cell stage wild-type embryos. The marginal
zone was chosen as the injection site because it was shown that nuclear staining
of endogenous XMI·ER1 is first observed in this region (Luchman et al., 1999).
The subcellular localiZation was assessed al stage 13. well past the stage, when
full length XMI-ER1 was shown to be exclusi....ely nuclear (Luchman at al., 1999).
The ad....antage of using embryos for this experiment was that Xmi-er1 is isolated
from Xenopus, thus expression in embryos will show how nuclear translocation of
endogenous XMI-ER1 may be regulated. One disad....antage of injecting into
embryos is the fact that injected RNA remains n~ar the site of injection and thus,
not all cells will contain injected cRNA. Furthermore, the cells that contain
injected cRNA will contain different concentrations of cRNA and subsequently
different levels of protein, depending on the distance from the injection site.
Therefore, subcellular localization of the EGFP-fusion protein was determined by
counting cells in the injection patch. Another disad....antage of using Xenopus
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embryos for analyzing the subcellular localization of EGFP-ER1 fusion proteins is
that Xenopus embryos contain yolk platelet proteins, which autofluoresce at
wavelengths between 488nm and 568 nm, which includes the wavelength of the
excitation energy for EGFP (495 nm), making it very difficult to investigate the
subcellular localization of EGFP fusion proteins (Beumer et al., 1995). The yolk
protein is the embryo'srilain source of nutrition and is therefore very abundant,
especially during earlier stages (Danilchik and Gerhart, 1987). Also, the cell
nuclei are relatively small compared to the large cell (small N/C ratio) making it
difficult to assess the subcellular localization of the protein. Moreover, because
the injected RNA has to be translated and protein has to accumulate to reach a
detectable level, it is difficult to investigate the subcellular localization before
stage 8 (Beumer et al., 1995). However, by assessing the nuclear localization of
the EGFP-MI-ER1 fusioo proteins at later stages. we were able to determine
whether the NLS4 was necessary and sufficient for the nuclear translocation of
MI-ER1 in Xenopus.
First the subcellular localization of EGFP and EGFP-ERl-493 (full-length)
was assessed. The results resembled what was seen in NIH 3T3 cells, EGFP
showed whole cell staining (N=C), whereas EGFP-ER1 showed exclusive
nuclear staining (Figure 3.16).
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Figure 3.16 EGFP-ER339-493. containing NLS4, Is translocated to the nuclei of
developing Xenopus /aevis embryos at stagc J3.
Xenopus laevis embryos werc injected in the marginal zone at the l-cell stage with RNAs
encoding EGFP, EGFP-ERl·493, EGFP-ERl-143, EGFP·ERI45·250, EGFP·ER251-340
or EGFP-ER339-493. Subcellular localization of the EGFP-ERI fusion proteins was
determined, after fixation of the embryos at stage 13, by fluorescence microscopy.
Embryos injected with EGFP show whole cen staining, EGFP-ERI-493 is exclusively
localizcd to the nucleus, EGFP-ERI-143 shows nuclear greater than cytoplasmic staining,
EGFP-ERI45-250 and EGFP-ER251-340 show whole cell staining. EGFP-ER339-493 is
exclusively nuclear.
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To investigate the whether NLS4 was the only (dominant) functional NL$
in Xenopus embryos, cRNAs encoding the following proteins were injected:
EGFP-ER1-143, EGFP-ER145-250, EGFP-ER251·340 and EGFp·ER339-493.
At stage 13, the subcellular localization of the EGFP-fusion proteins was
compared to EGFP and· EGFP-ER1: ER1-143 showed nuclear greater than
cytoplasmic staining, ER145-250 and ER251·340 showed cytoplasmic staining
and ER339-493 showed eXclusively nuclear staining. This corresponds to what
was seen after transfection of these regions in NIH 3T3 cells, which showed that
only constructs containing the NLS4, EGFP-ER1-493 and EGFP-ER33~93. are
exclusively localized to the nucleus
Table 3.7 Subcellular localization of different EGFP constructs after injedlon into
Xenopus embryos. Embryos were fixed at stage 13 and viewed under V.V. light (495
nm)with a lOx objective.
Protein
EGFP
EGFP-ERI-493
EGFP-ERI-l44
EGFP-ERI45·250
EGFP-ER251-340
EGFP-ER339-493
EGFP·ERI-473
EGFP·ERI-461
EGFP-ER457-475
Subcellular localization
Wholecellstainin inallcells
Nuclear in all cells
Nuc1ear>Cvtoplasmic in all cells
Whole cell stainin in all cells
Whole cell stainin in all cells
Nuclear in aJl cells
Nuclear in all cells
Nuc1ear>C 0 lasmic in all cells
Nuc1earinall cells
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To verify that the NLS4 is necessary and sufficient for nuclear
translocation of XMI-ER1 in embryos, additional cRNAs including EGFP-ER1-
461 (not incl. NLS4), EGFP-ER1-473 (incl. NLS4), EGFP-ER457-475 (NLS4) and
EGFP-ERl!.NLS4 were injected into the marginal zone of 1-ee1l stage embryos.
The subcellular localization was determined at stage 13 and compared to EGFP
and EGFP-ER1-493. Embryos injected with EGFP-ER1-473 displayed nuclear
staining, while embryos injected with EGFP-ER1-461 showed whole cell staining
(Figure 3.17). Injection of EGFP-ER457-475 showed nuclear staining (Table 3.7).
Unfortunately, no fluorescence could be detected in embryos injected with
cRNA encoding EGFP·ERl!.NLS4, indicating that there is no protein expression,
even though embryos from the same batch injected with cRNAs encoding EGFP
or EGFP-ER1-493 did express protein in these experiments. However, protein
could be detected after in vitro translation of pT7Ts-EGFP-ERl!.NLS4. Moreover,
EGFp·ERl!.NLS4 protein could be detected after transfeetion into NIH 3T3 cells
by fluorescence microscopy as well as Western Blot analysis. This indicates that
the lack of EGFp·ERaNLS4 protein expression in Xenopus embryos is not a
result of an error in the sequence. However, injection of EGFP-ER1-461, which is
cytoplasmic, and EGFP-ER1-473, which is nuclear, showed that the NLS4 region
was necessary for the nuclear translocation of XMI-ER1.
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Figure 3.17 NLS4 is necessary and sufficient for the nuclear translocation of MI-
ERl In stage I3 Xenopus embryos.
cRNAs encoding EGFP, EGFP-ERI, EGFP·ERI-461, EGFP-ERI-473, EGFP-ER339-
493 and EGFP·ER457-475 were injected into the marginal zone of Xenopus laevis
embryos. Subcellular localization of the EGFP·ERI fusion proteins was detennined by
fluorescence microscopy at stage 13. All proteins containing the NLS4: EGFP·ERI,
EGFP-ERI-473, EGFP-ER339-493 and EGFP-ER457-475, were localized 10 the nucleus.
EGFP and EGFP-ERI-461 displayed whole cell staining.
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Thus, injection of these cRNAs into Xenopus embryos shows that the
NLS4 is necessary and sufficient for the nuclear translocation of XMI-ER1 in
Xenopus laevis embryos. These results are similar to what was observed after
transfection of these constructs in NIH 3T3 cells, which showed NLS4 was
necessary and sufficient" for the nuclear localization of XMI-ER1. This indicates
that the mechanisms for recognition of the XMI·ER1 NLS are present in Xenopus
embryonic cells as well as in NIH 3T3 cells. Therefore, similar soluble transport
factors are present and active in NIH 3T3 cells and Xenopus embryos at the
stage observed. This suggests that NLS found in different animals are
interchangeable, indicating that these sequences and the recognition of these
sequences by the import machinery are well conserved during evolution. This is
also shown for XNF7, whose bipartite NLS is functional in cells in culture as well
as in Xenopus embryos (Li et al., 1994b; Li et al., 1994a).
3.9 Conclusion
In this chapter I have shown that full-length XMI-ER1 is actively
transported to the nuclei of transfected NIH 3T3 cells as well as in Xenopus
embryos. The active import of XMI-ER1 into nuclei is dependent on the presence
of an intact NLS located near the C-terminus of the protein. The core of this NLS
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consists of amino acids 463RPIKRQRM0471 but it was shown that addition of
amino acids flanking this region results in more efficient nuclear import.
I have also shown that an additional, albeit weak, NLS is present in the N·
tenninus of XMI·ER1, 138RPRRCK143. Although this NLS, called NLS1, is not
efficient in translocating a cytoplasmic protein to the nucleus, definite nuclear
greater than cytoplasmic staining of NIH 3T3 cells could be detected when the N·
tenninus of XMI-ER1 (ER1-143) was fused to EGFP as well as to I}-
galactosidase. However. ER1-137, which contains no classic NLS, translocated
to the nucleus in a smaller (45%) subset of transfected cells, indicating that this
region might be translocated by an alternative method, like binding to another
nuclear protein (piggy backing) or even by use of an alternate, not previously
described NLS.
There are different mechanisms whereby proteins can translocate into the
nucleus, either by binding of the NLS directly to import receptors or by binding of
the protein to another nuclear protein. Identification of a functional NLS implies a
direct binding of XMI·ER1 to import receptors. However, this gives us no
information about the temporal regulation of nuclear transport of XMI·ER1 in
Xenopus embryos. Investigation of the regulation of the timing of nuclear
translocation of XMI·ER1 during Xenopus embryonic development will be
described in chapter 4.
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Chapler4
Regulation of nuclear transport of XMI·ER1 during Xenopus
laevis development
4.1 Introduction
During oogenesis, a stockpile of structural and regulatory factors
accumulates which is used during early developmental stages. As a
consequence, many of these factors are present in 100 to 100,000 fold excess
compared to somatic cells (A1mouzni and Walffe, 1993a). These include
transcriptional activators thai are inert during the rapid cell cycling that precedes
the mid-blastula transition (MBT). Regulallon of nuclear transport of maternally
derived transcription factors may provide a mechanism by which the
transcriptional machinery is constrained in vivo during specific stages in
development.
In this chapter, il is shown that the cytoplasmic localization of XMI-ER1
before stage 8 is not a result of lack. of NLS recognition and binding by the import
machinery. The regulation of nudear transport of XMI-ER1 during Xenopus
laevis development is .not regulated by phosphorylation of a site dose to the
NLS, as ·has been observed for other proteins. Furthennore, cytoplasmic
localization of XMI-ER1 before stage 8 in embryos appears to be regulated by
binding of XMI·ER1 to an "anchor" in the cytoplasm. The region responsible for
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the cytoplasmic localization of XMI-ER1 until stage 8 is present in the N-tenninal
half of XMI-ER1.
4.2 Nuclear Localization of XMI-ER1 during Xenopus development
XMI-ER1 is localiZed in the cytoplasm of developing Xenopus embryos
until the embryos reach blastula stage (stage 8), when XMI-ER1 is localized in
the nuclei of cells in the marginal zone (Luchman et al., 1999), Over time. more
and more nuclei in the animal hemisphere become stained. By late blastula stage
(9) XMI-ER1 is found in virtually all nuclei in the animal hemisphere and by early
gastrula, stage 10, ubiquitous nuclear staining is observed (Luchman et al.,
1999).
In order to compare the temporal patterns of nuclear localization of
proteins tested, the exact temporal pattern of nuclear translocation of full-length
XMI-ER1 was first detennined. This was done by compiling data of embryos
injected with EGFp·ER1-493 or (l-GAL-ER1-493, Embryos were fixed at different
stages during development, followed by whole, mount staining using an anti-
EGFP antibody or staining with X-gal, respectively. For each stage a minimum of
40 embryos were examined (Table 4.1).
At sta'ge 8. 7% of embryos show some nuclear staining, while cytoplasmic
staining is predominant. At stage 8.5, 67% of the embryos injected with XMI-ER1
show some cells with exclusive nuclear staining, while cytoplasmic staining is
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also present. At stage 9, almost all embryos show nuclear staining (97%) and at
stages 10 and 13 exclusive nuclear staining is observed (100%).
Table 4.1 Temporal pattern of nuclear Irans!oc:alloD of~-ERI.
t., 6.5 7 7.5 8 8.5 9 10 13
MI-ERI % nuclear stainin 0 0 0 7 67 97 100 100
otal number ofemb 55 52 45 73 135 71 42 51
SO of 0 0 3 2 0
In table 4.1 and figure 4.1, the percentage of embryos showing nuclear staining
at stages 6.5, 7, 7.5, 8, 8.5, 9, 10 and 13 is shown.
When XMI-ER1 is injected in the marginal zone, nuclear staining will be detected
earlier than when XM1·ER1 is injected in the animal pole. To avoid
misinterpretation of the timing of nuclear entry, all injections were done at the 2-
cell stage and embryos were injected in one cell in the animal pole next to the
first cleavage furrow. Although there may be slight variations in the development
of embryos during different experiments as well as variations in determining the
stage by morphology, the graph (figure 4.1) shows a sharp increase in nuclear
staining from stage 8 to 9. indicating a sharp threshold. Because exclusive
nuclear staining of XMI-ER1 injected cells is observed at stage 9, we define this
as the threshold for XMI-ER1 nuclear entry. For our experiments, translocation of
proteins before stage 9 is defined as being premature nuclear localization.
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Figure 4.1 Nuclear localization or MI-ERI during Xenopus embryonic development.
Data of embryos injected with EGFP-ERI-493 or ~-GAL-ERl-493 were compiled. The
percentage of nuclear localization of ERI-493 was calculated. Nuclear translocation of
MI-ERI begins at stage 8 (7%), and 67% of embryos show nuclear staining in about 50%
of the cells in the injection patch at stage 8.5, at stage 9 almost all nuclei (97%) in the
injection patch show exclusive nuclear staining. We define stage 9 as the threshold for
nuclear entry ofMJ-ERI. Translocation of proteins before stage 9 is defined as being pre-
mature nuclear localization.
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4.3 P-GAL-NLS4 translocates to the nucleus prematurely
It was shown that in NIH 3T3 cells and in stage 13 Xenopus embryos
ER457-475 is localized in the nucleus (figures 3.9 and 3.17). This region includes
the basic core of NLS4 and 6 amino acid residues on either side of the core NLS.
This region is the smallest region tested and was shown to be able to direct
EGFP and p·GAL to the nucleus in NIH 3T3 cells as well as Xenopus embryos. It
is important therefore, to investigate whether this region behaves like fuU.length
XMI·ER1 or whether ER457-475 is able to translocate to the nucleus of
developing embryos at earlier stages when nuclear translocation of proteins like
nucleoplasmin, N1 and N2 is known to occur (Dreyer, 1987). Therefore, whether
or not the XMI·ER1 NLS is functional before stage 9 was investigated by
generating a ~·GAL-ER457-475 fusion construct and injection of cRNA encoding
this protein into albino embryos.
The use of ~GAL fusions over EGFP fusions has a great advantage
because of the ease of detection of p-GAL in Xenopus embryos. ~GAL proteins
are shown to be translated to high concentrations during early stages and are
easily detected by staining of the e~bryo with X-gal (Rupp et af., 1994; Tumer
and Weintraub, 1994). Therefore, use of ~GAL·ER1 fusion proteins in embryos
facilitates detection of subcellular localization of these proteins before stage 8.
For all experiments using ~GAL-ER1 fusions, ~GAL and ~GAL·ERl-493 are
used as controls; injection of cRNA encocling p-GAl and ~GAL-ERl-493
showed that ~GAL is not localized to nuclei of Xenopus cells during any of the
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stages observed, namely stage 6.5, 7, 7.5, 8, 8.5 and 9. f}-GAL-ERl-493
however, shows nuclear localization in 6% of embryos at stage 8, with increasing
nuclear staining as development progresses. At stage 9, 100% of cells
expressing 13-GAL·ER1-493 show nuclear staining.
Injection of cRNA encoding 13-GAL-ER457-475 into embryos showed
premature nuclear staining (Figure 4.2, 4.3). Nuclear staining increased- as the
stages progressed and exclusive nuclear staining was observed in all cells
expressing 13-GAL-ER457-475 in about 50% of embryos at stage 8.5 (Figure 4.3).
At stage 9, 93% of staining is exclusively nuclear.
These results show that the NL$4 is recognized by the import machinery
and is able to cause premature translocation of the f}-GAL protein. The
observation that f}-GAL·ER457-475 translocates prematurely suggests that
regions outside ER457-475 are important for regulating the temporal
translocation of XMI·ERl to the nuclei of embryonic cells.
Regulation of nuclear transport is often dependent on specific
phosphorylation patterns (Jans and Hubner, 1996), for example, XNF7 is
localized in the cytoplasm in a hyperphosphorylated state. Dephosphorylation of
XNF7 results in release from its cytoplasmic anchor and subsequent nuclear
translocation of XNF7 (Li et af., 1994b; Li at al., 1994a). In the next section I
investigated whether the cytoplasmic retention of XMI·ER1 is regulated by
phosphorylation on a site in the vicinity of the NLS.
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Figure 4.2 Injection of MI-ER4S7-475 (NLS) into Xenopus embryos results in pre-
mature nuclear translocation.
Embryos were injected wilh cRNA encoding ll-GAL-ER457-475 (D) and the subcellular
localization of the fusion protein was compared [0 ll-GAL (B), and ll-GAL·ER1-493 (C).
ll-GAL was localized in the cytoplasm of all stages tested. p-GAL-ERl-493 showed
nuclear staining beginning stage 8.5, but was not exclusively nuclear until stage 9.
Control embryos were injected with DEPC·treate<l H20 and showed no staining at all
(A).
Scale bar = lmm.
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Figure 4.3 Subcellular localization of j}-GAL-ER4S7-47S during different stages of
Xenopus development, compared to ~-GAL-ERl-493.
Percentages are based on embryos examined after two injection experiments and
subcellular localization of fusion protein was examined for at least 5 embryos per cRNA,
per stage. per experiment.
Legend shown on bottom left: N= exclusive nuclear staining (solid black); N+C= most
cells in the injection patch show exclusivc nuclear staining, but some cells show nuclear
staining with faint cytoplasmic staining (striped); C= cytoplasmic staining (white).
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4.4 Cytoplasmic retention of XMI·ER1 is not dependent on cdc2
phosphorylation of Its CcN motif
Sequences flanking NLSs, which can contain potential phosphorylation
sites, can influence regulation of nuclear import (Jans and Hubner, 1996). For
example, the SV40 large T-Ag NLS is flanked by two phosphorylation sites, a
casein kinase II and a cdc2 kinase site. Together with the NLS this motif is called
a CcN box, for ~asein kinase, £dc2k and ~LS.
Putative phosphorylation sites can be identified by computer analysis of
the protein sequence using pbaseyrediet (www.cbs.dtu.dkldatabaseslPhosphcr
Base/predictlpredform.html) and NetPhos (www.cbs.dtu.dklserviceslNetPhos)
(Blom 81 a/., 1999). Analysis of the XMI·ER1 protein sequence using these
programs revealed 15 putative CKII sites, of which 4 were in the C·terminal
region in the vicinity of the NLS (appendix A1), 1 putative cdc2 kinase site, 8
putative PKA sites as well as putative phosphorylation sites for PKC, CKI and
others. Analysis of these putative phosphorylation sites using NetPhos gives an
indication of the probability of phosphorylation. For example, the threonine in the
putative CKII site KTD"ssrNDP has a probability of phosphorylation of 0.330 and
will probably not be phosphorylated, while the serine in the putative cdc2IPKA
site RMO.(72SPGK has a probability of 0.997 and therefore is more likely to be
phosphorylated (appendix A2).
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Figure 4.4 Amino acid sequence of Xl\fl-ERt Indicating a putative CcN motif
A CcN motif consists ofa CKlJ site, a cdc2 kinase site and an NLS. XMI-ERI possesses
a putative ede2 kinase site (underlined in red) and two putative CKII sites (underlined in
blue). The ede2 kinase site, together with one of the CKII sites and the NLS (box) fonn a
putative CcN motif.
MAEPSlRTAS PGGSAASDDH EFEPSADMLV HEFDDEQTLE EEEMLEGEVN
51 FTSEIEHlER ESEMPIDELL RlYGYGSTVP lPGEEDEEDM DNDCNSGCSG
101 EIKDEAIKDS SGQEDETQSS NDDPTPSFTC RDVREVIRPR RCKYFDTNHE
151 IEEESEDDED YVPSEDWKKE IMVGSMFQAE IPVGICKYRE TEKVYENDDQ
201 llWNPEYVlolE ERVIDFLNEA SRRTCEERGL DAIPEGSHIK DNEQAlYEHV
251 KCNFDTEEAL RRlRFNVKAA REELSVWTEE ECRNFEQGlK AYGKDFHLIQ
301 ANKVRTRSVG ECVAFYYMWK KSERYDFFAQ QTRFGKKKYN LHPGVTDYMD
351 RlLDESESAT SSRAPSPPPT TSNSNTSQSE KEDCTASNNT QNGVSVNGPC
401 AITAYKDEAK QGVHLNGPTI SSSDPSSNET DTNGYNRENV TDDSRFSHTS
451 G~TNPDDT NERPIKRQRM QsPG~ESTGS SEFSQ~~~_~_~~V*
c:::J NLS'
putative cdc2/PKA site
-~ putative CKII site
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XMI-ER1 has two putative CKII sites in the vicinity of the NLS, as well as a
putative cdc2k site (see figure 4.4). This forms a putative CcN motif and it is
important to investigate whether this CcN is functional for the regulation of
nuclear import of XMI-ER1 in NIH 3T3 cells as well as Xenopus embryos. Since
phosphorylation of the CcN motif by cdc2 kinase is known to have an inhibiting
effect on nuclear translocation of the SV40 large T-antigen as well as other
proteins (Jans and Hubner, 1996; Jans and Jans, 1994), phosphorylation of the
CcN motif by cdc2 in XMI-ER1 dUring early embryonic development could
explain cytoplasmic localization of XMI-ER1 during early stages.
To identify whether the cdc2 kinasel PKA site, e-terminal of the NLS, in
XMI·ER1 is important in the regulation of nuclear import, different mutations were
made and transfecled into NIH 3T3 cells. Substitution of the serine with either
alanine, asparagine or aspartic acid had no effect on the nuclear uptake when
mutated in the fUll-length XMI-ER1, ER339-493 or ER457-475 (only S~ A and
S? 0), which all showed nuclear localization of the protein. There were some
differences in the numbers of nuclear cells, but no consistent pattern was found
(see table 4.1 and figures 4.5, 4.6 and 4.7).
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Figure 4.5 Substitution or mserine to alanine (A), asparagine (N) or aspartic acid
(D) has no effect on the nuclear localization or EGFP-ERt-493 In NIH 3T3 cells.
Cells were transfeClcd with EGFP-ER 1·493 fusion constructs containing serine to alanine
(A), asparagine (N) or aspartic acid (0) substitutions. A, Subcellular localization of the
fusion proteins was detennined by fluorescence microscopy 48 hours post-transfection.
Photographs illustrating the subceilular localization of each of the fusion proteins and
Hoechst 33342 staining of the same field are shown for each construct. Arrows indicate
cells that show subcellular localization of the fusion protein that is most representative of
the subcellular localization of the majority of cells expressing the indicated protein and
the corresponding nuclei as identified by Hoechst staining. B, Protein expression levels of
the EGFP-ERI-493 fusions were detennined by Western Blot analysis using an anti-GFP
antibody. Molecular weight markers are indicated on the left.
Scale bar'" 0.01 mm.
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Figure 4.6 Substitution of mserine to alanine (A), asparagine (N) or aspartic acid
(D) has no effed on the nuclear localizatioo of EGFp·ER339-493 In NIH 3T3 cells.
Cells were transfected with EGFP·ER339·493 fusion constructs containing serine to
alanine, asparagine or aspartic acid substitutions. A, Subcellular localization of the fusion
proteins was determined by fluorescent microscopy 48 hours posHransfection.
Photographs illustrating the subcellular localization of each of the fusion proteins and
Hoechst 33342 staining of the same field are shown for each construct. Arrows indicate
cells that show subcellular localization of the fusion protein that is most representative of
the subcellular localization of the majority of cells expressing the indicated protein and
the corresponding nuclei as identified by Hoechst staining.
B, Protein expression levels of the EGFp·ERJ39·493 fusions were determined by
Westem Blot analysis using an anti·GFP antibody (panel B). Molecular weight markers
are indicated on the left.
Scale har =" 0.0 I mm.
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Figure 4.7 Substitution of mserlne to alanine (A) or aspartic acid (0) has no effed
on the nuclear localization of EGFP·ER457-475 in NIH 3T3 cells.
Cells were transfccted with EGFP·ER457-475 fusion constructs containing serine to
alanine or aspartic acid substitutions. A, Subcellular localization of the fusion proteins
was determined by fluorescent microscopy 48 bours post-transfection. Photograpbs
illustraling tbe subcellular localization of each of the fusion proteins and Hoechst 33342
staining of the same field are shown for each construct. Arrows indicate cells that show
subcellular localization of the fusion protein that is most representative of the subcellular
localization of the majority of cells expressing the indicated protein and the
corresponding nuclei as identified by Hoechst staining. B, Protein expression levels of the
EGFP·ER457-475 fusions were determined by Western Blot analysis using an anti·GFP
antibody (panel B). Molecular weight markers are indicated on the left.
Scale bar = 0.01 mm.
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Table 4.2 Transfectlon of cdc2 kinase1 PKA phosphorylation site mutations In
different ERI constructs into NIH 3D cells.
Construct %N %N>C %N=C
EGFP 0 5 95
-
99 1 0
~APGK 89 7 4
ERl-49 ~NPGK 84 13 3
ERl-493 SPGK ~ DPGK 99 1 0
ER339493 97 3 0
ER339493 SPGK ~ APGK 92 8 0
ERJ39-493 SPGK ~ NPGK 99 1 0
ER339-493 SPGK ~ DPGK 87 7 6
ER457-475 76 22 2
ER457-475 SPGK ~ APGK 83 15 2
ER457-475 SPGK ~ DPGK 71 15 14
This indicates that this putative phosphorylation site is not used for the
regulation of nuclear transport of XMI-ER1 in NIH 3T3 cells, which is consistent
with our previous observation that XMI-ER1 is constitutively localized to the
nucleus in these cells (Patemo et al., 1997). If this phosphorylation site would be
important for the regulation of nuclear transport of XMI-ER1 one would expect
that the nuclear localization XMI·ER1 in NIH 3T3 cells would be significantly
below 100% because some of the XMI·ER1 protein would be in a phosphorylated
state that prevents nuclear translocation.
The phosphorylation state of the cdc21 PKA site in the vicinity of the NLS
of XMI·ER1 in embryos might be different from the phosphorylation state of this
site in an established cell line like NIH 3T3 cells. The phosphorylation slate of
many proteins is dependent on activation of cell surface receptors and their
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signaling pathways (Karin, 1994). During embryonic development, different
signaling pathways are activated at the start of zygotic transcription (Newport and
Kirschner, 1982b). Activation of these pathways results in a cascade of
phosphorylation of proteins downstream of the receptor, changing
phosphorylation states of many proteins. In tum, these changes in
phosphorylation patterns "before and after the start of zygotic transcription may
have a profound effect on the phosphorylation state of XMI-ER1.
In Xenopus embryos, a delay in the nuclear uptake of XMI·ER1 is
observed until after stage 8, wtlich is around the start of zygotic transcription, at
MBT. To investigate whether this putative PKA/ cdc2 site is important for the
cytoplasmic retention of XMI-ER1 seven different constructs were generated in
pT7Ts, which can be used for in vitro RNA transcription: EGFP, EGFP·ER1493,
EGFp·ERl-493 S-?A, EGFp·ERl-493 S-?D, EGFP·ER339-493, EGFp·ER339-
493 S~A and EGFp·ER339-493 S~D. cRNA was transcribed and injected into
the animal pole of 2.ce1l stage albino embryos. The embryos were left to develop
and were fixed at stage 7, 8-8.5, 9 and 10 to' investigate whether a difference in
the timing of nuclear import could be detected. The embryos were stained in a
whole mount detection procedure using a GFP antibody (Clontech) and
visualized by NBTIBCIP staining. At least ten embryos were examined per RNA
per stage. Photographs were taken of the embryo that showed a staining pattern
most representative for the subcellular localization of each EGFP·ER1 fusion
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protein at the stages indicated. Expressed EGFP-ER1 fusion protein could be
detected in embryos beginning at stage 7.
Injection of EGFP-ER1-493 S~ A and EGFP-ER1-493 S~ D, showed
similar staining patterns compared to EGFP-ER1-493 (Figure 4.8). No nuclear
localization was observed until the beginning of stage 8 and exclusive nuclear
staining was observed at stage 9. This indicates that there is no difference in the
"
timing of nuclear translocation of the protein with the alanine or aspartic acid
substitution compared to the wild type counterpart. In some embryos background
staining was high. For these embryos an enlargement of the injection patch is
shown for better analysis of the subcellular localization of the EGFp·ER1 protein
(Figure 4.8 B).
Embryos expressing EGFP-ER339-493 S~A and EGFP-ER339-493 S~
o did not show a difference in timing of nuclear translocation compared to EGFP-
ER1-493 and EGFP-ER339-493 (data not shown). EGFP-ER339-493 localized to
the nucleus at stage 8, the same time as the full length XMI-ER1, indicating that
regulation of cytoplasmic localization may be dependent on residues between
339 and 493. The EGFP control was cytoplasmic durin9 all stages. These results
indicate that the cdc21PKA site is not used for the regulation of timing of nuclear
import during embryonic development. However, the mechanism of cytoplasmic
localization of XMI·ER1 may-be dependent on phosphorylation of other putative
phosphorylation sites within XMI·ER1.
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XMI-ER1 contains many CKH sites, which may be important for the
regulation of nuclear transport. The CKII site described for the SV40 T-Ag CcN,
for example, is important for the rate of nuclear uptake (Jans and Hubner, 1996:
Jans and Jans, 1994). The experimental approach for investigating a role for the
putative CKII sites in the temporal regulation of nuclear translocation of XMI·ER1
is microinjection of mUtated constructs into cells followed by confocal
microscopy. This would allow fOf' the measurement of rates of nuclear import of
proteins in live cells. This experimental set-up was not available and therefore
the potential function of the CK II sites in XMI-ER1 was not investigated.
I showed that mutation of the putative cdc2lPKA site localized in the C-
terminus of XMI·ER1 has no effect on nuclear import of XMI·ER1 in NIH 3T3
cells as well as in Xenopus embryonic cells. Furthermore, substitution of this
putative cdc2J PKA site indicated that phosphorylation on this site has no effect
on the regulation of the temporal pattern of XMI-ER1 nuclear localization during
Xenopus development.
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Figure 4.8 Substitution of 472serlne with alanine (A) or aspartic acid (0) in EGFP-
ERl-493 does not Influence the temporal pattern of nuclear Import of MI-ERI
during Xenopus embryonic development.
A, cRNA encoding the indicated EGFP-ERI-493 fusion proteins was injected into the
animal pole of2-cell stage albino embryos. Embryos were fixed at different stages during
development and whole mount staining was perfonned using an anti-OFP antibody.
EGFP is localized in the cytoplasm during all stages tested. EGFP.ERI, EGFP-ERl(A)
and EGFP-ERl(D) localize to the nucleus beginning stage 8 and exclusive nuclear
localization is observed at stage 9. Photographs were taken of embryos that were the most
representative of its group. Results are based on 2 injection experiments. For each
injected eRNA at least 5 embryos were examined per stage, per experiment.
Scale bar = Imm.
B, Enlargement of the injection pateh of embryos expressing EGFP.ER1, EGFP-ERI-A
and EGFP-ER I-D at stage 8. In all embryos nuclear staining was visible at this stage.
Scale bar" 0.5 mm.
A Stage 7 8.5 10
B EGFP-ER1-A EGFP-ERI-D
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4.5 XMI·ER1 contains a cytoplasmic retention domain, which prevents
nuclear translocation before stage 8.
A protein containing a functional NLS can be localized in the cytoplasm as
a result of binding to a molecule that prevents it from translocating into the
nucleus. This mechanism can be divided into two categories: NLS·masking or
binding of the protein to a cytoplasmic anchoring molecule. If the delay in nuclear
import of XMI-ER1 in Xenopus embryos is due to binding to a cytoplasmic
anchor, then addition of an NLS will not influence the timing of translocation.
However, if the regulation is due to masking of the NLS by inter- or
intramolecular binding, addition of an additional NLS will result in nuclear
translocation of XMI-ER1.
To investigate whether the cytoplasmic retention of XMI·ER1 is a result of
NUS..masking or binding to a cytoplasmic anchoring protein, the CS2+·n~al
vector was used, which contains the SV40 large T-Ag NLS fused to the N-
tenninus of the ~alactosidase cDNA, and CS2+-cf3gal, which does not contain
the SV40 NLS. The $V40 T·Ag NLS is shown to be a very strong NL$ that is
able to translocate large cytoplasmic proteins to the nuclei of cells in culture
(Lanford at 81., 1986; Ribbeck and Gorlich, 2001). j}-GAl was chosen for the
fusion constructs because of the easy and very rapid detection of the j}-GAL-ER1
fusion proteins, within 3 hours after fixation of the embryos. Embryos injected
with n~-gal cRNA, did not show nuclear staining before stage 9, which is
simultaneously.with j}-GAL- ER1 injected embryos (data not shown).
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Investigation as to whether cytoplasmic localization is caused by NLS-
masking or cytoplasmic anchoring, is based on the ability of the additional NLS to
cause premature translocation. The SV40 T-Ag NLS is not able to direct l}-GAL
to the nucleus prematurely. Therefore a different NLS was used to investigate
whether XMI·ER1 is localized in the cytoplasm as a result of NLS-masking or as
a result of binding to a cytoplasmic anchor.
Investigation of the literature on nuclear transport in Xenopus embryos
shows that most proteins able to translocate before the start of zygotic
transcription possess a bipartite NLS, like nucleoplasmin, N1 and N2 (BoulikaS,
1994: BoulikaS, 1997; Dreyer, 1987). This suggests that bipartite NLS can be
used to translocate proteins into the nucleus prematurely, well before MBT in
Xenopus embryos. One well-described protein, which possesses a bipartite NLS,
is the zinc-finger protein. XNF7. XNF7 is retained in the cytoplasm of developing
Xenopus embryos due to binding of its "cytoplasmic retention domain~ (CRD) to
an "anchor" protein in the cytoplasm. When the CRD of XNF7 was deleted, the
prolein was detected in the nucleus as early as stage 7 (Li et a/., 1994a).
Therefore, we used the XNF7 bipartite NLS fused to XMI·ER1 to test
whether XMI-ER1 was retained by cytoplasmic anchoring or NLS masking. RNAs
of I}-GAL, j3-GAL·ER1, j3-GAL-XNF7NLS and ~-GAL-XNF7NLS-ER1 were
injected into 2-ce1l stage albino embryos and the subcellular localization of the
corresponding proteins was examined at stage 6.5, 7, 7.5, 8, 8.5 and 9 by X-gal
staining of whole embryos (Figure 4.9 and 4.-10 and 4.11). The stages of the
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embryos to be examined were selected to make a distinction between proteins
that translocated at the same time as full length XMI·ER1. which showed nuclear
staining at stage 9. and proteins that showed nuclear staining before that time,
i.e. premature translocation of the protein.
At stage 7 to 7.5 the embryos injected with ~-GALXNF7 ·NLS began
showing nuclear staining, which increased as the embryo developed and
exclusive nuclear staining was observed at stage 8 (Figure 4.9 and 4.10 and
4.11). In the embryos injected with I}-GAL-ER1 and ~-GAL·XNF7NLS·ER1,
however, nuclear staining was detected beginning around stage 8.5 and staining
was not exclusively nuclear until late stage 9 (see figures 4.9 and 4.10 and 4.11).
The ~GAL control was always located in the cytoplasm. There was no
background staining for embryos injected with DEPC-treated H20.
Although the XNF7NLS was able to translocate ~GAL to the nuclei
prematurely, addition of the XNF7NLS to full-length MI-ER1 did not; nuclear
staining was first detected at stage 8.5 and MI-ER1 was not eXclusively nuclear
until late during stage 9. This suggests that XMI·ER1 contains a cytoplasmic
retention domain and is retained in the cytoplasm by binding of this region to an
anchor in the cytoplasm during earty stages of Xenopus embryonic development,
with release of t.h~ protein and subsequent nuclear translocation during stages a-
9. Investigation of the location of the possible CRD within XMI·ER1 was
pel10rmed and is described in the following sections.
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Figure 4.9 Ml-ERI is retained In the cytoplasm by binding to a cytoplasmic anchor.
Embryos wcre injected at the 2-cell stage with the RNAs indicated. At different stages
during development embryos were fixed, followed by staining with X-gal to detect the
subcellular localization of the p-GAL fusion proteins. The subcellular localization of P-
GAL-XNF7NLS (D) and p-GAL-XNF7NLS-ERI (E) was compared to p-GAL (B) and
p-GAL-ERI (C). Embryos injected with DEPC·treated H20 did not show staining (A).
Scale bar = I mm.
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Figure 4.10 Subcellular localization of ~GA"""ER1, Il-GAL-XNF7NLS and ~GAL­
XNF7!'o'L5-ERl in Xenopus laevis embryos.
Enlargement of the embryos shown in figure 4.9. Stages 6.5, 7, 8, 8.5 and 9 are shown. A,
13·GAL.ERL S, 13-GAL-XNF7NLS. C, 13-GAL-XNF7NLS-ERI.
Scale bar ... 0.5 mm.
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Figure 4.11 Subcellular localization of Il-GAL- ERl, Il-GAL-XNF7NLS and !}-GAL-
XNF7NLS·ERJ during different stages ofXenopus development
Percentages are based on embryos examined after two injection experiments and
subcellular localization of fusion protein was examined for at least 5 embryos per cRNA,
per stage, per experiment.
Legend shown on bottom left: N'" exclusive nuclear staining (solid black); N+C'" most
cells in the injection patch show exclusive nuclear staining, but some cells show nuclear
staining with faint cytoplasmic staining (striped); C'" cytoplasmic staining (white).
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4.6 XMI~ER1 has a retention domain in Its N~tenninus
To ,investigate whether the cytoplasmic retention domain of ER-1 is
localized in the N-terminal or C.terminal half of the protein, two j3-GAL-
XNF7Nl5-ER1 fusions were generated. The first comprised amino acids 1-282.
which included the acidic domains, the weak NlS (NlS1) and the ELM2 domain.
The second fusion was generated by addition of amino acids 267493, which
contains the SANT domain, the proline rich region and the NlS (NlS4). cRNA
was generated and injected into 2-eeli stage albino embryos. At stages 6.5, 7,
7.5,8,8.5 and 9. the embryos were fixed and stained to identify the subcellular
localization of the fusion protein. Stages 6.5, 7, 8, 8.5 and 9 are shown in figure
4.12i and it As controls 13-GAL-XNF7NlS and j}-GAl-XNF7NlS-ER1493 were
used. As shown in figures 4.12i, ii, and 4.13 the XNF7Nl5-ER267-493
translocation to the nucleus was premature, similar to that observed for the
embryos injected with j}-GAl-XNF7-NlS. However, XNF7NlS-ER1-282 was not
nuclear until stage 8.5, showing a similar pattern to the 13-GAl-XNF7-NlS-ER1-
493. This indicates that the possible CRD is located in the N-terminal half of XM1-
ER1.
To narrow down the region important for the cytoplasmic retention of XMI-
ER1 before stage 8 in embryos, XMI-ER1 was divided into smaller regions, as
described below.
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Figure 4.12i Ml-ERI possesses a cytoplasmic retention domain in its N·terminal
half.
Embryos were injected with cRNA encoding ~-GAL-XNF7NLS, ~-GAL-XNF7NLS·
ERI, p-GAL-XNF7NLS-ERI-282 and ~-GAL-XNF7NLS-ER267-493 at the 2-cell stage.
The subcellular localization of the fusion proteins was detennined by X-Gal staining at
different stages during development. The subcellular localization of ~-GAL-Xl\'f7NLS·
ERI-282 (C) and ~-GAL-XNF7NLS-ER267-493 (0) at stages 6.5, 7 and 8 was compared
to ~·GAL-XNF7NLS·ERl (A) and j3·GAL.XNF7NLS (B).
Scale bar = lmm.
A:Il-GAL-
XNF7NLS-
ERI
B:~-GAL­
XNF7NLS
C:~-GAL­
XNF7NLS-
ERI-282
D:Il-GAL-
XNF7NLS-
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Figure 4.12ii Ml-ERJ possesses a cytoplasmic retention domain in its N-terminus.
Embryos were injected with cRNA enooding p-GAL-XNF7NLS, ll-GAL.XNF7NLS-
ERI, p-GAL-XNF7NLS-ERI-282 and ll-GAL-XNF7NLS-ER267-493 at the 2-cell stage.
The subcellular localization of the fusion proteins was detennined by X-Gal staining at
different stages during development. The subcellular localization of l}-GAL-XNF7NLS-
ERl-282 (C) and j3-GAL-XNF7NLS-ER267-493 (D) at stages 8, 8.5 and 9 was compared
to j3-GAL.XNF7NLS·ERI (A) and !3-GAL.XNF7NLS (B).
Scale bar = 1mm.
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XNF7NLS-
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Figure 4.13 Subcellular localization of fl-GAL-XNF7NLS-ERI-282 and fl-GAL-
XNF7NLS-ER267-493 during different stages of Xenopus development, compared to
p-GAL-XNF7NLS-ERI and fl-gal-XNF7NLS at these stages.
Stages shown are 6.5, 7, 7.5, 8, 8.5 and 9. Percentages are based on embryos examined
after two injection experiments and subcellular localization of fusion protein was
examined for at least 5 embryos per cRNA, per stage, per experiment.
Legend shown on bottom left: N",- exclusive nuclear staining (solid black); N+C= most
cells in the injection patch show exclusive nuclear staining, but some cells show nuclear
staining with faint cytoplasmic staining (striped); C= cytoplasmic staining (white).
XNF7NlS-ER267-49J
XNF7NLS-ERI·282
XNF7NLS-ERI493
XNF7NLS
~ ~ f-
r- r- r-
r- r- r-
r- r- r- ~r- r- r- r- r-r- r- r- r- r-r- r- f- f- f-f- f- f- f- f-
f-
~ ~
r- r-
r- r-
f- f-
f- f- 1
f- f- !~ ~ ~ ---j
r- r- r-
r- r- r-
r- r- f-
~ ~ f-f-
r-
r-
f-
f-
f- l- f-
.. u ..
Stages
202
4.7 Attempts to Identify the minImal region necessary for retention of XMI·
ER1 during Xenopus development
To narrow down the region necessary for retention of XMI·ER1 during
Xenopus development, cRNAs of 13-GAl·XNF7NLS fusions containing different
regions of ER1 were injected into 2·cell stage embryos. Since the N·terminal half
of XMI-ER1 was shown to contain the cytoplasmic retention domain, this· region
was divided into smaller regions. To be complete, the regions used span the
complete XMI·ER1 sequence. The regions used were: ER1-143, ER145-250,
ER251-340 and ER339-493. Embryos were left to develop to stages 7, 7.5, 8, 8.5
or 9 and were then examined for subcellular localization of the fusion protein.
The subcellular localization of j}-GAl·XNF7NLS·ER1·143, t3-GAl·XNF7NL$-
ER145-250, j}-GAL·XNF7NLS·ER251-340 and j}-GAL-XNF7NLS·ER339-493
was compared to the localization of j}-GAL, j}-GAL·ER1-493, IJ·GAl-XNF7NLS,
and ~·GAL·XNF7NLS·ER1-493.
Nuclear staining of XNF7NL$-ER1-143 and ,:<NF7NLS-ER251-340 was
observed in embryos beginning stage 7 (figures 4.14, 4.15, 4.16 and 4.17).
Nuclear staining was observed beginning stage 7.5 for XNF7NL$-ER145-250
and XNF7NLS·ER339-493 (figures 4.14, 4.15, 4.16 and 4.17). Thus, nuclear
translocation of XNF7NLS·ER1·143, XNF7NL$-ER145-250, XNF7NLS-ER251-
340 and XNF7NLS·ER339-493 was premature. This suggests that the possible
CRD may be split in these smaller regions.
203
There may be many possible motifs responsible for the cytoplasmic
retention of XMI·ER1 during development. However, no known CRO could be
identified in the N-terminal region. All regions smaller than ER1-282 (ER1·143,
ER145-250 and ER251·340) translocated to the nudeus prematurely, therefore
the smallest region necessary for cytoplasmic retention of XMI·ER1 identified
was ER1·282.
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Figure 4.14 Addition of the XNF7NLS fo ERI·143, ERI4>.Z50, ER251-340 and
ER339-493 results in pre-mature nuclear translocation.
cRNA encoding I3-GAL.XNF7NLS, I3·GAL-XNF7NLS-ERl, I3-GAL-XNF7NLS·ERl.
143, I3·GAL·XNF7NLS-ERI45-250, I3-GAL-XNF7NLS-ER251-340 and I3-GAL·
XNF7NLS-ER339-493 were injected into 2-cell stage Xenopus embryos. The embryos
were fixed at different stages during development and I3-GAL fusion proteins were
stained with X-Gal. Embryos most representative of its group at stages 7, 7.5, 8 and 8.5
are shown. The subcellular localization of I3-GAL-XNF7NLS-ERI-143 (C), I3-GAL·
XNF7NLS·ERI45·250 (D),I3·GAL.XNF7NLS.ER251·340 (E) and I3-GAL-XNF7NLS-
ER339-493 (F) was compared to I3-GAL-XNF7NLS (A) and I3-GAL-XNF7NLS·ERI
(8).
Scale bar: Imm.
Slage 7 7.5 8.5
A:~-GAL­
XNF7NLS
B:~-GAL­
XNF7NLS-
ERI
C:~-GAL­
XNF7NLS-
ERl-143
D:~-GAL­
XNF7NLS-
ER145-250
E:~-GAL­
XNF7NLS-
ER251-340
F:~-GAL­
XNF7NLS-
ERJ39-493
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Figure 4.15 Addition of the XNF7NLS to ERI-143, ER145-250, ER251-340 or
ER339-493 results in pre-mature nuclear translocation.
Enlargement of embryos shown in figure 4.14. Stages 7, 7.5, 8 and 8.5 are shown.
Scale bar = 0.5 mm.
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Figure 4.16 Subcellular localization of Xt~F7NLS-ERI-143 and XNF7NLS-ER14S-
250. compared to XNF7NLS-ERI and XNF7NLS.
Stages shown are 7, 7.5, 8, 8.5 and 9. Percentages are based on embryos examined after
two injection experiments and subcellular localization of fusion protein was examined for
at least 5 embryos per cRNA, per stage, per experiment.
Legend shown on bottom left: N= exclusive nuclear staining (solid black); N+C= most
cells in the injection patch show exclusive nuclear staining, but some cells show nuclear
staining with faint cytoplasmic staining (striped); C= cytoplasmic staining (white).
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Figure 4.17 Subcellular localization of XNF7NL5-ER251-340 and XNF7NL5-
ER339-493, compared to XNF7NLS-ERI and XNF7NLS
Stages shown are 7, 7.5, 8, 8.5 and 9. Percentages are based on embryos examined after
two injection experiments and subcellular localization of fusion prolein was examined for
at least 5 embryos per cRNA, per stage, per experiment.
Legend shown on bottoJ;ll left: N= exclusive nuclear staining (solid black); N+C= mosl
cells in the injection palch show exclusive nuclear staining, but some cells show nuclear
staining with faint cytoplasmic staining (Slriped); C= cytoplasmic staining (white).
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Figure 4.18 Schematic illustrating different j>-GAL fusions used to identify the
mechanism of regulation of nuclear transport of MI·ERI during Xenopus
embryonic development.
Colored boxcs represent some of the domains present in MI-ERI, see boxed legend.
Amino acid numbers of different regions of XMI-ERI are indicated. ~-GAL·XNLS'" p.
GAL·XNF7NLS. Whether proteins were translocated prematurely is indicated on the
right.
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4.8 Conclusion
The results shown in this ct1apter are summarized in figure 4.18. The
regulation of cytoplasmic retention of XMI·ER1 in Xenopus laevis embryos was
investigated. It was shown that the NLS (ER457-475) of XMI-ER1 was able to
translocate ~-GAL to the nucleus prematurely, whict1 suggested that cytoplasmic
retention of XMI-ER1 is not dependent on NLS recognition and binding by the
import machinery. Investigation of a phosphorylation site in the vicinity of this
NLS showed, that the subcellular localization of XMI-ER1 is not regulated by
phosphorylation of this putative cdc21 PKA site. Furthermore, I have shown that
retention of XMI-ER1 before stage 8 in embryos appears to be regulated by
binding of XMI-ER1 to an "anct1or" molecule in the cytoplasm. This was shown by
addition of the XNF7NLS to XMI-ER1. XNF7NLS-ER1 translocated to the nuclei
beginning at stage 8.5. similar to what is observed for full length XMI-ER1, while
the XNF7NLS by itself translocated pre-maturely. This indicates that the
cytoplasmic anchoring of XMI-ER1 is dominant over the addition of a functional
NLS. Although the smallest region responsible for cytoplasmic retention of XMI-
ER1 has not been identified, it is localized in a region between amino acid
residues 1 and 282.
In an attempt to identify the smallest region of XMI-ER1 responsible for
cytoplasmic localization during earty development, the N-terminal half of XMI-
ER1 was divided into the following regions: ER1-143, ER145-250. and ER251-
340. ER339-493, which was predicted to translocate prematurely since ER267-
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493 translocated prematurely, was used as a control. These regions were fused
to I3·GAl·XNF7NLS and expressed in Xenopus embryos. Premature
translocation was observed for each of these regions.
Possible motifs responsible for the cytoplasmic retention of XMI-ER1
during development include CROs. However, no known CRO could be identified
in XMI-ER1. Since all regions smaller than ER1-282 (ER1-143, ER145-250 and
ER251-340) translocated to the nucleus prematurely, the smallest region
necessary for cytoplasmic retention of XMI-ER1 identified was ER1-282. These
results indicated that binding of a CRO in XMI·ER1 to a cytoplasmic anchoring
molecule is responsible for the cytoplasmic retention of XMI-ER1 in developing
Xenopus laevis embryos.
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Chapter 5 General Discussion
XMI-ER1 is located in the cytoplasm of developing embryos until stage 8,
around the start of the mid-blastula transition, when it localizes to the nucleus.
MBT is characterized by a series of significant cellular and molecular changes
including changes in cell cycle rate and synchrony, onset of cell movement and
activation of zygotic gene transcription. The correlation between entry of XMI-
ER1 into nuclei and MBT suggests a potential role for XMI-ER1 in zygotic
transcription. XMI-ER1 possesses several characteristics of a regulator of gene
expression. It is an immediate early gene, which 'localizes to the nucleus a~d
contains acidic domains capable of trans-activating transcription (Paterno et al.,
1997). It also contains an ELM2 domain, which in its human homologue is shown
to bind HDAC1/2 (Ding at a/., unpublished data), and a SANT domain, which is
found to be a DNA binding motif in other proteins (Aasland at al., 1996), and
which possibly can bind HAT (Sterner et a/., 2002). Taken together, this suggests
that XMI-ER1 may function in regulating the expression of at least a subset of
zygotic genes at MBT.,
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5.1 Analysis of NlS in XMI-ER1
Nuclear translocation of proteins is dependent on the presence of a
nuclear localization signal, NLS. Based on computer analysis and analysis of the
basic amino acids in XMI-ER1, four putative NLS have been identified, of which
one was shown to be functional. NLS4, located near the C-terminus of XMI·ER1,
is able to directly localize a carrier protein to the nucleus. Moreover, deletion of
the core NLS4 from the full-length XMI-ER1 sequence results in cytoplasmic
localization of XMI-ER1, indicating that the nuclear translocation of XMI-ER1 is
dependent on NLS4.
The sequence of the NLS4 (463RPIKRORM0471) is similar to one of the
NLSs found in human c-MYC (PAAKRVKLD) (Makkerh at af., 1996; Post at al.,
2001). Both NLS have a proline in the N-tenninal flanking region, followed by one
(XMI·ER1) or two (c-MYC) amino acids with a non-polar side chain. Addition of
PAA to a region of basic amino acids is necessary for the import of a synthetic
peptide KKKK (Makkerh at al., 1996). The core NLS is made up of three basic
amino acids, KR.R (XMI-ER1) and KR.K (c-MYC). The C-tenninal flanking region
contains one nonpolar amino acid (M in XMI·ER1; L in c-MYC), followed by an
acidic amino acid and an uncharged polar amino acid, DS. An acidic amino acid
when preceded by the leucine residue has been shown to greatly enhance import
into the nucleus for the c·MYC NLS (Makkerh at al., 1996). The main difference
between the two NLS is the amino acid in the core region, which contains an
uncharged polar residue (a) in the XMI-ER1 sequence (KRQR), and a nonpolar
218
residue (V) in the c-MYC (KRVK). Small changes between NLS have been
shown to determine specific recognition between importin-a isoforms or influence
the binding strength of the NLS to importin-a, thereby creating a hierarchy in
transport of the protein (Kohler et al., 1999; Moroianu, 1999).
Analysis of the efficiency of NLS4 to carry a cytoplasmic protein to the
nucleus showed that in addition to the residues described above, flanking regions
were necessary. Indusion of these flanking regions increased the percentage of
cells with nuclear staining from 38% to 74%. Interestingly, when the NLS4
including the flanking regions is fused to a larger protein, !}-galactosidase, the
nuclear localization increases from 74% to 93%. This is could be due to
differences in the conformation of EGFP-ER457-475 vs. ~-GAL-ER457-475,
and/or the ability of the ER457-475 region to be recognized by the import
receptors (Makkerh et al., 1996). It could also be due to diffusion of EGFP-
ER457-475 from the nucleus to the cytoplasm.
Analysis of the secondary structure of the EGFP-ER457-475 and ~GAL~
ER457-475 by nnpredict (www.cmpharm.ucsf.edu/nnpredict), showed no
difference in the presentation of the NLS. However, this is a prediction based on
the conformational specification of short peptides, instead of full-length proteins
and therefore may not correspond to the true conformation of the fusion protein.
Another explanation could be that EGFP-ER457-475 is able to diffuse out
of the nucleus, because of its small size, whereas ~-GAL-ER457-475 cannot.
Diffusion is ba~ed on movement of molecules in a solution from a high to a low
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concentration until equilibrium is reached, whereby the movement of molecules is
random and the molecules are spread out so that the concentration is equal in
the solution. In cells, molecules smaller than 4045 kDa will diffuse freely through
the NPC. The proteins will diffuse either way unless they possess nuclear export
signals (NES) or nuclear retention domains (NRD) (Radtke et a/., 2001; Ribbeck
and Gorlich, 2001). No known NRO or NES could be identified in XMI-ER1. While
the protein is translated, there is a steady import of protein into the nucleus. This
results in accumulation of the transiently expressed protein in the nucleus and
generation of a concentration gradient, with a low concentration of the protein in
the cytoplasm and a high concentration in the nucleus. When the molecular
weight of the protein is below the limiting size (of 40-60 kOa), some protein may
"leak" out of the nucleus by simple diffusion, resulting in cytoplasmic staining.
However, active imporl of molecules into the nucleus is rapid, while diffusion is
slow (Gorlich, 1997; Gorlich and Mattaj, 1996; Ribbeck and Gorlich, 2001),
resulting in a high level of protein in the nucleus with very tittle protein in the
cytoplasm.
The EGFp·ER457475 has a predicted size of 32 kDa making it possible
to diffuse through the NPC. Therefore, the lower percentage of cells showing
nuclear staining in the EGFP-ER457475 construct, as compared to the ll-gal-
ER457475 construct, could be explained by diffusion. The ~al·ER457-475,
however, cannot diffuse out of the nucleus because its molecular weight is 120
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kDa and will thus remain in the nucleus after import, while more protein Is still
being Imported, resulting in a higher percentage of exclusive nuclear staining.
Fusion of ER461-471, containing the basic cluster of the NLS4 including 2
flanking amino acid residues, to a cytoplasmic protein resulted in nuclear staining
in about 40% of NIH 3T3 cells. There was no notable difference in nuclear
localization between fusion to EGFP or lliJal. This indicates that for constructs
containing ER461-471 vs. ER457-475, the recognition of the basic cluster of the
NLS (.(63RPIKRaR~69) by import receptors is optimized when 6 flanking amino
acid residues are present, compared to 2 amino acid residues in the region within
ER461-471. However, the minimum flanking sequences important for the
recognition of NLS4 has not been determined. Identification of the exact
sequences is difficult given the importance of both primary sequence and the
secondary structure in contributing to efficiency.
The sequence used for the analysis is as follows:
mpDDTNERPIKRQRMDSPGK475, in which the basic cluster of the NLS4 is
noted in bold. The NLS4 flanking regions both contain a proline ~S7p and 473P),
which act as helix breakers and might be important for the presentation of the
NLS to import receptors (Boulikas, 1994; Boulikas, 1997; Makkerh et al., 1996).
Acidic residues are present at the N·termlnal flanking region, a common feature
of NLS fou'nd in many nuclear proteins, indicating that these hydrophilic residues
facilitate binding to the importins (Boulikas, 1994; Boulikas, 1997; Makkerh at 81.,
1996). Introducing point mutations within the flanking regions of the ER457-475
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peptide and analyzing the efficiency to translocate either ~-gal or EGFP to the
nucleus could help identify the importance of the flanking amino acid residues.
In addition to the NLS in the C-terminus of XMI·ER1. a weak NLS was
identified in the N·terminus of XMI·ER1, NLS1 C38RPRRCKH3). Although NLS1
was not efficient in directing a protein exclusively to the nucleus, 80% of cells
transfected with EGFp·NLS1 displayed definite nuclear greater than cytoplasmic
(N)C) staining, showing that it functioned as a weak NLS. Moreover, when the
ER1-143, including the NLS1 region was fused to EGFP, nuclear greater than
cytoplasmic staining was observed in about 90% of the transfected cells. When
ER1-143 is fused to ~-GAL, 30% of the cells show exclusive nuclear staining (N),
indicating that nuclear accumulation is not a result of diffusion followed by
binding of a nuclear retention domain to nuclear structures. However, this
difference in N>C versus N staining might be the result of diffusiOf1 of EGFp·
ER1·143 out of the nucleus or may be a result of export of ER1·143 from the
nucleus by use of an NES.
Nuclear localization of ER1·143 is not a result of translocation by simple
diffusion, because ~·GAL·ER1-143 translocates to the nucleus. Furthermore,
since EGFP-ER1-143 is not exclusively nuclear, it is unlikely that there is an NRD
present in this region, as this would lead to accumulation of the fusion protein
into the nucleus.
Experiments to determine the strength of NLS1 could include transfection
of a construct containing a nuclear retention signal in addition to the EGFP-ER1-
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143 fusion. If the nuclear greater than cytoplasmic staining in the cells is a result
of diffusion out of the nucleus, than addition of this nuclear retention signal wilt
result in a slow accumulation of the transient protein in the nuclei of transfected
cells, similar to the results with the l3-gal fusion. Also, co-transfection of a (fusion)
protein containing a stronger NLS might result in a reduction in nuclear staining
because the importins will bind to an NLS with a stronger affinity for the receptor
and will translocate this protein before the protein containing a weak NLS
(Ribbeck and Gorlich, 2001).
The observation that there is N>C staining in cells transfected with ER1·
143 cannot be explained by existence of a bi-directional transport signal or a
nuclear export signal (NES) (Fischer et a/., 1995; Schmidt-zachmann et al.,
1993). I was not able to identify a consensus sequence for either a bi-directional
transport signal or a NES in XMI-ER1. Moreover, the low percentage nuclear
staining could only be explained if the NLS1 is the bi-directional transport signal,
because EGFp·NLS1 and EGFP-ER1·143 show the same percentage of nuclear
,. cytoplasmic (80% N>C) staining. Moreover, this signal would have to be
inhibited in the full length XMI·ER1, because transfection of EGFp·ER1-493 into
NlH3T3 celts results in exclusive nuclear staining in 100% of transfected celts,
which would be unlikely if an NES Of bi-directional NLS were present in the
sequence.
When ER1·137, which does not include the NLS1, is fused to either EGFP
or ~-gal, 50% of the cells show nuclear greater than cytoplasmic (N)C) staining,
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and 6% of the ~-ga'-ER1-137 transfected ceUs showed exdusive nudear (N)
staining. While this percentage nuclear staining is lower than nuclear staining
observed for cells transfected with EGFp·ER1-143 (no exclusive nuclear
staining, 90% N>C) or ~-GAL-ER1-143 (30% N), the observed level of nuclear
(N) staining suggests active nuclear targeting of ER1-137 independent of the
NLS1. The N-terminus of XMI-ER1 does not contain any additional regions rich in
basic amino acids; actually, the N·terminus is very rich in acidic residues. An
alternative NLS, consisting mainly of acidic amino acids has been shown to direct
the nuclear translocation of Human Topoisomerase I (Mo et a/., 2000). Although
XMJ-ER1 does not contain a similar motif within the acidic regions in the N-
terminus, the existence of an acidic NLS in this region cannot be excluded.
Mutation analysis of the acidic regions might elucidate the potential of the acidic
regions to direct XMI-ER1 to the nucleus. However, since transfeetion of ER1-
137 into NIH 3T3 cells shows only a low percentage of protein to be translocated
to the nucleus (6%), it seems unlikely that the nuclear localization of XMI-ER1 is
the result of an alternate NLS in the N-terminus.
Active import by piggy backing with another nuclear protein might be
responsible for the partial nuclear localization of ER1-137. We were not able to
recognize any known protein binding sites in the N-terminus, but whether
proteins bind to this region could be investigated by yeast two-hybrid analysis or
analysis of labeled proteins which might co-immunoprecipitate with ER1-137.
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Two additional putative NLS in XMI·ER1 were unable to translocate a
fusion protein to the nucleus in NIH 3T3 cells as well as Xenopus embryos;
NLS2, 279ALRRLRFNVKAAREE293, contains a phenylalanine (F), which is a very
bulky residue known to interfere with the binding to importin-a (Boulikas, 1994:
Boulikas, 1997). Also the basic amino acids are interspersed over 11 residues
resulting in a different pattem from what is normally seen in the NLS of nuclear
proteins, where four basic residues are found in a hexapeptide (Boulikas, 1994;
Boulikas, 1997). The sequence of NLS3 is similar to a bipartite NLS:
320KKSERYDFFAOOTRFGKKK338. Analysis of the functional residues of the
bipartite NLS found in nUdeoplasmin, KRPAATKKAGQAKKKK, has shown that
the arginines and Iysines shown in bold are important for the nuclear
translocation of the protein (Dingwall et al., 1988; Gorlich at a/., 1995a). Analysis
of the amino acids in the spacer between these basic residues showed thai the
spacer can be quite variable in length and in type of residues, but in most
functional NLS the spacer is 1()..12 amino acids and contains no bulky amino acid
residues (Jans and Hubner, 1996; Robbins elal., 1991). However, Robbins et a/.
showed that the spacer length could be doubled and the protein still localized to
the nucleus, although a peptide with a spacer length of 14 amino acids was not
efficient for nuclear localization, probably because of the reduced ability to bind
to importin-o. (Robbins aI81., 1991). The NLS3 region in XMI·ER1 contains a
spacer of 14 amino acids, indicating that the spacer length might be the reason
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that it is not a functional NLS. Also, the presence of three phenylalanines, which
are very bulky, might change the affinity of the NLS for the import receptors.
There are numerous proteins whose nuclear localization is dependent on
the presence of multiple NLSs, which act together to direct the protein to the
nucleus. One example is b-MYB (Takemoto et a/., 1994), whose nuclear
localization is dependent on co-operation of a monopartite and a bipartite NLS in
the protein. In proteins thai possess multiple NLSs, the individual NLS are often
weak NLS, but when used together are efficient for exclusive nuclear staining of
transfected cells. The existence of a weak NLS in the N~terminus of XMI·ER1
might suggest a similar mechanism of action between NLS1 and NLS3 or NLS1
and NLS4. The possibility of NLS4 co-operating with another basic region in the
XMI-ER1 sequence was investigated by deletion and/or mutation of NLS1 and
NLS3. However, deletion of NLS1, NLS3 and NLS1 and 3 resulted in exclusive
nuclear staining of the transfected cells. Transfection of EGFp·ER339-493.
containing only the NLS4, resulted in exclusive nuclear staining, while deletion of
NLS4 from fuH~length XMI-ER1 abolished nuclear transport, indicating that
nuclear translocation of XMI·ER1 is not dependent on co-operation of NLS4 with
the weak NLS1, nor on co-operation of NLS4 with the putative bipartite NLS3.
Moreover, when EGFP·tt.NLS1, EGFp·tt.NLS3 and EGFp·tt.NLS1+3 were
injected into Xenopus embryos, followed by whole mount staining using our anti-
XMI·ER1 antibody, exclusive nuclear staining was observed in all embryos at
stage 10 (data not shown). The putative NLS2 was excluded from these
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experiments because it did not show any ability to target a cytoplasmic protein to
the nucleus as well as because analysis of its sequence indicated that although
there are basic amino acid residues present. it is not likely function as an NLS in
NIH 3T3 cells as well as Xenopus embryos. These results show that the ability of
NLS4 to translocate XMI-ER1 to the nucleus is not dependent on co-operation of
NLS4 with any other sequences in XMI-ER1.
Investigation into the ability of four putative NLS present in XMI-ER1 to
direct the protein to the nucleus showed that only NLS4 is functional. NLS4 was
shown to be necessary and sufficient for the nuclear localization of XMI-ER1 in
NIH 3T3 cells and in Xenopus embryos. An additional, weak NLS, NLS1 is
located in the N-terminus of XMI-ER1. Interestingly, human MI-ER1-p isoforms
(which are orthologues of XMI-ER1) contain both NLS, whereas the human MI-
ER1-a isoforms only contain the NLS1 region 138RPRRCKI43. Transfection into
NIH 3T3 cells has shown that the human Ml-ER1-P isoforms are constitutively
localized to the nucleus, whereas the human MI-ER1-a isoforms are mainly
localized in the cytoplasm (Paterno at al. manuscript SUbmitted). This is
consistent with what was found for XMI-ER1, where deletion of the NLS4 results
in a pattern similar to that found after transfection of human MI-ER1a. This
shows that the r-uclear localization of XMI-ER1 is comparable to hMl-ER1-P,
whereas the subcellular localization of XMI-ER1-ANLS4 is comparable to the
subcellular localization of hMI-ER1-o..
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However, the NLS found in the C-terminus of HuMI·ER1~ is different from
the XMJ·ER1 NLS in that it is a classic monopartite NLS, -468pAKRRRy474. The
basic amino acid residues are flanked by a proline, which acts as a helix breaker
and thus the conformation results in better presentation of the NLS to the import
receptors (Boulikas, 1994; Boulikas, 1997). The observation that the c-MYC-like
NLS found in XMI-ER1 is not conserved between Xenopus and human suggests
that the recognition and/or the regulation of this NLS may be different between
the two proteins. There are no examples in the literature showing different NLS
between orthologues of different species. Since our interest is the identification of
regulation of nuclear import of XMI-ER1 during Xenopus development, further
investigation into the differences in function of the NLS found in hMI·ER1 ~ vs. the
XMI·ER1 NLS4 has not been performed.
To investigate whether the NLS4 is necessary and sufficient for the
nuclear translocation of XMI·ER1 in Xenopus embryos, different regions of XM1-
ER1 were injected into Xenopus embryos. Injection of different EGFP-ER1
cRNAs into Xenopus embryos showed that NLS4 is necessary and sufficient for
nuclear translocation of the fusion protein during stage 13 in Xenopus embryos.
The XMI·ER1 NLS1 seems to be recognized as a weak NLS, since injection of
EGFP·ER1~143 cRNA results in nuclear greater than cytoplasmic staining in
stage 13 embryos. similar to what was observed in NIH 3T3 cells. This suggests
that the import machinery of both mouse and Xenopus cells recognize the XMI·
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ER1 NLS4 and are able to translocate the EGFP-XMI-ER1 fusions containing
this NLS.
I showed that in NIH 3T3 celts as well as in Xenopus embryos NLS4 is
necessary and sufficient for the nuclear translocation of XMI-ER1. Since nuclear
translocation of XMI·ER1 in Xenopus embryos is stage dependent, additional
regulatory sequences important for the regulation of nuclear transport of XMI·
ER1 during early development may be present. The investigation of these
possible regulatory sequences is discussed below.
5.2 Temporal regulation of nuclear import of XMI-ER1 in Xenopus embryos
This section will consider possible mechanisms used for the regulation of
nuclear import of XMI-ER1, and using the results of experiments in this thesis,
attempt to develop a possible model for the regulation of nuclear transport of
XMI-ER1 during Xenopus embryonic development.
I showed that the NLS4, located near the C-terminus in XMI-ER1, is
necessary and sufficient for the nuclear translocation of XMI-ER1 in NIH 3T3
cells as well as Xenopus embryos. However, since XMI·ER1 is localized in the
cytoplasm of developing embryos until the mid-blastula stages, the function of
NLS4 must be regulated. Therefore, I investigated the possible mechanisms by
which XMI·ER1 nuclear import is regulated.
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, have shown, that addition of [3-GAL Of EGFP to XMI-ER1 does not
interfere' 'with the temporal pattem of nuclear import in Xenopus embryos.
Injection of [3-GAL-ER1 or EGFP-ER1 into embryos showed that the fusion
proteins start showing nuclear staining in the injection patch, beginning at stage 8
and that at stage 8.5 67% of the embryos show nuclear staining. During stage 9
97% of embryos show nuclear staining and at stage 10 100% of nuclei in the
injection patch display nuclear staining (figure 4.1).
There are different mechanisms by which the cytoplasmic localization of
XMI-ER1 could be regulated during early Xenopus development (also see figure
1.3.3.):
1) It was possible that NLS4, which is shown to be necessary and sufficient for
the nuclear import of XMI-ER1 in NIH 3T3 cells as well as in Xenopus embryos,
was not recognized and transported until the beginning of stage 8. This could be
explained if factors necessary for import of XMI-ER1 are not present or active
until the beginning of stage 8.
2) Cytoplasmic localization of XMI-ER1 could be due to binding of the protein to a
cytoplasmic anchor, like RNA Of a protein.
3) Cytoplasmic localization of XMI-ER1 could also be due to masking of the NLS,
preventing NLS binding to the import receptors. This may be a result of inter-
molecular masking by binding to another molecule or by dimer formation, or intra-
molecular masking of the NLS by an XMI-ER1 precursor.
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4) Regulation of nuclear import could be influenced by phosphorylation of XMI-
ER1 or phosphorylation ofaXMI-ER1 interacting protein.
5) Cytoplasmic localization of XMI-ER1 during Xenopus embryonic development
could be a result of one or a combination of the mechanisms described above.
1) Cytoplasmic localization of XMI·ER1 during Xenopus embryonic
development is not caused by lack of recognition of the NLS by Import
receptors.
Investigation of the literature has shown that many of the proteins
translocated early during cleavage stages in Xenopus laevis contain a bipartite
NLS (Dingwall at af., 1982; Laskey et aI., 1993; Robbins et al., 1991). Also,
proteins lranslocating during a specific stage in development that contain a
functional bipartite NLS all seem to be actively retained in the cytoplasm.
Examples of this are Xnf7and Pwa33, which contain cytoplasmic retention
domains (CRD), and do not translocate until MBT (El Hodiri at al., 1997)) (Bellini
at al., 1993). CBTF, which also contains a bipartite NLS is retained in the
cytoplasm until MBT-by binding to maternal RNA, which is degraded at the start
of zygotic transcription (BrzostowskJ at af., 2000). XMI-ER1 does not contain a
functional bipartite NLS, but the functional NLS is a rare type similar to the NLS
found in human c-MVC. There are no reports describing the function of an NLS
similar to the XM1-ER1 NLS in Xenopus. Therefore, it was difficult to predict
whether this type of NLS will be recognized by the import receptors and
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transported into the nucleus directly after fertilization or whether the import
receptors for this type of NLS were not activel present until stage 8.
If the NLS would not be recognized and bound by the import receptors
until stage 8, then the cytoplasmic localization of XMI·ER1 until this stage is a
result of lack of recognition of the NLS. However, if the NLS is bound and
transported prematurely,· there must be alternate mechanisms by which XMI·ER1
was retained in the cytoplasm.
I showed that lJ·GAL-ER457-475 was localized in the nuclei of stage 7-7.5
embryos, indicating that the NLS was functional during these stages and that
cytoplasmic localization of XMI·ER1 until stage 8 is not dependent on the inability
of NLS4 to be recognized and transported. Clearly. cytoplasmic retention of XMI-
ER1 before stage 8 is dependent-on other mechanisms of regulation of nuclear
transport. Moreover, this experiment shows that nuclear import of XMI-ER1 in
Xenopus embryos is independent of the transcription, translation or activation of
new molecules. After all, if nuclear transport of XMI·ER1 were dependent on
transcription or translation or activation of a molecule, premature nuclear import
of ER457-475 would be unlikely. This is supported by the observation that when
RNA transcription by RNA polymerases I and II is inhibited by a.-amanitin, no
difference in the temporal pattern of nuclear translocation was observed,
indicating that nuclear import of XMI·ER1 ,is not dependent on protein(s)
translated from zygotic messages that are newly transcribed at MBT (Luchman et
al., 2002).
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2) Cytoplasmic localization of XMI·ER1 could be due to binding of the
protein to a cytoplasmic anchor, like RNA or a protein.
And/or
3) Cytoplasmic localization could also be due to masking of the NLS. which
thereby inhibits the binding of the NLS by Import receptors. This may be a
result of inter-molecular masking by binding to another molecule or by
dlmer formation, or intra-molecular masking of the NLS by a XMI·ER1
precursor.
Although cytoplasmic retention by binding to an anchor and NL5-masking
are two separate mechanisms, use of these mechanisms can be differentiated by
perfonning one experiment. The addition of another functional NLS to a protein
that is localized in the cytoplasm due to NLS masking has been shown to
promote its nuclear import. as shown for NF·KB/I-KB (Li at a/., 1994a). However.
cytoplasmic sequestration by binding of the protein to a cytoplasmic anchor is
dominant over the function of the additional NLS. as shown for XNF7 (Li at 81.•
1994a). Therefore, to investigate whether XMI·ER1 is localized in the cytoplasm
as a result of binding to a cytoplasmic anchoring protein or as a result of NL5-
masking. the XNF7 NLS was fusecl to the N·tenninus of XMI-ER1.
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Addition of the bipartite NLS of XNF7 to full length XMI·ER1 had no effect
on the timing of nuclear translocation. This indicates that XMI-ER1 is retained in
the cytoplasm as a result of binding to a cytoplasmic "anchor". Interaction of
proteins with cytoplasmic anchoring molecules occurs via a cytoplasmic retention
domain, CRD. However, although this experiment indicated that XMI·ER1 is
retained in the cytoplasm by binding to a cytoplasmic anchoring molecule, it does
not indicate whether binding to this anchoring molecule is dependent on the NLS
region or another region within XMI·ER1. Therefore, we cannot exclude that
masking of the XMI-ER1 NLS occurs as an additional mechanism.
To identify the location of the CRD in XMI·ER1, the protein was divided
into two regions: ER1-282 and ER267493. Addition of the XNF7NLS to ER1-282
resulted in cytoplasmic retention, while addition of the XNF7NLS to ER267-493
did not. This indicates that the CRD is located in the N·terminal half of XMI-ER1.
In an attempt to narrow down the region responsible for the cytoplasmic retention
of XMI-ER1 in Xenopus embryos, the N·terminal half of XMI-ER1 was further
subdivided: ER1·143, ER145-250 and ER251-340. Addition of the XNF7NLS to
these regions resulted in premature nuclear localization of all the p·GAL-
XNF7NL5-ER1 fusion proteins. This indicates that the binding of the CRD in
XMI·ER1 to the cyt~plasmic anchor is inhibited. This could be a result of
cleavage of the CRD or change in conformation of the protein so that the CRD ;s
no longer able to bind to the cytoplasmic anchor. It is also possible that binding of
XMI·ER1 to the cytoplasmic anchor requires two regions within XMI·ER1 that
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work in concert to fonn a binding site. Division of the XMI·ER1 into smaller
regions might separate these two regions.
Investigation of the CRD could be performed using three different
strategies. One strategy is based on identification of conserved regions; a
second strategy is based on identification of motifs in the XMI-ER1 N-tenninus.
The third strategy for identifying the smallest region responsible for cytoplasmic
retention on XMI-ER1 is based on progressive deletion of residues from the N-
tenninus and! or the C-tenninus.
To identify the function of col)served regions, hMI-ER1 ~ may be injected
into embryos to give an indication whether the CRD is conserved between
human and Xenopus. If the temporal pattern of nuclear translocation of hMI-
ER1 ~ is similar to the temporal pattern of XMI-ER1. the CRD is present in both
proteins. Comparison of conserved amino acid sequences might give an
indication of the localization of the CRD. On the other hand, if the temporal
regulation of HuMI-ER1~ is different from XMI-ER1, non-eonserved amino acid
residues may be responsible for cytoplasmic retention of XMI-ER1 during
embryonic development.
The second strategy is based on identification of motifs in the XMI-ER1 N-
tenninus, which might be responsible for cytoplasmic retention. When the
XNF7NLS is added to ER1-282, the fusion protein localized to the nucleus
beginning at stage 8, indicating that the CRD is located between residues 1 and
282. The motifs present in ER1·282 include the acidic regions, the NlS1 and~
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ELM2 domain. The acidic domains are intact in ER 1-143 and ER145-250,
although the first, second and third acidic domains are located within ER1-143
and the fourth is located in ER145-250. If the acidic domains are wOrXing
together in forming a binding site for a cytoplasmic anchoring protein, dividing
ER1-282 into smaller regions may disrupt this function. The NLS1 is intact in
ER1-143. suggesting that the CRD does not span the NLS1. However, in dividing
XM1-ER1 region into regions containing residues 145-250 and 251-340, the
ELM2 domain is split. The fact that these smaller regions are not retained in the
cytoplasm suggests that amino acid residues within the ELM2 domain may be
responsible for binding to a cytoplasmic anchor, with release and subsequent
nuclear translocation at MBT. Interestingly, the ELM2 domain is responsible for
binding HDAC1 (Ding et aI, unpublished data). Whether the ELM2 domain could
be responsible for the cytoplasmic localization of XMI-ER1 before MBT requires
further investigation. Investigation of the role of the ELM2 domain or sequences
within this domain could be performed by deletion of the ELM2 region from the
full length XMI-ER1. Injection into Xenopus embryos and examination. of the
temporaf pattern will show whether this region is responsible for the cytoplasmic
retention. Addition of the XNF7NLS to the XM1-ER16ELM2 might be necessary,
since existence of NLS masking or additional regulation of the NLS of XMI-ER1
has not yet been excluded. If the fusion proteins localize prematurely, the ELM2
domain or sequences within this region are responsible for the retention in the
cytoplasm.
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A third strategy for identifying the smallest region responsible for
cytoplasmic retention on XMI-ER1 is based on progressive deletion of residues
from the N-terminus and! or the C·terminus. Deletion of 5 residues at a time, for
example, from the N-terminus andl or the C-terminus followed by injection into
Xenopus embryos might give an indication as to which amino acid residues are
important for the cytoplasmic retention. This might also show whether the
cytoplasmic retention is a result of binding of two or more regions within XMI·ER1
to the cytoplasmic anchor.
I have not yet identified the smallest region responsible for' cytoplasmic
retention of XMI-ER1 and can therefore not discuss how different the CRO in
XMI-ER1 is from CROs found in other proteins. However. the cytoplasmic
retention domain found in XNF7 is a motif of 22 amino acid residues, conserved
between XNF7 and the newt orthologue, Pwa33 (U at al., 1994a). A cytoplasmic
retention domain is also described for XMyoD, and consists of two regions, one
in the N-terminus which co-operates with a region in the G-terminus of the protein
(Rupp at al., 1994). Closer analysis of the CRD of XMI-ER1 will be necessary to
be able to compare the XMI·ER1 CRD to CRDs found in other proteins.
However, there are no regions o(similarity between XMI-ER1 and XNF7 or
XMyoD that would suggest the presence of a conserved CRD sequence.
I did not investigate the nature of the cytoplasmic anchOr of XMI-ER1. To
date not man¥ cytoplasmic anchoring molecules have been identified. It is as yet
unknown which molecule(s) XNF7 binds in the cytoplasm, but it is described that
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the cytoplasmic anchor of XNF7 most likely is a protein (Li at 8/., 1994a).
Release of XNF7 form its cytoplasmic anchor is shown to be a result of
dephosphorylation of XNF7 at MBT (Li at al., 1994b: Li at al., 1994a). However,
the cytoplasmic anchoring molecules for the transcription factor CBTF are
maternal RNA transcripts as injection of RNase into developing embryos results
in premature localization of CBTF. Therefore, nuclear translocation of CBTF
dUring MBT is believed to be a result of degradation of maternal RNA transcripts
(Brzostowski et al., 2000). The cytoplasmic anchor for the Drosophila
transcription factor annadil10 is cytoplasmic axin (Tolwinski and Wieschaus,
2001). Identification of the nature of the cytoplasmic anchoring molecule(s) 'for
XMI-ER1 may be combined with investigation of the mode of release of XMI·ER1
from this molecule. For example, release of XMI·ER1 from the cytoplasmic
anchoring protein could be a result of direct phosphorylation of XMI·ER1, causing
a change in conformation and subsequent release from the anchor, as seen for
XNF7 (Li at al., 1994b; Li at al., 1994a). Release from the cytoplasmic anchor
could also be a result of phosphorylation of the cytoplasmic anchoring prolein, as
seen for NF·KB. which is released after phosphorylation of 'K8 (Kidd, 1992; Zabel
et a/., 1993).
Investigation of the release of XMI·ER1 from its cytoplasmic anchor could
include injection of RNAse, to test whether cytoplasmic retention is a result of
binding of XMI-ER1 to matemal RNA transcripts, as in the case of CBTF.
Another approach could involve in vivo labelin9 of proteins with radioactive (32p)
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inorganic phosphates. This would show wtIether there is a difference in the
phosphorylation state of XMI-ER1 before and after nuclear import. Moreover, in
vffro labeling of proteins may show wtIether XMI·ER1 is associated with
phosphoproteins before andl or after nuclear import (vide infra).
Cytoplasmic localization of XMI-ER1 during embryonic development is not
likely due to NlS masking by an XMI-ER1 precursor followed by cleavage and
subsequent nuclear translocation. This was shown by luchman et al. who did not
find an additional XMI·ER1 protein and showed that there is no difference in size
of XMI·ER1 protein isolated from Xenopus embryos before and after nuclear
import, as shown by separation of proteins by denatUring gel-electrophoresis
(luchman et al., 2002).
There is evidence that the cytoplasmic localization of XMI·ER1 during
Xenopus development is not likely to be a result of NlS-masking. NlS masking
can be identified by immunohistochemistry using an antibody specifically against
the NlS region. If the antibody is able to bind to the NlS. thus showing staining,
it indicates there is no NLS·masking. If however, no staining is observed. the
NlS could be masked. This was shown to be the case for the NF-KB p50
precursor p105: the C-terminal of p105 appears to retain the p50 subunit in the
cytoplasm by intramolecular masking of its NlS. Antibodies specific to the NlS
recognize p50, but not p105. implying that the, NlS is inaccessible in the larger
precursor (Henkel at a/.• 1992). The mechanism of unmasking appears to be
through proteolysis of the p105 C-terminal (Blank at al., 1991; Jans and Hubner.
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1996). Luchman et al. used an anti-XMI-ER1 antibody to show that endogenous
XMI-ER1 was localized in the cytoplasm of Xenopus embryos until stage 8, and
that al the beginning of stage 8 XMI-ER1 translocated to the nucleus (Luchman
et a/.• 1999). The anti-XMI-ER1 antibody was raised against amino acid residues
464-478, which spans the NLS sequence. Considering the size of the antibody, it
would be unlikely that an antibody would be able to bind to the NL$4 region if this
was masked by intta- or intermolecular binding. Therefore, it seems unlikely that
regulation of cytoplasmic retention of XMI·ER1 is due to masking of its NLS.
Moreover, cytoplasmic localization of XMI-ER1 is not likely to be a result
of activation of maternal proteins at stage 8.5 or translation of matemal
transcripts at stage 8. This is shown by injection of ER457-475, which was
capable of premature nuclear entry. This would be unlikely if new factors are
necessary for the nuclear import of XMI-ER1.
Another possibility for regulation of cytoplasmic localization of XMI-ER1 is
regulation by phosphorylation. I showed that phosphorylation of a putative cdc21
PKA site in the vicinity of the NLS has no effect on nuclear translocation.
However, although XMI-ER1 possesses multiple putative phosphorylation sites
that could influence the regulation of nuclear transport, in vivo labeling of proteins
in NIH 3T3 cells, using 32p, showed that XMI-ER1 is not phosphorylated in these
cells (Paterno at al., unpublished results). However, since nuclear import is
regulated in Xenopus embryos, in vivo labeling of XMI-ER1 with inorganic
phosphate at different stages during development might prove a useful tool for
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investigation of the phosphorylation state of the protein in Xenopus embryos,
before and after nuclear import of XMI-ER1. If the protein is phosphorylated,
mutations of other putative phosphorylation sites might prove useful for
identifying the role of these sites in nuclear transport of XMI-ER1 during
embryonic development.
4) Regulation of nuclear import could be a result of phosphorylation of XMI·
ER1 or phosphorylation of an XMI-ER1 Interacting protein.
Two major mechanisms of regulation of nucleocytoplasmic transport have
been dewibed: one is based on masking and unmasking the transport signal;
the other is based on anchoring and release. Furthermore, both these
mechanisms can be regulated by phosphorylation (reviewed in(Jans, 1995; Jans
and Hubner, 1996; Vandromme at 81., 1996).
XM1-ER1 contains multiple putative phosphorylation sites, including
several CKII sites and a cdc2 kinase site in the vicinity of the NLS, which forms a
putative CcN motif. The putative cdc21 PKA phosphorylation site, located C-
terminal of the NLS in XMI·ER1, has a high probability of phosphorylation as
predicted by Netphos (0.997, appendix A-2). Investigation of the putative
cdc21PKA showed that neither substitution of the serine with alanine to simulate
a dephosphorylated site nor substitution of the serine for an aspartic acid to
simulate a phosphorylated site had any effect on the nuclear' translocation of
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ER1-493 and ER339-493 in NIH 3T3 cells or Xenopus embryos. This indicates
that phosphorylation on this site is not important for regulation of cytoplasmic
retention of XMI-ER1 In Xenopus embryos.
XMI-ER1 contains many more potential phosphorylation sites. In vitro
labeling of XMI-ER1 with inorganic phosphate at different. ~~ges during
development might prove a useful tool for investigation of the phosphorylation
state of the protein, before and after nuclear import. If the protein is
phosphorylated, mutations of other putative phosphorylation sites might prove
useful for identifying the role of these sites in nuclear transport of XMI-ER1
during embryonic development. However, Luchman at al. have examined the
possibility of phosphorylation of XMI-ER1 by using phosphotyrosine,
phosphoserine and phosphothreonine specific antibodies. Embryo extracts were
immunoprecipitated with anti-XMI-ER1 at stages when XMI-ER1 is cytoplasmic
(stage 7) or predominantly nuclear (stage 9). Westem blots were stained with
phosphotyrosine, phosphothreonine, phosphoserine or XMI-ER1 specific
antibodies (Luchman at al., 2002). It was shown that XMI-ER1 itself is not
phosphorylated and that there was no difference in the phosphorylation pattern of
co-migrating phosphoproteins at stage 7 vs.· stage 9 when anti-phosphotyrosine
or anti-phosphothreonine was used (Luchman et al., 2002). However, analysis of
phosphorylation using anti-phosphoserine revealed the presence of four major
phosphorylated bands that are associated with XMI-ER1, indicating that XMI-
ER1 itself is not phosphorylated on serine residues, but is associated with
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several phosphoprotelns. PhosphOrylation of one of these proteins, a protein with
a predicted size of 226 kOa, is very prominent at stage 7 but decreases at stage
9 when XMI·ER1 is nuclear (Luchman et sl., 2002). The identity of these
phosphoserylproteins is unknown, therefore it could not be determined whether
the decrease in band intensity was a result of changes in the amount of
associated protein or due to the level of phosphorylation (Luchman et al., 2002).
Injection of a dominant negative FGF receptor (Amaya et af., 1991) resulted in a
similar phosphorylation pattern of the 226 kDa protein at stage 9 vs. stage 7, as
well as a delay in nuclear translocation of XMI-ER1 (Luchman at al., 2002). This
indicates that activation of the FGF signaling pathway is important for the nuclear
translocation of MI·ER during Xenopus embryonic development (Luchman at af.,
2002).
5) Cytoplasmic localization of XMI·ER1 during Xenopus embryonic
development could be a result of one or a combination of the mechanisms
described above.
The possible regulatory mechanisms by which XMI-ER1 can be localized
in the cytoplasm during early Xenopus embryonic development and the
translocation of the protein into the nucleus beginning at stage 8 have been
discussed. RegUlation of nuclear import of transcription factors is often a result
of a combination of multiple mechanisms.
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The results of the present study show, that XMI-ER1 is retained in the cytoplasm
by binding to a cytoplasmic anchor. The minimal CRD necessary for binding to
this anchor has not yet been determined, but is located between residues 1 and
282. 1 also found that ER457-475 translocates prematurely, indicating that this
cytoplasmic localization is not due to inability of the import machinery to
recognize and transport the NLS. I showed that regulation of the NLS is not a
result of phosphorylation of a putative cdc21 PKA site in the vicinity of the NLS.
Conclusion:
The results of the work described In this thesis, indicate that nuclear
translocation of XMI·ER1 is directed by NLS4, which Is located near the C·
terminus of XMI·ER1. Inclusion of flanking regions In addition to the core
NLS greatly enhances the efficiency of nuclear transport. Binding of a CRD
In XMI·ER1 to a cytoplasmic anchor, is responsible for the cytoplasmic
localization of XMI-ER1 In developing Xenopus laevis embryos.
Phosphorylation of a cdc21 PKA site in the vicinity of the NLS has no effect
on the regulation of nuclear translocation of XMI·ER1 during early
development of Xenopus laevis.
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5.3 Model of regulation of nuclear Import of XMI·ER1 during Xenopus
development.
In order to prevent aberrant expression of genes nonnally transcribed at or
soon after the start of transcription, the activity of maternal transcription factors
present in the early embryo must be tightly regulated. Cytoplasmic sequestration
of maternally inherited transcription factors may provide a mechanism by which
the transcriptional machinery is restrained (Veenstra et al., 1999). Understanding
the mechanisms that might be important for the regulation of nuclear transport of
transcription factors during development might provide important infonnation
about the general regulation of these transcription factors and their function in
nonnal embryonic development.
Binding of a CRD within XMI-ER1 to a cytoplasmic anchoring molecule in
combination with phosphorylation of the cytoplasmic anchor, may be responsible
for the cytoplasmic retention of XMI·ER1 in developing Xenopus !aevis embryos.
In addition, Luchman et al. have shown that inhibition of the FGF pathway, by
injection of a dominant negative FGFR1 receptor (XFD) results in cytoplasmic
retention of ER1 after stage 8, indicating that FGFR1 activation is necessary for
the transport (Luchman at al., 2002). Moreover, Luchman et al. showed that a
phosphoserylprotein with a predicted molecular weight of 226 kDa co-
immunoprecipates with XMI·ER1 and that phosphorytation of this
phosphoserylprotein decreases at stage 9, when XMI-ER1 is nuclear. However,
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after injection of XFD, the phosphorylation of the phosphoserylprotein does not
decrease,"but is similar to the phosphorylation al stage 7 (Luchman et a/., 2002).
This, together with the observation that injection of XFD results in a delay in
nuclear import of XMI-ER1, suggests that activation of the FGF signaling
pathway is important for the regulation of nuclear import of XMI-ER1 during
Xenopus embryonic deveiopment (Luchman at 81.,2002).
As described before, activation of the FGF signaling pathway results in a
cascade of proteins being activated until the signal reaches the cell nucleus,
where subsequent activation or inhibition of transcription can occur (Karin, 1994).
Activation of these proteins occurs by phosphorylation or dephosphorylation.
There are many possible combinations of phosphorylation on either XMI·ER1 or
the cytoplasmic anchoring protein or both.
Figure 5.1 shows a model of the possible regulation of nuclear import of XMI-
ER1 during Xenopus embryonic development: The transcription factor XMI-ER1
is an FGF induced immediate early gene. FGF signaling may play a role in
regulation of nuclear transport of transcription factors like XMI-ER1. Therefore,
activation of the FGF signaling pathway during mid blastula stages in Xenopus
laevis could be necessary for the release of XMI-ERl from its cytoplasmic
anchor, followed by translocation to the nucleus.
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Figure S.l Schematic illustrating a possible mechanism of regulation of cytoplasmic
retention of X~U~ERI.
Binding of a CRD in XMI·ERI to a cyt!?plasmic anchor, is responsible for the
cytoplasmic localization of XMI-ERI in developing Xenopus laevis embryos.
Dephosphorylation of this cytoplasmic anchor after activation of the FGF signaling
pathway may be responsible for the release ofXMl-ERI from its anchor and subsequent
nuclear translocation.
r::::::J XMI-ERI
.. NLS
® Pllospnory\lllion
.... ~.m',"_
~ .....
• Cytoplasmic retenlion domain
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5.4 Future work
Investigation into the regulation of cytoplasmic retention of XMI-ER1 in
Xenopus embryos showed that import of XMI-ER1 during Xenopus development
is dependent on the NLS located near the C-terminus of ER1. Also, XMI·ER1 is
retained in the cytoplasm by binding to a cytoplasmic anchor, with release and
subsequent nuclear translocation beginning at stage 8. Dephosphorylation of the
cytoplasmic anchoring protein is proposed to be the mechanism of release of
XMI-ER1.
Future wor1< would indude investigation of the CRD sequence and the
regulation of release of XMI·ER1from the cytoplasmic anchor. The ELM2 domain
is intact in the region ER1·282, which is retained in the cytoplasm, and split in the
smaller regions tested. Therefore, sequences within this region may be important
for the cytoplasmic retention of XMI·ER1. Injection of cRNA encoding ~·GAL­
6ELM2, followed by assessment of the subcellular localization of this protein at
stages 7, 7.5, 8, 8.5 and 9, would identify whether the CRD is located within this
region. If the ~-GAL-6ELM2 translocates prematurely, the CRD is within the
region of the ELM2 domain. Further deletion of this region would help identify the
minimal CRD. Injection of XMI-ER1 constructs, in which the CRD is deleted, into
Xenopus embryos might give us information about the possible function of XMI-
ER1 in embryonic development. Also, injection of 6CRD and XMI-ER1 full-length
into embryos might help us identify possible zygotic genes that are transcribed in
response to XMI-ER1 translocation.
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If the CRD is not localized within the ElM2 domain, progressive deletions
of XMI·ER1, followed by injection into Xenopus embryos may give information on
the location of the CRO. Constructs containing a functional NlS (like the XMI·
ER1 NlS4 or the XNF7NlS) fused to the mutated regions of XMI·ER1 should be
used to ensure that a functional NlS is present in aU of the proteins tested.
The cytoplasmic anchoring protein of XMI·ER1 should be identified.
Isolation of the anchor by co-immunoprecipitation with an anti·XMI·ER1 antibody,
followed by proteomic analysis and protein sequencing, may provide information
about the identity of the anchoring protein. Knowing the identity of the anchoring
protein may provide us with information about the FGF signal transduction
pathway important for the regulation of nuclear translocation of XMI·ER1 during
embryonic development.
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Phosphorylation site prediction for sequence
Sequence identifier:
Number of residues: 493
Full sequence:
MAEPSLRTASPGGSAASDDltEFEPSADMLVHEFODEQTLEEEE:MLEGEVNFT5EIEHLERE5EMPIDELLR
LYGYG5TVP
LPGEEDEEDMDNDCNSGCSGEII<DEAI I<DSSGQEDETQSSNDDPTPSFJ'CRI)VREVIRPRRCKYFDTNHEI
EEESEDDED
YVP5EDWKKEIMVGSMFOAE I PVGICKYRETEKV¥ENDDQLLWNPEYVMEERVIDFLNEASRRTCEERGLO
AIPEGSRIK
DNEQALYEHVKCNFDTEEALRRLRFNVKAAREELSVIn'EEECRNFEOGLKAYGKDFHLlQANKVRTRSVG5
CVAFYYMWK
KSERYDFFAOQ'TRFGKKKYNLHPGVTDYMORLLDESESATSSRAPSPPP'ITSNSNTSQSEKEDCTASNNTQ
NGVSVNGPC
AITAYKDEAKQGVHLNGPTISSSDPSSNETDTNGYNRENVTDDSRFSHT5GK'I'DruPDDTNERPIKRQRMD
SPGKESTG5
SEF5QEVFSHGEV
The prediction is based on the consensus sequence motifs. For the Jist oftbe used motifs
see here.
The consensus sequences for 10 different-protein kinases are scanned for potential
phosphorylation sites.
Potential phosphorylation sites for protein kinase CaMll:
5-10 RTASPGG
5·308 RTRSVGE
5-366 RAP5PPP
5-472 RMD5PGK
Potential phosphorylation sites for protein kinase CKI (N-terminal srr must be
prephosphorylated):
T-8 SLRTASP
5-14 SPGGSAAS
5-99 SGCSGEI
5-120 TQSSNDD
T-129 TP5FTCRD
T-224 5RRTCEE
T-278 5VWTEEE
T-360 5e5ATSSR
5-366 SRAPSPPP
5-374 TI'SNSNTS
5-379 TSQSEKE
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T-390 SNNTQNG
S-423 TISSSDPS
T-HO SSNETDTN
S - 44 4 TDDSRF9
9-450 SHTSGKT
S-481 STGSSEFS
Potential phosphorylation sites for protein kinase CKII:
T-38 DEQTLEE
S-53 NFTSBIE
9-111 KDSSGQB
S - 119 BTQSSND
T-129 PSFTCRD
T-147 YFD'TNHE
S-155 BEESEDD
T-224 SRRTCEE
T·278 SVWTEEE
S-308 RTRSVGE
9-377 SNTSQSE
5·421 PTIS5SD
S-426 SDPSSNE
T~45S KTDTNPD
5-489 EVFSHGE
Potential phosphorylation sites for protein kinase aSIO (C-tenninal +4 S must be
prephosphorylated):
S-10 RTASPGGS
S~358 E5ESAT9S
S-362 ATSSRAPS
T-370 PPP'M'9N9
T·419 NGPTISSS
S-423 ISSSDPSS
9-477 GKE9TGSS
No phosphorylation sites for protein kinase MLCK found.
Potential phosphorylation sites for protein kinase p34cdc2:
Potential phosphorylation sites for protein kinase p70s6k:
9-308 K\1RTR9VGE
S~472 RQRMDSPGK
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Potential phosphorylation sites for protein kinase PKA:
$-10 RTASPGG
5-62 RB5EMP
T-191 RETEICV
T·224 RRTCEE
5-308 R'I'R5VGE
S-366 RAPSPPP
5-"47 RFSlITS
S-472 RMD5POK
Potential phosphorylation sites for protein kinase PKC:
5-5 AEPSLRT
T-129 PSFTCRD
T-191 YRETEICV
5-221 NEASRRT
5·322 WKKSERY
5-361 5AT5SRA
S-379 T5QSEKE
5-450 SlIT5GKT
No phosphorylation sites for protein kinase PKG found.
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NetPhos 2.0 Prediction Results
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Appendix B
CONSTRUCT PRIMER SEQUENCE
EGFP·ER11-493 Er14 ga~aacal99cg9a9cct1cactca9
Er13 ga~aacctctccatgtg
EGFP-ER11-137 Er14
Er26 ct~allacttctcgtacatctc
EGFP·ER11-144 Er14
Em ct~cttgcaccgacglggacggallac
EGFP·ER1 145-250 E". ag~ttttgatacaaatcatgaaatagaagagg
Er.lO ~cttacatgllcatalag9Qcctgc
EGFp·ER1 251·319 Er.l1 ag~aaatgcaattttgacacagaagaggc
E". ga~tagallatacttcttttllcc
EGFp·ER1 251-340 Er.l1
Er32 c~ccacalgtagtagaalgccacacallc
EGFP·ER1 339-.493 Em ga~cgtataalctacatcctggtgtaacgg
Er13
EGFP-ER11-461 Er14
Er34 ~ccgttIgtatcatctggatttgtgtcag
EGFP-ER1 1-473 E"4
Er35 gg!gILceagggctgtccatacgttgcc
EGFp·ER1 339-461 Em
E,34
EGFp·ER1 339-473 Em
Er.l5
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EGFP-NL8-1 Er23K ~cgtaatccgtccacglcgglgcaaga
Er33 gmgcttgcaccgacglggacggattacgca
EGFP-NL8-2 Er36s ~aggcallgagaagaetaagatllaatgtcaaagccgccag
agaagaag
Er36a ~cttetetggcggcttlgacallaaalcttagtcttetcaalgcct
a
EGFp·NLS·3 Er24 ag~etacatgtggaaaaaaicagaacg
Er25
EGFP-NL5-4 (a) Er37s gmgcaaacgaaaggccaataaaaaggcaacglaiggacg
Er37as ~lccatacgllgcctttttallggcclltcgtllga
EGFP·NLS-4 (b) Er3S gagaletatccagalgatacaaacg
Er39 cagatetcttcccagggetgtcc
Egfp.NLS-4 (stop, c) Er38
Ern2 gagatctacttcccagggctgtccatacg
SPGK ., NPGK (erf.!) Er40K ggcaacgtaiggacaaccctgggaaggaaag
Er40R cttlcctlcccagggllgtccatacgllgcc
SPGK ., APGK (erfl) Er41K ggcaacgtaiggacgcccctgggaaggaaag
Er41R cttlcctlcccaggggcgtccatacgttgcc
SPGK ., DGPK (erfl) Er53K ggcaacgtaiggacgaccclgggaaggaaagtac
Er53R gtactttcettcccagggtcgtccatacgttgcc
SPGK .. APGK ER45K ggcaacgtaiggacgcecctgggaagagaic
(NL54B)
ER45R galctcttcccaggggcgtccatacgttgcc
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SPGK ~ DPGK (nls4b) Er46K ggcaacgtatggacgaccctgggaagagatctcg
Er46R cgagatctcllcccagggtcgtccatacgllgcc
EGFP·ER446-493 Er50
Er13
caagatctgatttagtcatacaagtgg
l!.PIKR
l!.NlS1
l!.NlS3
l!.KKK (bipartite)
KK~AA (bipartite)
For cloning into pT7Ts
ErS1K ccagatgatacaaacgaaaggcaacgtatggacagccctggg
Er51 R cccagggctgtccatacgllgccttlcgtllgtatcalclgg
Xen1s gtacgagaagtaatctgcaagtattllgatac
Xen1as gtatcaaaatactlgcagatlactlctcgtac
Xnrs2s ctacatgtggtataaletacatcctggtg
Xnls2as ggalgtagallataccacatgtagtagaatgccac
ERN2- gcccaacaaacacgatllggatataatctacatcclgg
k3s
ERN2- ccaggatgtagatlatatccaaatcgtgmgllgggc
k3,
Er21K ggcatietactacatgtgggcagcatcagaacgttatgactlc
Er21R gaagtcataacgttctgalgctgcccacaigtagtagaatgcc
Gfp-, getm9s!cgcIagcgclaccggtc
Gfp-as g~gctgattatgatcag
For cloning into n~al. PEGFP· g~ccggactcagatc
CS2+ and ~ar.cS2+ 5'
For colony screening PCZ.s' cactctcggcalggacgagc
and sequencing of PC2..J' cccgcggtaccgtcgactgc
EGFP-C2 plasmlds
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:nf7 lpartite NLS XnI7. Icgagactccccagaagagaaagatigaggaacctgagcctgaa
ccgaagaaagcaaagc
Xnf7as tcgagctttgctttctlcggttcaggctcaggttcetcaatetttetcttctg
gggagtc
~al-xnf7NLS·ER1·282 E<54 gcctetagacatggcggagccttcactcagg
EmS cggtetagactacattcttcttcagtcc
jl.ga1-xnf7NLS-ER267- E156 gcctetagacgtcaaagccgccagagaag
493 Ern7 cggtctagattaaacetctccalgtgaaaac
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